<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>d31682_10k.htm
<DESCRIPTION>10-K
<TEXT>
<HTML>
   <HEAD>
      <TITLE>HTML</TITLE>
   </HEAD>
   <BODY style="font-size: 10pt; ">
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: center; ">
               <P></P><BR><P></P><BR><P style="padding-left: 0pt; padding-top: 6px; line-height: 1.3; text-align: center; "><B style="text-align: center; font-size: 14.0pt; ">UNITED STATES</B></P>
               <P style="padding-left: 0pt; padding-top: 6px; line-height: 1.3; text-align: center; "><B style="text-align: center; font-size: 14.0pt; ">SECURITIES AND EXCHANGE COMMISSION</B></P>
               <P style="padding-left: 0pt; padding-top: 6px; line-height: 1.3; text-align: center; "><B style="text-align: center; font-size: 12.0pt; ">Washington, D.C.&nbsp;20549</B></P>
               <P style="padding-left: 0pt; padding-top: 6px; line-height: 1.3; text-align: center; "><B style="text-align: center; font-size: 18.0pt; ">Form 10-K</B></P>
               <P style="padding-left: 0pt; padding-top: 6px; line-height: 1.3; text-align: left; "><U style="text-align: left; font-size: 10.0pt; ">(Mark One)</U></P>
               <P style="text-align: left; margin: 0pt; padding: 0pt; ">
                  <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                     <TR>
                        <TD style="font-size: 1pt;">&nbsp;</TD>
                        <TD style="width: 11.84%; font-size: 1pt;">&nbsp;</TD>
                        <TD style="font-size: 1pt;">&nbsp;</TD>
                        <TD style="font-size: 1pt;">&nbsp;</TD>
                        <TD style="width: 88.16%; font-size: 1pt;">&nbsp;</TD>
                        <TD style="font-size: 1pt;">&nbsp;</TD>
                     </TR>
                     <DIV style="padding-top: 3px; text-align: center; ">
                        <TR style="text-align: left; ">
                           <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                           <TD colspan="1" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;<FONT style="font-family: Wingdings">&#254;</FONT></TD>
                           <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                           <TD style="vertical-align: top; padding-left: 0pt; width: 15px; ">&nbsp;</TD>
                           <TD colspan="1" style="vertical-align: top; padding-left: 0pt; ">
                              <P style=" line-height: 1.3; margin-top: 0pt; text-align: left; "><B>ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)<BR>OF THE SECURITIES EXCHANGE ACT OF 1934</B><BR></P>
                              <P style=" line-height: 1.3; margin-top: 0pt; text-align: left; "><B>For the fiscal year ended September 30, 2014</B><BR></P>
                           </TD>
                           <TD style="vertical-align: top; padding-left: 0pt; ">&nbsp;</TD>
                        </TR>
                     </DIV>
                  </TABLE>
               </P>
               <P style="padding-left: 0pt; padding-top: 6px; line-height: 1.3; text-align: center; "><B style="text-align: center; font-size: 12.0pt; ">or</B></P>
               <P style="text-align: left; margin: 0pt; padding: 0pt; ">
                  <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                     <TR>
                        <TD style="font-size: 1pt;">&nbsp;</TD>
                        <TD style="width: 11.84%; font-size: 1pt;">&nbsp;</TD>
                        <TD style="font-size: 1pt;">&nbsp;</TD>
                        <TD style="font-size: 1pt;">&nbsp;</TD>
                        <TD style="width: 88.16%; font-size: 1pt;">&nbsp;</TD>
                        <TD style="font-size: 1pt;">&nbsp;</TD>
                     </TR>
                     <DIV style="padding-top: 3px; text-align: center; ">
                        <TR style="text-align: left; ">
                           <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                           <TD colspan="1" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; "><FONT style="font-family: Wingdings">o</FONT></TD>
                           <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                           <TD style="vertical-align: top; padding-left: 0pt; width: 15px; ">&nbsp;</TD>
                           <TD colspan="1" style="vertical-align: top; padding-left: 0pt; ">
                              <P style=" line-height: 1.3; margin-top: 0pt; text-align: left; "><B>TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)<BR>OF THE SECURITIES EXCHANGE ACT OF 1934</B><BR></P>
                              <P style=" line-height: 1.3; margin-top: 0pt; text-align: left; "><B>For the transition period from &nbsp;&nbsp;&nbsp; to &nbsp;&nbsp;&nbsp;.</B><BR></P>
                           </TD>
                           <TD style="vertical-align: top; padding-left: 0pt; ">&nbsp;</TD>
                        </TR>
                     </DIV>
                  </TABLE>
               </P>
               <P style="padding-left: 0pt; padding-top: 6px; line-height: 1.3; text-align: center; "><B style="text-align: center; font-size: 10.0pt; ">Commission File Number 001-33451</B></P>
               <P style="padding-left: 0pt; padding-top: 6px; line-height: 1.3; text-align: center; "><B style="text-align: center; font-size: 24.0pt; ">BIODEL INC.</B></P>
               <P style="padding-left: 0pt; padding-top: 6px; line-height: 1.3; text-align: center; "><I style="text-align: center; font-size: 8.0pt; ">(Exact Name of Registrant as Specified in Its&nbsp;Charter)</I></P>
               <P style="text-align: center; margin: 0pt; padding: 0pt; ">
                  <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                     <TR>
                        <TD style="font-size: 1pt;">&nbsp;</TD>
                        <TD style="width: 50.00%; font-size: 1pt;">&nbsp;</TD>
                        <TD style="font-size: 1pt;">&nbsp;</TD>
                        <TD style="font-size: 1pt;">&nbsp;</TD>
                        <TD style="width: 50.00%; font-size: 1pt;">&nbsp;</TD>
                        <TD style="font-size: 1pt;">&nbsp;</TD>
                     </TR>
                     <DIV style="padding-top: 3px; text-align: center; ">
                        <TR style="text-align: left; ">
                           <TD style="vertical-align: top; ">&nbsp;</TD>
                           <TD colspan="1" style="vertical-align: top; padding-left: 0pt; ">
                              <P style=" line-height: 1.3; margin-top: 0pt; text-align: center; "><B>Delaware</B><BR></P>
                              <P style=" line-height: 1.3; margin-top: 0pt; text-align: center; "><I style="text-align: center; font-size: 8.0pt; ">(State or Other Jurisdiction of<BR>Incorporation or Organization)</I><BR></P>
                           </TD>
                           <TD style="vertical-align: top; padding-left: 0pt; width: 15px; ">&nbsp;</TD>
                           <TD style="vertical-align: top; padding-left: 0pt; width: 15px; ">&nbsp;</TD>
                           <TD colspan="1" style="vertical-align: top; padding-left: 0pt; ">
                              <P style=" line-height: 1.3; margin-top: 0pt; text-align: center; "><B>90-0136863</B><BR></P>
                              <P style=" line-height: 1.3; margin-top: 0pt; text-align: center; "><I style="font-size: 8.0pt; ">(I.R.S. Employer</I><BR><I style="font-size: 8.0pt; ">Identification No.)</I><BR></P>
                           </TD>
                           <TD style="vertical-align: top; padding-left: 0pt; ">&nbsp;</TD>
                        </TR>
                        <TR style="text-align: left; ">
                           <TD style="vertical-align: top; ">&nbsp;</TD>
                           <TD colspan="1" style="vertical-align: top; padding-left: 0pt; ">
                              <P style=" line-height: 1.3; margin-top: 0pt; text-align: center; "><B>100 Saw Mill Road<BR>Danbury, CT</B><BR></P>
                              <P style=" line-height: 1.3; margin-top: 0pt; text-align: center; "><I style="text-align: center; font-size: 8.0pt; ">(Address of Principal Executive Offices)</I><BR></P>
                           </TD>
                           <TD style="vertical-align: top; padding-left: 0pt; width: 15px; ">&nbsp;</TD>
                           <TD style="vertical-align: top; padding-left: 0pt; width: 15px; ">&nbsp;</TD>
                           <TD colspan="1" style="vertical-align: top; padding-left: 0pt; ">
                              <P style=" line-height: 1.3; margin-top: 0pt; text-align: center; "><B>06810</B><BR></P>
                              <P style=" line-height: 1.3; margin-top: 0pt; text-align: center; "><I style="text-align: center; font-size: 8.0pt; ">(Zip Code)</I><BR></P>
                           </TD>
                           <TD style="vertical-align: top; padding-left: 0pt; ">&nbsp;</TD>
                        </TR>
                     </DIV>
                  </TABLE>
               </P>
               <P style="padding-left: 0pt; padding-top: 6px; line-height: 1.3; text-align: center; "><B style="text-align: center; font-size: 10.0pt; ">Registrant's telephone number, including area&nbsp;code<BR><U><B>(203) 796-5000</B></U></B></P>
               <P style="padding-left: 0pt; padding-top: 6px; line-height: 1.3; text-align: center; "><B style="text-align: center; font-size: 10.0pt; ">Securities registered pursuant to Section 12(b) of the&nbsp;Act:</B></P>
               <P style="text-align: center; margin: 0pt; padding: 0pt; ">
                  <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                     <TR>
                        <TD style="font-size: 1pt;">&nbsp;</TD>
                        <TD style="width: 50.00%; font-size: 1pt;">&nbsp;</TD>
                        <TD style="font-size: 1pt;">&nbsp;</TD>
                        <TD style="font-size: 1pt;">&nbsp;</TD>
                        <TD style="width: 50.00%; font-size: 1pt;">&nbsp;</TD>
                        <TD style="font-size: 1pt;">&nbsp;</TD>
                     </TR>
                     <DIV style="padding-top: 3px; text-align: center; ">
                        <TR style="text-align: left; ">
                           <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                           <TD colspan="1" style="vertical-align: middle; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center; "><U><B style="text-align: center; font-size: 8.0pt; ">Title of Each Class</B></U></TD>
                           <TD style="vertical-align: middle; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                           <TD style="vertical-align: middle; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                           <TD colspan="1" style="vertical-align: middle; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center; "><U><B style="text-align: center; font-size: 8.0pt; ">Name of Each Exchange on Which Registered</B></U></TD>
                           <TD style="vertical-align: middle; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                        </TR>
                        <TR style="text-align: left; ">
                           <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                           <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">Common Stock, par value $0.01 per share</TD>
                           <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                           <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                           <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">The NASDAQ Capital Market</TD>
                           <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                        </TR>
                     </DIV>
                  </TABLE>
               </P>
               <P style="padding-left: 0pt; padding-top: 6px; line-height: 1.3; text-align: center; "><B style="text-align: center; font-size: 10.0pt; ">Securities registered pursuant to Section 12(g) of the Act:<BR>None</B></P>
               <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 03.00pt; text-align: left; ">Indicate by check mark if the registrant is a well-known seasoned
                  issuer, as defined in Rule 405 of the Securities Act. Yes&nbsp;<FONT style="font-family: Wingdings">o</FONT>&nbsp;&nbsp;&nbsp;No&nbsp;<FONT style="font-family: Wingdings">&#254;</FONT></P>
               <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 03.00pt; text-align: left; ">Indicate by check mark if the registrant is not required to file
                  reports pursuant to Section 13 or Section 15(d) of the Act. Yes&nbsp;<FONT style="font-family: Wingdings">o</FONT>&nbsp;&nbsp;&nbsp;No&nbsp;<FONT style="font-family: Wingdings">&#254;</FONT></P>
               <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 03.00pt; text-align: left; ">Indicate by check mark whether the registrant (1) has filed all
                  reports required to be filed by Section 13 or 15(d) of the Securities
                  Exchange Act of 1934 during the preceding 12 months (or for such
                  shorter period that the registrant was required to file such
                  reports), and (2) has been subject to such filing requirements for
                  the past 90 days Yes&nbsp;<FONT style="font-family: Wingdings">&#254;</FONT>&nbsp;&nbsp;&nbsp;No&nbsp; <FONT style="font-family: Wingdings">o</FONT></P>
               <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 03.00pt; text-align: left; ">Indicate by check mark whether the registrant has submitted
                  electronically and posted on its corporate Web site, if any, every
                  Interactive Data File required to be submitted and posted pursuant to
                  Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the
                  preceding 12 months (or for such shorter period that the registrant
                  was required to submit and post such files). Yes&nbsp;<FONT style="font-family: Wingdings">&#254;</FONT>&nbsp;&nbsp;&nbsp;No&nbsp; <FONT style="font-family: Wingdings">o</FONT></P>
               <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 03.00pt; text-align: left; ">Indicate by check mark if disclosure of delinquent filers pursuant to
                  Item 405 of Regulation S-K (&#167; 229.405) is not contained herein, and
                  will not be contained, to the best of registrant's knowledge, in
                  definitive proxy or information statements incorporated by reference
                  in Part III of this Form 10-K or any amendment to this Form 10-K.&nbsp;<FONT style="font-family: Wingdings">o</FONT></P>
               <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 03.00pt; text-align: left; ">Indicate by check mark whether the registrant is a large accelerated
                  filer, an accelerated filer, a non-accelerated filer, or a smaller
                  reporting company. See the definitions of "large accelerated filer,"
                  "accelerated filer" and "smaller reporting company" in Rule 12b-2 of
                  the Exchange Act. (check&nbsp;one):
               </P>
               <P style="text-align: left; margin: 0pt; padding: 0pt; ">
                  <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                     <TR>
                        <TD style="font-size: 1pt;">&nbsp;</TD>
                        <TD style="width: 71.34%; font-size: 1pt;">&nbsp;</TD>
                        <TD style="font-size: 1pt;">&nbsp;</TD>
                        <TD style="font-size: 1pt;">&nbsp;</TD>
                        <TD style="width: 28.66%; font-size: 1pt;">&nbsp;</TD>
                        <TD style="font-size: 1pt;">&nbsp;</TD>
                     </TR>
                     <DIV style="padding-top: 3px; text-align: left; ">
                        <TR style="margin-top: 03.00pt; text-align: left; ">
                           <TD style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 03.00pt; ">&nbsp;</TD>
                           <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 03.00pt; ">Large accelerated filer <FONT style="font-family: Wingdings">o</FONT></TD>
                           <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 03.00pt; width: 15px; ">&nbsp;</TD>
                           <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 03.00pt; width: 15px; ">&nbsp;</TD>
                           <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 03.00pt; ">Accelerated filer <FONT style="font-family: Wingdings">o</FONT></TD>
                           <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 03.00pt; ">&nbsp;</TD>
                        </TR>
                        <TR style="margin-top: 03.00pt; text-align: left; ">
                           <TD style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 03.00pt; ">&nbsp;</TD>
                           <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 03.00pt; ">Non-accelerated filer <FONT style="font-family: Wingdings">o</FONT></TD>
                           <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 03.00pt; width: 15px; ">&nbsp;</TD>
                           <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 03.00pt; width: 15px; ">&nbsp;</TD>
                           <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 03.00pt; ">Smaller reporting company <FONT style="font-family: Wingdings">&#254;</FONT></TD>
                           <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 03.00pt; ">&nbsp;</TD>
                        </TR>
                     </DIV>
                  </TABLE>
               </P>
               <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 45.00pt; margin-top: 03.00pt; text-align: left; ">(Do not check if a smaller reporting company)</P>
               <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 03.00pt; text-align: left; ">Indicate by check mark whether the registrant is a shell company (as
                  defined in Rule 12b-2 of the Exchange Act). Yes&nbsp;<FONT style="font-family: Wingdings">o</FONT>&nbsp;&nbsp;&nbsp;No&nbsp;<FONT style="font-family: Wingdings">&#254;</FONT></P>
               <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 03.00pt; text-align: left; ">The aggregate market value of the common stock of the registrant held
                  by non-affiliates was approximately $58 million based on the price at
                  which the common stock was last sold on the NASDAQ Capital Market on
                  March 31, 2014.
               </P>
               <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 03.00pt; text-align: left; ">The number of shares outstanding of the registrant's common stock, as
                  of November 28, 2014, was 23,445,600.
               </P>
               <P style="padding-left: 0pt; padding-top: 6px; line-height: 1.3; text-align: center; "><B style="text-align: center; font-size: 10.0pt; ">Documents Incorporated by&nbsp;Reference</B></P>
               <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 03.00pt; text-align: left; ">Portions of the registrant's definitive Proxy Statement, or the 2015
                  Proxy Statement, which will be filed with the Securities and Exchange
                  Commission not later than 120 days after September 30, 2014, for its
                  2015 Annual Meeting of Stockholders are incorporated by reference
                  into Part III of this Report. With the exception of the portions of
                  the 2015 Proxy Statement expressly incorporated into this
               </P>
            </DIV>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">Annual Report on Form 10-K by reference, such document shall not be
               deemed filed as part of this Annual Report on Form&nbsp;10-K.
            </DIV>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: center; ">
               <DIV style="padding-top: 0px; text-align: center; ">
                  <DIV style="padding-top: 0px; text-align: center; ">
                     <P>
                        <DIV style="padding-top: 0px; text-align: center; "><B style="text-align: center; font-size: 10.0pt; "><A name="ipages"></A>BIODEL INC.</B></DIV>
                     </P>
                  </DIV><BR><DIV style="padding-top: 0px; text-align: center; ">
                     <P>
                        <DIV style="padding-top: 0px; text-align: center; "><B style="text-align: center; font-size: 10.0pt; ">INDEX TO REPORT ON FORM 10-K</B></DIV>
                     </P>
                     <P style="text-align: left; margin: 0pt; padding: 0pt; ">
<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; ">
                           <TR>
                              <TD STYLE="font-size: 1pt">&nbsp;</TD>
                              <TD STYLE="width: 10.53%; font-size: 1pt">&nbsp;</TD>
                              <TD STYLE="font-size: 1pt; width: 15px">&nbsp;</TD>
                              <TD STYLE="font-size: 1pt; width: 15px">&nbsp;</TD>
                              <TD STYLE="width: 82.24%; font-size: 1pt">&nbsp;</TD>
                              <TD STYLE="font-size: 1pt; width: 15px">&nbsp;</TD>
                              <TD STYLE="font-size: 1pt; width: 15px">&nbsp;</TD>
                              <TD STYLE="width: 1.97%; font-size: 1pt">&nbsp;</TD>
                              <TD STYLE="font-size: 1pt; width: 15px">&nbsp;</TD>
                              <TD STYLE="font-size: 1pt; width: 15px">&nbsp;</TD>
                              <TD STYLE="width: 5.26%; font-size: 1pt">&nbsp;</TD>
                              <TD STYLE="font-size: 1pt">&nbsp;</TD>
                           </TR>
                           <DIV style="padding-top: 3px; text-align: center; ">
                              <TR style="text-align: left; ">
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center"><U><B style="text-align: center; font-size: 8.0pt; ">Page</B></U></TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 03.00pt; text-align: left; ">
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; text-indent: -10pt; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center"><B>PART I</B></TD>
                                 <TD STYLE="vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 0pt; margin-top: 6pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 0pt; text-indent: -10pt; margin-top: 6pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 0pt; margin-top: 6pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; text-align: left; padding-left: 10pt; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; text-align: left; padding-left: 10pt; text-indent: -10pt; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; text-align: left; padding-left: 10pt; margin-top: 3pt">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 03.00pt; text-align: left; ">
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; text-indent: -10pt; margin-top: 3pt">Item 1:</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: 0pt; margin-top: 3pt; text-align: left">Business </TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; text-align: right; margin-top: 3pt; text-indent: 0px">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: right"><FONT style="text-decoration: none; ">3</FONT></TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; margin-top: 3pt; text-align: left; text-indent: 0px; white-space: nowrap">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 03.00pt; text-align: left; ">
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; text-indent: -10pt; margin-top: 3pt">Item 1A:</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: 0pt; margin-top: 3pt; text-align: left">Risk Factors </TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: -10pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; text-align: right; margin-top: 3pt; text-indent: 0px">&nbsp;</TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: right"><FONT style="text-decoration: none; ">19</FONT></TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; margin-top: 3pt; text-align: left; text-indent: 0px; white-space: nowrap">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 03.00pt; text-align: left; ">
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; text-indent: -10pt; margin-top: 3pt">Item 1B:</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: 0pt; margin-top: 3pt; text-align: left">Unresolved Staff Comments </TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: -10pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; text-align: right; margin-top: 3pt; text-indent: 0px">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: right"><FONT style="text-decoration: none; ">19</FONT></TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; margin-top: 3pt; text-align: left; text-indent: 0px; white-space: nowrap">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 03.00pt; text-align: left; ">
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; text-indent: -10pt; margin-top: 3pt">Item 2:</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: 0pt; margin-top: 3pt; text-align: left">Properties </TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: -10pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; text-align: right; margin-top: 3pt; text-indent: 0px">&nbsp;</TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: right"><FONT style="text-decoration: none; ">20</FONT></TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; margin-top: 3pt; text-align: left; text-indent: 0px; white-space: nowrap">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 03.00pt; text-align: left; ">
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; text-indent: -10pt; margin-top: 3pt">Item 3:</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: 0pt; margin-top: 3pt; text-align: left">Legal Proceedings </TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: -10pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; text-align: right; margin-top: 3pt; text-indent: 0px">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: right"><FONT style="text-decoration: none; ">20</FONT></TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; margin-top: 3pt; text-align: left; text-indent: 0px; white-space: nowrap">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 03.00pt; text-align: left; ">
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; text-indent: -10pt; margin-top: 3pt">Item 4:</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: 0pt; margin-top: 3pt; text-align: left">Mine Safety Disclosures </TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: -10pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; text-align: right; margin-top: 3pt; text-indent: 0px">&nbsp;</TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: right"><FONT style="text-decoration: none; ">38</FONT></TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; margin-top: 3pt; text-align: left; text-indent: 0px; white-space: nowrap">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 06.00pt; text-align: left; ">
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; text-indent: -10pt; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center"><B>PART II</B></TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: center; padding-left: 0pt; margin-top: 6pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: center; padding-left: 0pt; text-indent: -10pt; margin-top: 6pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: center; padding-left: 0pt; margin-top: 6pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10pt">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 03.00pt; text-align: left; ">
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; text-indent: -10pt; margin-top: 3pt">Item 5:</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: 0pt; margin-top: 3pt; text-align: left">Market for Registrant's Common Equity, Related Stockholder Matters
                                    and Issuer Purchases of Equity Securities
                                 </TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: -10pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; text-align: right; margin-top: 3pt; text-indent: 0px">&nbsp;</TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: right"><FONT style="text-decoration: none; ">39</FONT></TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; margin-top: 3pt; text-align: left; text-indent: 0px; white-space: nowrap">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 03.00pt; text-align: left; ">
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; text-indent: -10pt; margin-top: 3pt">Item 6:</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: 0pt; margin-top: 3pt; text-align: left">Selected Financial Data </TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: -10pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; text-align: right; margin-top: 3pt; text-indent: 0px">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: right"><FONT style="text-decoration: none; ">41</FONT></TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; margin-top: 3pt; text-align: left; text-indent: 0px; white-space: nowrap">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 03.00pt; text-align: left; ">
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; text-indent: -10pt; margin-top: 3pt">Item 7:</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: 0pt; margin-top: 3pt; text-align: left">Management's Discussion and Analysis of Financial Condition and
                                    Results of Operations
                                 </TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: -10pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; text-align: right; margin-top: 3pt; text-indent: 0px">&nbsp;</TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: right"><FONT style="text-decoration: none; ">40</FONT></TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; margin-top: 3pt; text-align: left; text-indent: 0px; white-space: nowrap">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 03.00pt; text-align: left; ">
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; text-indent: -10pt; margin-top: 3pt">Item 7A:</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: 0pt; margin-top: 3pt; text-align: left">Quantitative and Qualitative Disclosures About Market Risk </TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: -10pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; text-align: right; margin-top: 3pt; text-indent: 0px">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: right"><FONT style="text-decoration: none; ">51</FONT></TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; margin-top: 3pt; text-align: left; text-indent: 0px; white-space: nowrap">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 03.00pt; text-align: left; ">
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; text-indent: -10pt; margin-top: 3pt">Item 8:</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: 0pt; margin-top: 3pt; text-align: left">Financial Statements and Supplementary Data </TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: -10pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; text-align: right; margin-top: 3pt; text-indent: 0px">&nbsp;</TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: right"><FONT style="text-decoration: none; ">52</FONT></TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; margin-top: 3pt; text-align: left; text-indent: 0px; white-space: nowrap">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 03.00pt; text-align: left; ">
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; text-indent: -10pt; margin-top: 3pt">Item 9:</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: 0pt; margin-top: 3pt; text-align: left">Changes in and Disagreements With Accountants on Accounting and
                                    Financial Disclosure
                                 </TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: -10pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; text-align: right; margin-top: 3pt; text-indent: 0px">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: right"><FONT style="text-decoration: none; ">52</FONT></TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; margin-top: 3pt; text-align: left; text-indent: 0px; white-space: nowrap">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 03.00pt; text-align: left; ">
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; text-indent: -10pt; margin-top: 3pt">Item 9A:</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: 0pt; margin-top: 3pt; text-align: left">Controls and Procedures </TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: -10pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; text-align: right; margin-top: 3pt; text-indent: 0px">&nbsp;</TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: right"><FONT style="text-decoration: none; ">52</FONT></TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; margin-top: 3pt; text-align: left; text-indent: 0px; white-space: nowrap">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 03.00pt; text-align: left; ">
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; padding-left: 0pt">
                                    <P style=" line-height: 1.3; text-indent: 0.00pt; margin-top: 03.00pt; text-align: left; ">Item 9B:<BR></P>
                                    <P style=" line-height: 1.3; text-indent: -10.00pt; margin-top: 03.00pt; text-align: left; "></P>
                                 </TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; padding-left: 0pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: 0pt; margin-top: 3pt; text-align: left">Other
                                    Information
                                 </TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: -10pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; padding-left: 0pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; padding-left: 0pt">
                                    <P style=" line-height: 1.3; margin-top: 03.00pt; text-align: right; "><FONT style="text-decoration: none; ">52</FONT><BR></P>
                                    <P style=" line-height: 1.3; margin-top: 03.00pt; text-align: right; "></P>
                                 </TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; padding-left: 0pt">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 06.00pt; text-align: left; ">
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; text-indent: -10pt; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center"><B>PART III</B></TD>
                                 <TD STYLE="vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 0pt; margin-top: 6pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 0pt; text-indent: -10pt; margin-top: 6pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 0pt; margin-top: 6pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10pt">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 03.00pt; text-align: left; ">
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; text-indent: -10pt; margin-top: 3pt">Item 10:</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: 0pt; margin-top: 3pt; text-align: left">Directors, Executive Officers and Corporate Governance </TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: -10pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; text-align: right; margin-top: 3pt; text-indent: 0px">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: right"><FONT style="text-decoration: none; ">54</FONT></TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; margin-top: 3pt; text-align: left; text-indent: 0px; white-space: nowrap">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 03.00pt; text-align: left; ">
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; text-indent: -10pt; margin-top: 3pt">Item 11:</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: 0pt; margin-top: 3pt; text-align: left">Executive Compensation </TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: -10pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; text-align: right; margin-top: 3pt; text-indent: 0px">&nbsp;</TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: right"><FONT style="text-decoration: none; ">54</FONT></TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; margin-top: 3pt; text-align: left; text-indent: 0px; white-space: nowrap">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 03.00pt; text-align: left; ">
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; text-indent: -10pt; margin-top: 3pt">Item 12:</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: 0pt; margin-top: 3pt; text-align: left">Security Ownership of Certain Beneficial Owners and Management and Related<BR> Stockholder Matters
                                 </TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: -10pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; text-align: right; margin-top: 3pt; text-indent: 0px">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: right"><FONT style="text-decoration: none; ">54</FONT></TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; margin-top: 3pt; text-align: left; text-indent: 0px; white-space: nowrap">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 03.00pt; text-align: left; ">
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; text-indent: -10pt; margin-top: 3pt">Item 13:</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: 0pt; margin-top: 3pt; text-align: left">Certain Relationships and Related Transactions, and Director Independence </TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: -10pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; text-align: right; margin-top: 3pt; text-indent: 0px">&nbsp;</TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: right"><FONT style="text-decoration: none; ">54</FONT></TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; margin-top: 3pt; text-align: left; text-indent: 0px; white-space: nowrap">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 03.00pt; text-align: left; ">
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; text-indent: -10pt; margin-top: 3pt">Item 14:</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: 0pt; margin-top: 3pt; text-align: left">Principal Accountant Fees and Services </TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: -10pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; text-align: right; margin-top: 3pt; text-indent: 0px">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: right"><FONT style="text-decoration: none; ">54</FONT></TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; margin-top: 3pt; text-align: left; text-indent: 0px; white-space: nowrap">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 06.00pt; text-align: left; ">
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; text-indent: -10pt; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center"><B>PART IV</B></TD>
                                 <TD STYLE="vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 0pt; margin-top: 6pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 0pt; text-indent: -10pt; margin-top: 6pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 0pt; margin-top: 6pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
                                 <TD STYLE="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10pt">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 03.00pt; text-align: left; ">
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; text-indent: -10pt; margin-top: 3pt">Item 15:</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; text-align: left; padding-left: 10pt; margin-top: 3pt">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: 0pt; margin-top: 3pt; text-align: left">Exhibits and Financial Statement Schedules </TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; text-indent: -10pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: top; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: left">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; text-align: right; margin-top: 3pt; text-indent: 0px">&nbsp;</TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; padding-left: 0pt; margin-top: 3pt; text-align: right"><FONT style="text-decoration: none; ">54</FONT></TD>
                                 <TD STYLE="background-color: #CCEEFF; vertical-align: bottom; line-height: 1.3; margin-top: 3pt; text-align: left; text-indent: 0px; white-space: nowrap">&nbsp;</TD>
                              </TR>
                           </DIV>
                        </TABLE>
                     </P>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">i</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: center; ">
               <DIV style="padding-top: 0px; text-align: center; ">
                  <DIV style="padding-top: 0px; text-align: center; ">
                     <P style="padding-left: 0pt; padding-top: 6px; line-height: 1.3; text-align: center; ">(This page intentionally left&nbsp;blank)</P>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: center; ">
               <DIV style="padding-top: 0px; text-align: center; "><BR><DIV style="padding-top: 0px; text-align: center; ">
                     <P>
                        <DIV style="padding-top: 0px; text-align: center; "><B style="text-align: center; font-size: 10.0pt; "><A name="allpages"></A>FORWARD-LOOKING STATEMENTS</B></DIV>
                     </P>
                     <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">This Annual Report on Form 10-K contains forward-looking statements
                        within the meaning of the Private Securities Litigation Reform Act of
                        1995, that involve substantial risks and uncertainties. All
                        statements, other than statements of historical facts, included in
                        this Annual Report on Form 10-K regarding our strategy, future
                        operations, future financial position, future revenues, projected
                        costs, prospects, plans and objectives of management are
                        forward-looking statements. The words "anticipates," "believes,"
                        "could," "estimates," "expects," "intends," "may," "plans,"
                        "potential," "predicts," "projects," "should," "will," "would" and
                        similar expressions are intended to identify forward-looking
                        statements, although not all forward-looking statements contain these
                        identifying words.
                     </P>
                     <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Our forward-looking statements in this Annual Report on Form 10-K are
                        subject to a number of known and unknown risks and uncertainties that
                        could cause actual results, performance or achievements to differ
                        materially from those described or implied in the forward-looking
                        statements, including:
                     </P>
                     <DIV style="padding-left: 37pt; ">
                        <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the progress, timing or success of our research and development and
                           clinical programs for our product candidates, particularly our
                           glucagon emergency management, or GEM, product candidate, which
                           comprises lyophilized glucagon and an aqueous diluent in an automatic
                           reconstitution device, and our concentrated ultra-rapid-acting
                           insulin product candidate, BIOD-531, which uses regular human
                           insulin, or RHI, as the active pharmaceutical ingredient in a
                           concentration of 400 units per milliliter;
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to conduct the development work necessary to finalize the
                           formulation and presentation of our GEM product candidate, as well as
                           the preclinical studies, clinical trials and manufacturing activities
                           necessary to support the submission of a new drug application, or
                           NDA, to the U.S. Food and Drug Administration, or FDA, for that
                           product candidate;
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the ability and willingness of our existing strategic partners,
                           service providers and suppliers, upon which we rely in the
                           advancement of our product candidates, to meet the obligations set
                           forth in our agreements with them, including Unilife Medical
                           Solutions, Inc., or Unilife, which is responsible for designing and
                           manufacturing the device intended for use with our GEM product
                           candidate, as well as delivering three registration lots of the
                           filled and finished GEM device required for submitting an NDA to
                           the&nbsp;FDA;
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the success of our formulation development work to improve the
                           stability of our newer ultra-rapid-acting insulin analog-based
                           formulations while maintaining the pharmacokinetic and injection site
                           toleration characteristics associated with earlier formulations;
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the results of our real-time stability programs for our glucagon-,
                           RHI-, and insulin analog-based product candidates, including the
                           reproducibility of earlier, smaller scale, stability studies and our
                           ability to accurately project long term stability on the basis of
                           accelerated testing;
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to accurately anticipate technical challenges that we may
                           face in the development of our glucagon-, RHI-, and insulin
                           analog-based product candidates;
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to secure approval by the FDA for our product candidates
                           under Section 505(b)(2) of the Federal Food, Drug and Cosmetic Act,
                           or&nbsp;FFDCA;
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to enter into collaboration arrangements for the
                           commercialization of our product candidates and the success or
                           failure of any such collaborations into which we enter, or our
                           ability to commercialize our product candidates ourselves;
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to enforce our patents for our product candidates and our
                           ability to secure additional patents for our product candidates;
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to protect our intellectual property and operate our
                           business without infringing upon the intellectual property rights
                           of&nbsp;others;
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the degree of clinical utility of our product candidates,
                           particularly with regard to our ultra-rapid-acting insulin
                           formulations, which have not yet been shown to be clinically superior
                           to existing rapid-acting insulin analogs;
                        </P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">1</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-left: 37pt; ">
                        <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the emergence of competing technologies and products and other
                           adverse market developments, such as advancements in glucagon
                           stabilization technologies that could enable a room-temperature
                           rescue product in a portable, easy to use presentation;
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the ability of our contract manufacturing organizations or
                           collaborators to properly produce our products in our final dosage
                           form and in the quantities we may&nbsp;require;
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to secure adequate supplies of active pharmaceutical
                           ingredients to support our product development programs and, if
                           successful, the commercialization one or more product candidates;
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our capabilities and strategies for manufacturing, marketing and
                           commercializing a product candidate; and
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to accurately estimate anticipated operating losses,
                           future revenues, capital requirements and our needs for additional
                           financing.
                        </P>
                     </DIV>
                     <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We may not actually achieve the plans, intentions or expectations
                        disclosed in our forward-looking statements, and you should not place
                        undue reliance on our forward-looking statements. Actual results or
                        events could differ materially from the plans, intentions and
                        expectations disclosed in the forward-looking statements we make. We
                        have included important factors in the cautionary statements included
                        in this Annual Report, particularly in Item 1A of this Annual Report,
                        and in our other public filings with the Securities and Exchange
                        Commission that could cause actual results or events to differ
                        materially from the forward-looking statements that we&nbsp;make.
                     </P>
                     <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">You should read this Annual Report and the documents that we have
                        filed as exhibits to the Annual Report completely and with the
                        understanding that our actual future results may be materially
                        different from what we expect. It is routine for internal projections
                        and expectations to change as the year, or each quarter in the year,
                        progresses, and therefore it should be clearly understood that the
                        internal projections and beliefs upon which we base our expectations
                        are made as of the date of this Annual Report on Form 10-K and may
                        change prior to the end of each quarter or the year. While we may
                        elect to update forward-looking statements at some point in the
                        future, we do not undertake any obligation to update any
                        forward-looking statements whether as a result of new information,
                        future events or otherwise.
                     </P>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">2</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: center; ">
               <DIV style="padding-top: 0px; text-align: center; "><BR><DIV style="padding-top: 0px; text-align: center; ">
                     <P>
                        <DIV style="padding-top: 0px; text-align: center; "><B style="text-align: center; font-size: 10.0pt; "><A name="allpages_continue1"></A>PART I</B></DIV>
                     </P><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; "><A name="Item1"></A>ITEM 1:&nbsp;<I><B>BUSINESS</B></I></B></DIV>
                        </P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Overview</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We are a specialty biopharmaceutical company focused on the
                           development and commercialization of innovative treatments for
                           diabetes that may be safer, more effective and more convenient for
                           patients. We develop our product candidates by applying our
                           formulation technologies to existing drugs in order to improve their
                           therapeutic profiles. Our glucagon formulations and presentations are
                           designed to be stable at room temperature and are intended for use by
                           caregivers with little to no medical training as a rescue treatment
                           for diabetes patients experiencing severe hypoglycemia. Our
                           proprietary insulin formulations are designed to be more rapid-acting
                           than the formulations currently available to Type 1 and Type 2
                           diabetes patients. We refer to these as "ultra-rapid-acting" insulin
                           formulations.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; background-color: white; color: black; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Our lead product candidate is a glucagon emergency management, or
                           GEM, device that is intended to treat diabetes patients experiencing
                           severe hypoglycemia, or very low concentrations of blood glucose. GEM
                           is comprised of lyophilized glucagon and an aqueous diluent in a
                           proprietary injection device from Unilife Medical Solutions, Inc., or
                           Unilife. The GEM device is a dual-chamber design that automatically
                           reconstitutes lyophilized glucagon immediately prior to injection and
                           features automatic needle retraction on full dose delivery. We have
                           designed the GEM device with the goal of optimizing its ease of use
                           for patient caregivers in an emergency.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; background-color: white; color: black; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In the third calendar quarter of 2014, we submitted an
                           Investigational New Drug application, or IND, to the U.S. Food and
                           Drug Administration, or FDA, for our GEM product candidate. We have
                           initiated a Phase 1 clinical trial to assess the pharmacokinetic and
                           pharmacodynamic profiles of BIOD-961, the reconstituted glucagon
                           formulation intended for use in the GEM device, in the fourth
                           calendar quarter of 2014. If the Phase 1 clinical trial is
                           successful, we intend to complete the pivotal trial for our GEM
                           product candidate by the end of calendar year 2015 and submit a New
                           Drug Application, or NDA, to the FDA in calendar year&nbsp;2016.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; background-color: white; color: black; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In addition to our GEM product candidate, we are developing
                           ultra-rapid-acting proprietary insulin formulations that are designed
                           to be more rapid-acting than the formulations currently available to
                           Type 1 and Type 2 diabetes patients. For example, BIOD-123, which was
                           evaluated in a Phase 2 clinical trial, combines recombinant human
                           insulin, or RHI, with our proprietary combination of excipients to
                           increase the rate of absorption following subcutaneous injection when
                           compared to other commercially available insulin formulations,
                           including "rapid-acting" mealtime insulin analogs such as Humalog&#174;,
                           marketed by Eli Lilly, NovoLog&#174;, marketed by Novo Nordisk, and
                           Apidra&#174;, marketed by Sanofi. Similarly, we have developed BIOD-531, a
                           concentrated ultra-rapid-acting insulin formulation. BIOD-531
                           contains 400 units of RHI per milliliter (instead of the standard 100
                           units per milliliter), and, like BIOD-123, is formulated with
                           ethylenediaminetetraacetic acid, or EDTA, citrate and magnesium
                           sulfate. When delivered by subcutaneous injection, BIOD-531 is
                           characterized by a rapid onset of action and a prolonged duration of
                           action, which we believe could address an unmet medical need for an
                           insulin with an initial rate of absorption superior to that of
                           existing concentrated insulins and prandial/basal premixed insulins.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; background-color: white; color: black; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In addition to our RHI-based ultra-rapid-acting insulin formulations,
                           we are using our proprietary excipients to develop analog-based
                           ultra-rapid-acting insulin formulations using either insulin lispro,
                           the active pharmaceutical ingredient in Humalog&#174;, or insulin aspart,
                           the active pharmaceutical ingredient in&nbsp;NovoLog&#174;.
                        </P>
                     </DIV> <BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; "><A name="allpages_continue2"></A>Diabetes and Insulin Therapy Overview</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Glucose is a simple sugar used by all the cells of the body to
                           produce energy and support life. Humans need a minimum level of
                           glucose in their blood at all times to stay alive. The primary manner
                           in which the body produces blood glucose is through the digestion of
                           food. When a person is not getting this glucose from food digestion,
                           glucose is produced from stores and released by the liver. The body's
                           glucose levels are regulated by insulin. Insulin is a peptide hormone
                           that is naturally secreted by the pancreas. Insulin helps glucose
                           enter the body's cells to provide a vital source of&nbsp;energy.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">When a healthy individual begins a meal, the pancreas releases a
                           natural spike of insulin called the first-phase insulin release. In
                           addition to providing sufficient insulin to process the glucose
                           coming into the
                        </P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">3</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 0pt; margin-top: 06.00pt; text-align: left; ">blood from digestion of the meal, the first-phase insulin release
                           acts as a signal to the liver to stop making glucose while digestion
                           of the meal is taking place. Because the liver is not producing
                           glucose and there is sufficient additional insulin to process the
                           glucose from digestion, the blood glucose levels of healthy
                           individuals remain relatively constant and their blood glucose levels
                           do not become too&nbsp;high.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Diabetes is a disease characterized by abnormally high levels of
                           blood glucose and inadequate levels of, or response to, insulin.
                           There are two major types of diabetes &#151; Type 1 and Type 2. In Type 1
                           diabetes, the body produces no insulin. In the early stages of Type 2
                           diabetes, although the pancreas does produce insulin, the body loses
                           its early phase insulin response to a meal. In addition, the body's
                           cells do not respond as well as they should to a normal amount of
                           insulin, a condition known as insulin resistance. According to the
                           Centers for Disease Control and Prevention, or CDC, Type 2 diabetes
                           is the more prevalent form of the disease, affecting approximately
                           90% to 95% of all people diagnosed with diabetes.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Even before any other symptoms are present, one of the first effects
                           of Type 2 diabetes is the loss of the meal-induced first-phase
                           insulin release. In the absence of the first-phase insulin release,
                           the liver will not receive its signal to stop making glucose. As a
                           result, the liver will continue to produce glucose at a time when the
                           body begins to absorb new glucose through the digestion of the meal,
                           and the blood glucose level of patients with diabetes rises too high
                           after eating, a condition known as hyperglycemia. Hyperglycemia
                           causes glucose to attach unnaturally to certain proteins in the
                           blood, interfering with these proteins' ability to perform their
                           normal function of maintaining the integrity of the small blood
                           vessels. With hyperglycemia occurring after each meal, the tiny blood
                           vessels eventually break down and leak. The long-term adverse effects
                           of hyperglycemia include blindness, loss of kidney function, nerve
                           damage and loss of sensation and poor circulation in the periphery,
                           potentially requiring amputation of the extremities.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Patients with diabetes, particularly those with Type 1 diabetes, are
                           also at risk for abnormally low levels of blood glucose, known as
                           hypoglycemia, which can result from excessive insulin between meals.
                           Hypoglycemia can result in loss of mental acuity, confusion,
                           increased heart rate, hunger, sweating and faintness. At very low
                           glucose levels, hypoglycemia can result in loss of consciousness,
                           coma and even death. According to the American Diabetes Association,
                           or ADA, patients with Type 1 diabetes have a serious hypoglycemic
                           event an approximate average of once per year, many of which require
                           hospital emergency room&nbsp;visits.
                        </P><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Insulin Therapy and Its Limitations</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Because patients with Type 1 diabetes produce no insulin, the primary
                              treatment for Type 1 diabetes is daily intensive insulin therapy. The
                              treatment of Type 2 diabetes typically starts with management of diet
                              and exercise. Although helpful in the short-term, treatment through
                              diet and exercise alone is not an effective long-term solution for
                              the vast majority of patients with Type 2 diabetes. When diet and
                              exercise are no longer sufficient, treatment commences with various
                              non-insulin medications. These non-insulin medications may be limited
                              in their ability to manage the disease effectively and can have
                              significant side effects. Because of the limitations of non-insulin
                              treatments, many patients with Type 2 diabetes deteriorate over time
                              and eventually require insulin therapy to support their metabolism.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Insulin therapy has been used for more than 80 years to treat
                              diabetes. This therapy often involves administering several
                              injections of insulin each day. These injections consist of
                              administering a long-acting basal injection one or two times per day
                              and an injection of a rapid-acting insulin or RHI at mealtime.
                              Although this treatment regimen is accepted as effective, it has
                              limitations. Even when properly administered, insulin injections do
                              not replicate the natural time-action profile of insulin. In
                              particular, the natural spike of the first-phase insulin release in a
                              person without diabetes results in blood insulin levels rising within
                              several minutes of the entry into the blood of glucose from a meal.
                              By contrast, injected insulin enters the blood slowly, with peak
                              insulin levels occurring within 80 to 100 minutes following the
                              injection of recombinant human insulin.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">A potential solution is the injection of insulin directly into the
                              vein of diabetic patients immediately before eating a meal. In
                              studies of intravenous injections of insulin, patients exhibited
                              better control of their blood glucose for 3 to 6 hours following the
                              meal. However, for a variety of reasons, intravenous injection of
                              insulin before each meal is not a practical therapy.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">One of the key improvements in insulin treatments was the
                              introduction in the 1990s and 2000s of rapid-acting insulin analogs,
                              such as Humalog<SUP style="font-size: 8pt; ">&#174;</SUP>, NovoLog<SUP style="font-size: 8pt; ">&#174;</SUP> and Apidra<SUP style="font-size: 8pt; ">&#174;</SUP>. However, even with the rapid-acting
                           </P>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">4</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <DIV style="padding-top: 0px; text-align: left; ">
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 0pt; margin-top: 06.00pt; text-align: left; ">insulin analogs, peak insulin levels typically occur within 50 to 70
                              minutes following the injection. Because the rapid-acting insulin
                              analogs do not adequately mimic the first-phase insulin release,
                              diabetic patients using insulin therapy continue to have inadequate
                              levels of insulin present at the initiation of a meal and too much
                              insulin present between meals. This lag in insulin delivery can
                              result in hyperglycemia early after meal onset. Furthermore, the
                              excessive insulin between meals may result in hypoglycemia.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Additional complications of insulin therapy can arise if a patient's
                              response to insulin diminishes with the progression of the disease.
                              Some patients with Type 2 diabetes have severe insulin resistance,
                              resulting in the need to take more than 150 units of insulin per day
                              to control blood glucose elevations. In order to reduce the volume of
                              insulin needed for each injection, many of these patients use
                              Humulin&#174; R U-500, a presentation of Humulin&#174; R containing 500 units
                              of RHI per milliliter (instead of the standard 100 units per
                              milliliter). Humulin&#174; R U-500, which is indicated for Type 1 and Type
                              2 diabetes patients who require more than 200 units of insulin per
                              day, has a long duration of action, but its onset of action is very
                              slow and therefore is not ideally suited to cover the elevation of
                              glucose levels associated with meals. Humulin&#174; R U-500 is currently
                              the only concentrated insulin on the U.S. market. Many other patients
                              with Type 2 diabetes and lesser degrees of insulin resistance use
                              mixes of prandial and basal insulins, which offer a combination of
                              shorter- and longer-acting insulins in the convenience of one
                              injection. However, the mealtime component of these "pre-mixed"
                              insulin formulations is typically absorbed more slowly than what is
                              required to optimally cover the elevation of glucose levels
                              associated with meals. Examples of these "pre-mixed" insulins include
                              Humalog<SUP style="font-size: 8pt; ">&#174;</SUP> Mix 75/25, Humalog&#174; Mix 50/50 and NovoLog<SUP style="font-size: 8pt; ">&#174;</SUP> Mix 70/30.
                           </P>
                        </DIV> <BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Glucagon Rescue Treatment and Its Limitations</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Hypoglycemia is often treated by the oral administration of
                              carbohydrates, such as orange juice or glucose tablets. However, in
                              the case of severe hypoglycemia, the patient often experiences
                              neurologic compromise, such as loss of consciousness or seizure. In
                              these emergency cases, it is typically unsafe for carbohydrates to be
                              administered by mouth and the patient requires the assistance of
                              another person. In such cases, an injection of glucagon can be
                              administered to help quickly raise the patient's blood glucose
                              concentration.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Glucagon, like insulin, is a hormone secreted by the pancreas.
                              Glucagon opposes the action of insulin by promoting the breakdown of
                              glycogen into glucose in the liver, thereby raising the levels of
                              blood glucose. Although glucagon injections are useful in treating
                              severe hypoglycemia, glucagon is inherently unstable in a liquid
                              solution. Therefore, injectable glucagon for the treatment of severe
                              hypoglycemia is currently available only as a rescue kit consisting
                              of a vial containing a dry powder of glucagon and a syringe
                              containing a liquid solution. Two such kits are currently available
                              to patients - the Glucagon Emergency Rescue Kit, marketed by Eli
                              Lilly, and the GlucaGen&#174; HypoKit&#153;, marketed by Novo Nordisk. To
                              administer glucagon with either kit, the liquid solution in the
                              pre-filled syringe must first be injected into the vial with the dry
                              powder, the contents need to be adequately mixed and then the
                              solution is drawn back into the syringe. After the glucagon powder is
                              dissolved, it is injected into the patient. In order to properly
                              administer the glucagon, a caregiver must follow this multi-step
                              process in a situation typically made challenging by the patient's
                              condition.
                           </P>
                        </DIV>
                     </DIV> <BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Our Development of a Glucagon Rescue Product</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We believe that the complexity of the currently available rescue kits
                           and the training required for proper administration of glucagon using
                           those kits has resulted in the underuse of glucagon as a rescue
                           treatment for diabetes patients experiencing severe hypoglycemia. In
                           June 2013, we announced plans to develop our GEM product candidate in
                           collaboration with Unilife. The GEM device is a dual-chamber design
                           that automatically reconstitutes lyophilized glucagon immediately
                           prior to injection and features automatic needle retraction on full
                           dose delivery. We have designed the GEM device with the goal of
                           optimizing its ease of use for patient caregivers in an emergency.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">BIOD-961 is our reconstituted formulation of glucagon intended for
                           use in the GEM device. Our design in formulating BIOD-961 was to make
                           it comparable to the glucagon formulations used in the marketed
                           rescue kits. We believe that in order to receive approval from the
                           FDA to market our GEM product candidate we must, among other things,
                           demonstrate that BIOD-961 meets the FDA's requirements for
                           pharmacokinetic and pharmacodynamic bioequivalence when compared to a
                           reconstituted glucagon formulation from either of the two marketed
                           rescue kits as well as conduct a summative human factors study with
                           the GEM device to validate the instructions for use and operation of
                           the&nbsp;device.
                        </P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">5</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We submitted an IND to the FDA for our GEM product candidate in the
                           third calendar quarter of 2014. In the fourth calendar quarter of
                           2014, we initiated initiated Study 6-101, a Phase 1 clinical trial
                           that assesses the pharmacokinetic and pharmacodynamic profiles of
                           BIOD-961 compared to both of the marketed glucagon rescue
                           formulations. Study 6-101 is designed as a single center,
                           double-blind, six-way crossover study with twelve healthy volunteers.
                           If Study 6-101 is successful, we intend to initiate Study 6-301, a
                           pivotal clinical trial that would assess the pharmacokinetic and
                           pharmacodynamic profiles of BIOD-961 compared to one of the marketed
                           glucagon rescue formulations. Based on our current projections, we
                           anticipate announcing top line data from Study 6-101 in the first
                           calendar quarter of 2015, announcing top line data from Study 6-301
                           in the second half of 2015, and filing a Section 505(b)(2) NDA for
                           our GEM product candidate with the FDA in calendar year&nbsp;2016.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We also believe that the development of novel room temperature stable
                           liquid formulations of glucagon could overcome the limitations of the
                           marketed rescue kits. In addition to our GEM product candidate, we
                           are currently assessing several formulations of liquid glucagon in
                           preclinical studies that we intend for use with Becton Dickinson and
                           Company's Uniject disposable injection system.
                        </P>
                     </DIV> <BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Our Development of Ultra-Rapid-Acting Insulin Formulations</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Our proprietary ultra-rapid-acting insulin formulations are designed
                           to be absorbed into the blood faster than the currently marketed
                           rapid-acting insulin analogs. One of the key features of our
                           formulation technology is that it allows the RHI or insulin analog to
                           disassociate, or separate, from the six molecule, or hexameric, form
                           to the single molecule, or monomeric, form and inhibits
                           re-association to the hexameric form. We believe that by favoring the
                           monomeric form, our formulations may allow for more rapid delivery of
                           insulin into the blood because insulin in the form of a single
                           molecule is absorbed more efficiently into the bloodstream. Based
                           upon our preclinical and clinical data, we believe our RHI- and
                           insulin analog-based formulations may produce a profile of insulin
                           levels in the blood that is preferable to the profile typically
                           observed when using the currently marketed "rapid-acting" insulin
                           analogs.
                        </P><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Early Development of Ultra-Rapid-Acting insulin Formulations</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We have conducted Phase 1, Phase 2 and Phase 3 clinical trials
                              comparing the performance of our ultra-rapid-acting insulin
                              formulations to marketed insulins. An early formulation known as
                              Linjeta&#153; was studied in two pivotal Phase 3 clinical trials that
                              began in 2007. Our pivotal Phase 3 clinical trials were open-label,
                              parallel group, randomized trials conducted at centers in the United
                              States, Germany and India. The trials were designed to compare the
                              efficacy and safety of Linjeta<SUP style="font-size: 8pt; ">TM</SUP> to Humulin<SUP style="font-size: 8pt; ">&#174;</SUP> R, which is a branded form of RHI. One of the trials tested Linjeta<SUP style="font-size: 8pt; ">TM</SUP> in patients with Type 1 diabetes and the other in patients with Type
                              2 diabetes. We enrolled more than 400 patients in each trial for a
                              six month treatment period. Approximately one-half of the patients in
                              each trial were treated with Linjeta<SUP style="font-size: 8pt; ">TM</SUP> and the remainder with Humulin<SUP style="font-size: 8pt; ">&#174;</SUP> R. The primary objective of the trials was to determine if Linjeta<SUP style="font-size: 8pt; ">TM</SUP> was not inferior to Humulin<SUP style="font-size: 8pt; ">&#174;</SUP> R in the management of blood glucose levels, as measured by the mean
                              change in patients' HbA1c levels from baseline to the end of the
                              trial. HbA1c levels are a measure of patients' average blood glucose
                              levels over a period of approximately 3 months. HbA1c is the FDA's
                              preferred endpoint for diabetes trials. Approximately 400 patients
                              with Type 1 and Type 2 diabetes who completed the pivotal Phase 3
                              clinical trials elected to participate in a long term safety
                              extension trial in which all patients were treated with Linjeta<SUP style="font-size: 8pt; ">TM</SUP> as their mealtime insulin. The last patient visit in the extension
                              trial was in February 2010.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In December 2009, we submitted an NDA to the FDA under section
                              505(b)(2) of the FFDCA for clearance to market Linjeta<SUP style="font-size: 8pt; ">TM</SUP> as a treatment for diabetes. In November 2010, the FDA issued a
                              complete response letter to our NDA. The complete response letter
                              included comments related to clinical trials, statistical analysis
                              and chemistry, manufacturing and controls and tolerability issues
                              relating to localized discomfort upon injection. The FDA requested
                              that we conduct two new Phase 3 clinical trials using our preferred
                              commercial formulation of Linjeta<SUP style="font-size: 8pt; ">TM</SUP>, one in patients with Type 1 diabetes and the other in patients with
                              Type 2 diabetes prior to resubmitting the&nbsp;NDA.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Based upon the complete response letter and subsequent feedback that
                              the FDA provided to us, we decided to study newer RHI-based
                              formulations in earlier stage clinical trials. In the third calendar
                              quarter of 2012 we began enrolling patients in a Phase 2 clinical
                              trial of BIOD-123, a newer ultra-rapid-acting insulin formulation
                              that combines RHI with EDTA, citrate and magnesium sulfate. The
                              addition of magnesium sulfate
                           </P>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">6</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <DIV style="padding-top: 0px; text-align: left; ">
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 0pt; margin-top: 06.00pt; text-align: left; ">was intended to improve the formulation's tolerability upon
                              injection, as compared to Linjeta&#153;. The clinical trial was a
                              randomized, open label, parallel group study conducted at 32
                              investigative centers in the United States. In the clinical trial,
                              132 patients with Type 1 diabetes were randomized to receive either
                              BIOD-123 or Humalog&#174; to use as their mealtime insulin during an
                              18-week treatment period. Both arms of the study used insulin
                              glargine, sold as Lantus&#174;, as the basal insulin. The clinical trial
                              was designed to evaluate HbA1c control as the primary endpoint, and
                              secondary endpoints included postprandial glucose excursions,
                              glycemic variability, hypoglycemic event rates and weight changes.
                              Following randomization, subjects entered a six-week dose titration
                              period during which basal insulin and then prandial insulin doses
                              were titrated in order to reach standard ADA recommended preprandial
                              glucose targets. Upon completion of the titration period, patients
                              entered a "relative stable dosing period" for an additional 12&nbsp;weeks.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Phase 2 clinical trial of BIOD-123 completed patient dosing in
                              the second calendar quarter of 2013, and in September 2013 we
                              announced preliminary results from the trial. BIOD-123 achieved the
                              primary endpoint of noninferiority for HbA1c relative to Humalog&#174;.
                              The mean HbA1c change from baseline in the BIOD-123 group was -0.08 &#177;
                              0.064% and -0.25&#177; 0.063% in the Humalog&#174; group. The 95% confidence
                              interval (-0.01, 0.35) of the between group differences in change
                              from baseline HbA1c did not exceed the FDA-designated threshold of
                              0.40%, thereby establishing non-inferiority. HbA1c change during the
                              stable dosing period was similar in both treatment groups. During
                              this period, the mean change in HbA1c in the BIOD-123 group was
                              -0.01% and in the Humalog&#174; group was +0.02%. Additionally, we
                              observed comparable weight gain, mean hypoglycemia event rates and
                              postprandial glucose excursions between the treatment groups, as well
                              as some trends in favor of BIOD-123 in regard to postprandial glucose
                              excursions to a liquid meal challenge test. Comparable safety and
                              adverse event profiles were observed in the clinical trial, with the
                              exception of an increased frequency of injection site pain associated
                              with BIOD-123, which appeared to be clinically minor, short-lived and
                              distinctly superior to the toleration profile we observed with
                              Linjeta&#153; in our earlier Phase 3 clinical trials.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; background-color: white; color: black; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We believe that a pharmaceutical company with expertise in diabetes
                              and a significant commercial infrastructure will be in the best
                              position to maximize the value of BIOD-123, and we therefore do not
                              have plans to advance BIOD-123 into Phase 3 pivotal trials without
                              the assistance of a strategic partner.
                           </P>
                           <P style="padding-left: 0pt; padding-top: 6px; line-height: 1.3; text-indent: 20.05pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Development of BIOD-531 and Insulin Analog-Based Formulations</B></I></P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In November 2013, we announced that we had selected BIOD-531 as our
                              lead candidate for a concentrated ultra-rapid-acting insulin
                              formulation. In preclinical studies in diabetic swine, BIOD-531
                              demonstrated a more rapid rate of absorption and onset of action,
                              along with a similar duration of action, when compared to Humulin&#174; R
                              U-500, a presentation containing 500 units of RHI per millimeter. In
                              other preclinical studies, BIOD-531 also demonstrated a more rapid
                              rate of absorption and onset of action when compared to Humalog&#174; Mix
                              75/25. We believe BIOD-531 could address an unmet medical need for an
                              insulin with an initial rate of absorption superior to that of
                              Humulin&#174; R U-500 and prandial/basal pre-mixed insulins. BIOD-531
                              contains 400 units of RHI per milliliter (instead of the standard 100
                              units per milliliter), and, like BIOD-123, is formulated with EDTA,
                              citrate and magnesium sulfate.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; "><I>Study 3-150&#151;Phase 1 clinical trial comparing BIOD-531 to Humulin&#174; R
                                 U-500 and Humalog&#174; Mix&nbsp;75/25</I>. In February 2014, we announced the results from Study 3-150, a
                              Phase 1 clinical trial comparing BIOD-531 to the marketed products
                              Humulin&#174; R U-500 and Humalog&#174; Mix 75/25. Study 3-150 assessed the
                              pharmacokinetic, pharmacodynamic and injection site toleration
                              profiles of single doses of the study drugs in non-diabetic obese
                              volunteers. The clinical trial included 1.0 unit per kilogram and 0.5
                              unit per kilogram doses of BIOD-531, as well as a 1.0 unit per
                              kilogram dose of Humulin&#174; R U-500 and a 0.5 unit per kilogram dose of
                              Humalog&#174; Mix 75/25. Topline results from the clinical study were
                              as&nbsp;follows:
                           </P>
                           <DIV style="padding-left: 37pt; ">
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>When comparing 1.0 unit per kilogram doses of BIOD-531 and Humulin&#174; R
                                 U-500, BIOD-531 was associated with an increased rate of absorption
                                 as measured by multiple pharmacokinetic parameters, including a 92%
                                 shorter time to Early &#189; Tmax (11.0 &#177; 1.9 min) versus Humulin&#174; R U-500
                                 (135.3 &#177; 34.9 min), a 43% shorter time to Tmax (223.8 &#177; 62.3 min)
                                 versus Humulin&#174; R U-500 (393.3 &#177; 58.3 min) and a 765% increase in
                                 early insulin exposure as measured by AUCins0-30min (2966 &#177; 383
                                 mU*min/L) versus Humulin&#174; R U-500 (343 &#177; 74 mU*min/L).&nbsp;BIOD-531 was
                                 associated with a more rapid glucose lowering effect as measured by
                                 multiple pharmacodynamic parameters including a 169% increase in
                                 AUCGIR0-60min (108.5 &#177; 22.0 mg/kg) versus Humulin&#174; R U-500 (40.4 &#177;
                                 10.0 mg/kg).&nbsp;These differences were all statistically significant.
                              </P>
                           </DIV>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">7</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <DIV style="padding-top: 0px; text-align: left; ">
                           <DIV style="padding-left: 37pt; ">
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>When comparing 0.5 unit per kilogram doses of BIOD-531 and Humalog&#174;
                                 Mix 75/25, BIOD-531 was associated with an increased rate of
                                 absorption as measured by multiple pharmacokinetic parameters,
                                 including a 66% shorter time to Early &#189; Tmax (16.4 &#177; 4.9 min) versus
                                 Humalog&#174; Mix 75/25 (47.9 &#177; 2.6 min), an 18% shorter time to Tmax
                                 (131.3 &#177; 43.4 min) versus Humalog&#174; Mix 75/25 (160.0 &#177; 11.9 min) and a
                                 917% increase in early insulin exposure as measured by AUCins0-30min
                                 (1200 &#177; 141 min) versus Humalog&#174; Mix 75/25 (118 &#177; 22 mU*min/L).
                                 BIOD-531 was associated with a more rapid glucose lowering effect as
                                 measured by multiple pharmacodynamic parameters including a 375%
                                 &nbsp;increase in AUCGIR0-60min (68.9 &#177; 13.4 mg/kg) versus Humalog&#174; Mix
                                 75/25 &nbsp;(14.5 &#177; 4.7 mg/kg).&nbsp;With the exception of Tmax, these
                                 differences were all statistically significant.
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>Pharmacodynamic measurements for BIOD-531, including time to the end
                                 of the glucose lowering effect (TGIR Last), at both 1 U/kg (1170.0 &#177;
                                 59.3 min) and 0.5 U/kg (1076.2 &#177; 50.7 min) doses, suggested the
                                 potential for BIOD-531 to provide basal insulin needs. Mean visual
                                 analog scores and absolute severity scores were very low for all
                                 participants, suggesting excellent injection site tolerability. There
                                 were no statistically significant differences among the treatment
                                 groups.
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>Mean visual analog scores and absolute severity scores were very low
                                 for all participants, suggesting excellent injection site
                                 tolerability. There were no statistically significant differences
                                 among the treatment groups.
                              </P>
                           </DIV>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; "><I>Study 3-152</I>&#151; <I>Phase 2a clinical trial comparing BIOD-531 to Humalog&#174; Mix 75/25 and
                                 Humulin&#174; R&nbsp;U-500</I>. In August 2014, we announced the results from Study 3-152, a Phase
                              2a clinical trial comparing BIOD-531 to the marketed products
                              Humalog&#174; Mix 75/25 and Humulin&#174; R U-500. Study 3-152 assessed glucose
                              profiles of Type 2 diabetic subjects who use between 50 and 110 units
                              of insulin per day after a single subcutaneous injection of 0.6 U/kg
                              doses of the study drugs administered with a standardized breakfast
                              on separate days in a randomized four arm cross-over sequence in
                              which subjects received pre-meal BIOD-531, pre-meal Humalog&#174; Mix
                              75/25, pre-meal Humulin&#174; R U-500 and post meal BIOD-531.&nbsp;In order to
                              assess the duration of glucose lowering, subjects received a
                              standardized lunch at 330 minutes (5.5 hours) after test insulin
                              dosing at breakfast, but with no insulin administered at that
                              time.&nbsp;Blood glucose levels were measured every five minutes during
                              the 720 minutes (12 hours) after test insulin dosing at breakfast.
                              Topline results from the clinical study were as&nbsp;follows:
                           </P>
                           <DIV style="padding-left: 37pt; ">
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>When comparing 0.6 unit per kilogram doses of BIOD-531 and Humalog&#174;
                                 Mix 75/25 administered prior to a meal, BIOD-531 was associated with
                                 superior glucose control throughout the day of observation.&nbsp;A single
                                 dose of BIOD-531 administered immediately before breakfast (pre-meal)
                                 achieved significantly lower mean glucose concentrations than did
                                 Humalog&#174; Mix 75/25 administered immediately before breakfast.&nbsp;The
                                 mean glucose concentration after breakfast was 167.8 &#177; 10.4 mg/dl
                                 with BIOD-531 treatment compared to 205.1 &#177; 8.3 mg/dl with Humalog&#174;
                                 Mix 75/25 treatment (p &lt; 0.001).&nbsp;Mean glucose concentrations were
                                 also significantly improved after lunch with pre-meal BIOD-531.&nbsp;Over
                                 the course of the entire day of observation, pre-meal BIOD-531 was
                                 associated with an average glucose concentration of 177.8 &#177; 11.9
                                 mg/dl compared to 225.1&#177; 10.7 mg/dl with Humalog&#174; Mix 75/25 treatment
                                 (p &lt; 0.001).&nbsp;The percentage of glucose readings within the target
                                 range of 70-180 mg/dl was increased more than two-fold following
                                 BIOD-531 treatment (46.3 &#177; 8.4%) compared to&nbsp;Humalog&#174; Mix 75/25
                                 treatment (20.6 &#177; 5.9 %; p=0.002).&nbsp;Likewise, the post-breakfast area
                                 under the curve for the glucose excursion and the mean maximal
                                 glucose concentrations after breakfast and after lunch were
                                 significantly improved with pre-meal BIOD-531 treatment compared to
                                 Humalog&#174; Mix 75/25 treatment.
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>When comparing 0.6 unit per kilogram doses of BIOD-531 and Humulin&#174; R
                                 U-500 administered prior to the meal, BIOD-531 was associated with
                                 superior glucose control. Mean glucose concentrations after the
                                 standardized breakfast were 167.8 &#177; 10.4 mg/dl with BIOD-531
                                 treatment compared to 193.1 &#177; 8.3 mg/dl with Humulin&#174; R U-500
                                 treatment (p=0.006).&nbsp;Over the entire day of observation, mean glucose
                                 concentrations were 177.8 &#177; 11.9 mg/dl with BIOD-531 treatment
                                 compared to 197.2 &#177; 8.8 mg/dl with Humulin&#174; R U-500 treatment
                                 (p=0.042).&nbsp;Over the course of the entire day of observation, glucose
                                 concentrations were in the target range of 70-180 mg/dl 46.3 &#177; 8.4%
                                 of the time with BIOD-531 treatment compared to 29.1 &#177; 6.1% of the
                                 time with Humulin&#174; R U-500 treatment (p=0.032).
                              </P>
                           </DIV>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">8</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <DIV style="padding-top: 0px; text-align: left; ">
                           <DIV style="padding-left: 37pt; ">
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>When comparing 0.6 unit per kilogram doses of BIOD-531 administered
                                 twenty minutes after the start of the meal to 0.6 unit per kilogram
                                 doses of both Humalog&#174; Mix 75/25 and Humulin&#174; R U-500 administered
                                 prior to a meal, BIOD-531 demonstrated superior glucose control
                                 compared to either comparator.&nbsp;Mean glucose concentrations over the
                                 course of the day were 178.3 &#177; 11.2 mg/dl for post-meal BIOD-531
                                 treatment compared to 225.1 &#177; 10.7 for pre-meal Humalog&#174; Mix 75/25
                                 treatment (p &lt; 0.001).&nbsp;The percentage of readings within the 70-180
                                 mg/dl target range was 46.2 &#177; 7.6% for post-meal BIOD-531 treatment
                                 compared to 20.6 &#177; 5.9% for pre-meal Humalog&#174; Mix 75/25 treatment
                                 (p=0.003) and 29.1 &#177; 6.1% for pre-meal Humulin&#174; R U-500 treatment
                                 (p=0.040).
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>Mean visual analog scores and absolute severity scores were low for
                                 all participants, suggesting excellent injection site
                                 tolerability.&nbsp;There were no statistically significant differences in
                                 100 mm visual analog scores among the treatment groups.
                              </P>
                           </DIV>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">BIOD-531 is the subject of ongoing Study 3-151, a Phase 2a clinical
                              trial comparing BIOD-531 to the marketed products Humalog&#174; Mix 75/25
                              and Humulin&#174; R U-500 in diabetes patients who use greater than 150
                              units of insulin per day or greater than 100 units of insulin at a
                              single dosing session. During each visit, subjects in the clinical
                              trial will receive three standardized meals and two doses of the
                              study drug, one dose with breakfast and the other dose with dinner.
                              Blood glucose levels will be measured over a period of 24 hours.
                              Furthermore, we are making preparations to initiate Study 3-250, a
                              parallel group study in patients with Type 2 diabetes who use &gt; 50
                              units of insulin per day comparing BIOD-531 to Humalog&#174; Mix 75/25
                              over a six-month treatment period. We expect to initiate Study 3-250
                              in the first half of calendar year 2015, provided that we are
                              successful in our other development activities for BIOD-531.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In addition to BIOD-531, we continue to develop ultra-rapid-acting
                              insulin analog-based formulations, using our proprietary excipients
                              in combination with either insulin lispro, the active pharmaceutical
                              ingredient in Humalog&#174;, or insulin aspart, the active pharmaceutical
                              ingredient in&nbsp;NovoLog&#174;.
                           </P>
                        </DIV>
                     </DIV> <BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Government Regulation</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The FDA and other federal, state, local and foreign regulatory
                           agencies impose substantial requirements upon the clinical
                           development, approval, labeling, manufacture, marketing and
                           distribution of drug products. These agencies regulate, among other
                           things, research and development activities and the testing,
                           approval, manufacture, quality control, safety, effectiveness,
                           labeling, storage, record keeping, advertising and promotion of our
                           product candidates. The regulatory approval process is generally
                           lengthy and expensive, with no guarantee of a positive result.
                           Moreover, failure to comply with applicable FDA or other requirements
                           may result in civil or criminal penalties, recall or seizure of
                           products, injunctive relief including partial or total suspension of
                           production, or withdrawal of a product from the&nbsp;market.
                        </P><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">United States Government Regulation</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The FDA regulates, among other things, the research, manufacture,
                              promotion and distribution of drugs in the United States under the
                              FFDCA and other statutes and implementing regulations. We intend to
                              seek FDA approval for our product candidates in an NDA, and not under
                              an application submitted for approval as a biologic under the Public
                              Health Service Act. The process required by the FDA before a drug
                              product candidate may be marketed in the United States under an NDA
                              generally involves the following:
                           </P>
                           <DIV style="padding-left: 37pt; ">
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>completion of extensive nonclinical laboratory tests, animal studies
                                 and formulation studies, all performed in accordance with the FDA's
                                 Good Laboratory Practice, or GLP, regulations;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>submission to the FDA of an investigational new drug application, or
                                 IND, which must become effective before human clinical trials
                                 may&nbsp;begin;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>for some products, performance of adequate and well-controlled human
                                 clinical trials in accordance with the FDA's regulations, including
                                 Good Clinical Practices, to establish the safety and efficacy of the
                                 product candidate for each proposed indication;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>submission to the FDA of an NDA, and the acceptance for filing of the
                                 NDA by the&nbsp;FDA;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>satisfactory completion of an FDA preapproval inspection of the
                                 manufacturing facilities at which the product is produced to assess
                                 compliance with current Good Manufacturing Practice, or cGMP,
                                 regulations; and
                              </P>
                           </DIV>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">9</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <DIV style="padding-top: 0px; text-align: left; ">
                           <DIV style="padding-left: 37pt; ">
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>FDA review and approval of the NDA prior to any commercial marketing,
                                 sale or shipment of the&nbsp;drug.
                              </P>
                           </DIV>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The testing and approval process requires substantial time, effort
                              and financial resources, and we cannot be certain that any approvals
                              for our product candidates will be granted on a timely basis, if
                              at&nbsp;all.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Nonclinical tests include laboratory evaluations of product
                              chemistry, formulation and stability, as well as studies to evaluate
                              toxicity in animals and other animal studies. The results of
                              nonclinical tests, together with manufacturing information and
                              analytical data, are submitted as part of an IND to the FDA. Some
                              nonclinical testing may continue even after an IND is submitted. The
                              IND also includes one or more protocols for the initial clinical
                              trial or trials and an investigator's brochure. An IND automatically
                              becomes effective 30 days after receipt by the FDA, unless the FDA,
                              within the 30-day time period, raises concerns or questions relating
                              to the proposed clinical trials as outlined in the IND and places the
                              clinical trial on a clinical hold. In such cases, the IND sponsor and
                              the FDA must resolve any outstanding concerns or questions before any
                              clinical trials can begin. A clinical trial hold also may be imposed
                              at any time before or during studies due to safety concerns or
                              non-compliance with regulatory requirements. An independent
                              institutional review board, or IRB, monitors the clinical centers
                              proposing to conduct the clinical trial and must review and approve
                              the plan for any clinical trial before it commences. An IRB
                              considers, among other things, whether the risks to individuals
                              participating in the trials are minimized and are reasonable in
                              relation to anticipated benefits. The IRB also approves the informed
                              consent form signed by the trial participants and must monitor the
                              study until completed.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; "><I>Clinical Trials.</I> Clinical trials involve the administration of the product candidate
                              to human subjects under the supervision of qualified medical
                              investigators according to approved protocols that detail the
                              objectives of the study, dosing procedures, subject selection and
                              exclusion criteria, and the parameters to be used to monitor
                              participant safety. Each protocol is submitted to the FDA as part of
                              the&nbsp;IND.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Human clinical trials are typically conducted in three sequential
                              phases, but the phases may overlap, or be&nbsp;combined.
                           </P>
                           <DIV style="padding-left: 37pt; ">
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>Phase 1 clinical trials typically involve the initial introduction of
                                 the product candidate into human volunteers. In Phase 1 clinical
                                 trials, the product candidate is typically tested for safety, dosage
                                 tolerance, absorption, metabolism, distribution, excretion and
                                 pharmacodynamics.
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>Phase 2 clinical trials are conducted in a limited patient population
                                 to gather evidence about the efficacy of the product candidate for
                                 specific, targeted indications, to determine dosage tolerance and
                                 optimal dosage, and to identify possible adverse effects and safety
                                 risks.
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>Phase 3 clinical trials are undertaken to evaluate clinical efficacy
                                 and to test for safety in an expanded patient population at
                                 geographically dispersed clinical trial sites. The size of Phase 3
                                 clinical trials depends upon clinical and statistical considerations
                                 for the product candidate and proposed indications, but sometimes can
                                 include several thousand patients. Phase 3 clinical trials are
                                 intended to establish the overall risk-benefit ratio of the product
                                 candidate and provide an adequate basis for product labeling.
                              </P>
                           </DIV>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Clinical testing must satisfy extensive FDA regulations. Reports
                              detailing the status of the clinical trials must be submitted at
                              least annually to the FDA and safety reports must be submitted for
                              serious and unexpected adverse events. Success in early stage
                              clinical trials does not assure success in later stage clinical
                              trials. The FDA, an IRB or we may suspend a clinical trial at any
                              time on various grounds, including a finding that the research
                              subjects or patients are being exposed to an unacceptable health&nbsp;risk.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; "><I>New Drug Applications.</I> Assuming successful completion of the required clinical trials, the
                              results of product development, nonclinical studies and clinical
                              trials are submitted to the FDA as part of an NDA. An NDA also must
                              contain extensive manufacturing information, as well as proposed
                              labeling for the finished product. An NDA must contain information
                              about the chemistry and physical characteristics of the drug and a
                              final process for manufacturing the product in accordance with cGMP.
                              The manufacturing process must be capable of consistently producing
                              quality product within specifications approved by the FDA. The
                              manufacturer must develop methods for testing the quality, purity and
                              potency of the final product. In addition, appropriate packaging must
                              be selected and tested and stability studies must be conducted to
                              demonstrate that the product does not undergo unacceptable
                              deterioration over its shelf life. Prior to approval, the FDA will
                              conduct an inspection of the manufacturing facilities to assess
                              compliance with&nbsp;cGMP.
                           </P>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">10</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <DIV style="padding-top: 0px; text-align: left; ">
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The FDA reviews all NDAs submitted before it accepts them for filing.
                              The FDA may request additional information rather than accept an NDA
                              for filing. In this event, the NDA must be resubmitted with the
                              additional information and is subject to review before the FDA
                              accepts it for filing. After an application is filed, the FDA may
                              refer the NDA to an advisory committee for review, evaluation and
                              recommendation as to whether the application should be approved and
                              under what conditions. The FDA is not bound by the recommendation of
                              an advisory committee, but it considers them carefully when making
                              decisions. The FDA may deny approval of an NDA if the applicable
                              regulatory criteria are not satisfied. Data obtained from clinical
                              trials are not always conclusive and the FDA may interpret data
                              differently than we interpret the same data. The FDA may issue a
                              complete response letter, which may require additional clinical or
                              other data or impose other conditions that must be met in order to
                              secure final approval of the NDA. An applicant receiving a complete
                              response letter may resubmit the application with data and
                              information addressing the FDA's concerns or requirements, withdraw
                              the application without prejudice to a subsequent submission of a
                              related application or request a hearing on whether there are grounds
                              for denying approval of the application. If a product receives
                              regulatory approval, the approval may be significantly limited to
                              specific diseases and dosages or the indications for use may
                              otherwise be limited, which could restrict the commercial value of
                              the product. In addition, the FDA may require us to conduct Phase 4
                              testing which involves clinical trials designed to further assess a
                              drug's safety and effectiveness after NDA approval, and may require
                              surveillance programs to monitor the safety of approved products
                              which have been commercialized. Once issued, the FDA may withdraw
                              product approval if ongoing regulatory requirements are not met or if
                              safety or efficacy questions are raised after the product reaches the
                              market. The agency may also impose requirements that the NDA holder
                              conduct new studies, make labeling changes, implement Risk Evaluation
                              and Mitigation Strategies, and take other corrective measures.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; "><I>Section 505(b)(2) NDAs.</I> There are three types of drug registration applications: the full
                              NDA, the abbreviated NDA, which is used for generic drug
                              applications, and the Section 505(b)(2) NDA. We intend to file
                              Section 505(b)(2) NDAs that might, if accepted by the FDA, save time
                              and expense in the development and testing of our product candidates.
                              A full NDA is submitted under Section 505(b)(1) of the FFDCA and must
                              contain full reports of investigations conducted by the applicant to
                              demonstrate the safety and effectiveness of the drug. A Section
                              505(b)(2) NDA may be submitted for a drug for which one or more of
                              the investigations relied upon by the applicant was not conducted by
                              or for the applicant and for which the applicant has no right of
                              reference from the person by or for whom the investigations were
                              conducted. A Section 505(b)(2) NDA may be submitted based in whole or
                              in part on published literature or on the FDA's finding of safety and
                              efficacy of one or more previously approved drugs, which are known as
                              reference drugs. Thus, the filing of a Section 505(b)(2) NDA may
                              result in approval of a drug based on fewer clinical or nonclinical
                              studies conducted by the applicant than would be required under a
                              full NDA. The number and size of studies that need to be conducted by
                              the sponsor depends on the amount and quality of data pertaining to
                              the reference drug that are publicly available, and on the similarity
                              of and differences between the applicant's drug and the reference
                              drug. In some cases, extensive, time-consuming, and costly clinical
                              and nonclinical studies may still be required for approval of a
                              Section 505(b)(2) NDA.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Because we are developing new formulations of previously approved
                              chemical entities, such as insulin and glucagon, our drug approval
                              strategy is to submit Section 505(b)(2) NDAs to the FDA. We plan to
                              pursue similar routes for submitting applications for our product
                              candidates in foreign jurisdictions if available. The FDA may not
                              agree that our product candidates are approvable pursuant to Section
                              505(b)(2) NDAs. There is no specific guidance available for Section
                              505(b)(2) NDAs for insulin or glucagon. In addition, while there is
                              precedent for a glucagon product being approved under a Section
                              505(b)(2) NDA, we are not aware of any insulin product that has been
                              approved under a Section 505(b)(2) NDA. If the FDA determines that
                              Section 505(b)(2) NDAs are not appropriate and that full NDAs are
                              required for our product candidates, the time and financial resources
                              required to obtain FDA approval for our product candidates could
                              substantially and materially increase, and our product candidates
                              might be less likely to be approved. If the FDA requires full NDAs
                              for our product candidates, or requires more extensive testing and
                              development for some other reason, our ability to compete with
                              alternative products that arrive on the market more quickly than our
                              product candidates would be adversely impacted.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; "><I>Patent Protections.</I> An applicant submitting a Section 505(b)(2) NDA must certify to the
                              FDA with respect to the patent status of the reference drug upon
                              which the applicant relies in support of approval of its drug. With
                              respect to every patent listed in the FDA's Orange Book, which is the
                              FDA's list of approved drug
                           </P>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">11</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <DIV style="padding-top: 0px; text-align: left; ">
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 0pt; margin-top: 06.00pt; text-align: left; ">products, as claiming the reference drug or an approved method of use
                              of the reference drug, the Section 505(b)(2) applicant must certify
                              that: (1) there is no patent information listed by the FDA for the
                              reference drug; (2) the listed patent has expired; (3) the listed
                              patent has not expired, but will expire on a particular date; (4) the
                              listed patent is invalid, unenforceable, or will not be infringed by
                              the manufacture, use, or sale of the product in the Section 505(b)(2)
                              NDA; or (5) if the patent is a use patent, that the applicant does
                              not seek approval for a use claimed by the patent. If the applicant
                              files a certification to the effect of clause (1), (2) or (5), FDA
                              approval of the Section 505(b)(2) NDA may be made effective
                              immediately upon successful FDA review of the application, in the
                              absence of marketing exclusivity delays, which are discussed below.
                              If the applicant files a certification to the effect of clause (3),
                              the Section 505(b)(2) NDA approval may not be made effective until
                              the expiration of the relevant patent and the expiration of any
                              marketing exclusivity delays.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">If the Section 505(b)(2) NDA applicant provides a certification to
                              the effect of clause (4), referred to as a paragraph IV
                              certification, the applicant also must send notice of the
                              certification to the patent owner and the holder of the NDA for the
                              reference drug. The filing of a patent infringement lawsuit within 45
                              days of the receipt of the notification may prevent the FDA from
                              approving the Section 505(b)(2) NDA for 30 months from the date of
                              the receipt of the notification unless a court determines that a
                              longer or shorter period is appropriate because either party to the
                              action failed to reasonably cooperate in expediting the action.
                              However, the FDA may approve the Section 505(b)(2) NDA before the 30
                              months have expired if a court decides that the patent is invalid,
                              unenforceable, or not infringed, or if a court enters a settlement
                              order or consent decree stating the patent is invalid or not
                              infringed.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Notwithstanding the approval of many products by the FDA pursuant to
                              Section 505(b)(2), over the last few years certain pharmaceutical
                              companies and others have objected to the FDA's interpretation of
                              Section 505(b)(2). If the FDA's interpretation of Section 505(b)(2)
                              is successfully challenged in court, the FDA may be required to
                              change its interpretation of Section 505(b)(2) which could delay or
                              even prevent the FDA from approving any Section 505(b)(2) NDA that we
                              submit. The pharmaceutical industry is highly competitive, and it is
                              not uncommon for a manufacturer of an approved product to file a
                              citizen petition with the FDA seeking to delay approval of, or impose
                              additional approval requirements for, pending competing products. If
                              successful, such petitions can significantly delay, or even prevent,
                              the approval of the new product. Moreover, even if the FDA ultimately
                              denies such a petition, the FDA may substantially delay approval
                              while it considers and responds to the petition.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; "><I>Marketing Exclusivity.</I> Marketing exclusivity provisions under the FFDCA can delay the
                              submission or the approval of Section 505(b)(2) NDAs, thereby
                              delaying a product approved under Section 505(b)(2) from entering the
                              market. The FFDCA provides five-year marketing exclusivity to the
                              first applicant to gain approval of an NDA for a new chemical entity,
                              or NCE, meaning that the FDA has not previously approved any other
                              drug containing the same active moiety. This exclusivity generally
                              prohibits the submission of a Section 505(b)(2) NDA for any drug
                              product containing the active moiety during the five-year exclusivity
                              period. However, submission of a Section 505(b)(2) NDA that certifies
                              that a listed patent is invalid, unenforceable, or will not be
                              infringed, as discussed above, is permitted after four years. In that
                              case, if a patent infringement lawsuit is brought within 45 days
                              after such certification, FDA approval of the Section 505(b)(2) NDA
                              may automatically be stayed until 7.5 years after the NCE approval
                              date. The FFDCA also provides three years of marketing exclusivity
                              for the approval of new and supplemental NDAs for product changes,
                              including, among other things, new indications, dosage forms, routes
                              of administration or strengths of an existing drug, or for a new use,
                              if new clinical investigations, other than bioavailability studies,
                              that were conducted or sponsored by the applicant are deemed by the
                              FDA to be essential to the approval of the application. Five-year and
                              three-year exclusivity will not delay the submission or approval of
                              another full NDA; however, as discussed above, an applicant
                              submitting a full NDA under Section 505(b)(1) would be required to
                              conduct or obtain a right of reference to all of the preclinical and
                              adequate and well-controlled clinical trials necessary to demonstrate
                              safety and effectiveness.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Other types of exclusivity in the United States include orphan drug
                              exclusivity and pediatric exclusivity. The FDA may grant orphan drug
                              designation to a drug intended to treat a rare disease or condition,
                              which is generally a disease or condition that affects fewer than
                              200,000 individuals in the United States, or more than 200,000
                              individuals in the United States and for which there is no reasonable
                              expectation that the cost of developing and making available in the
                              United States a drug for this type of disease or condition will be
                              recovered from sales in the United States for that drug. Seven-year
                              orphan drug exclusivity is available to a
                           </P>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">12</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <DIV style="padding-top: 0px; text-align: left; ">
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 0pt; margin-top: 06.00pt; text-align: left; ">product that has orphan drug designation and that receives the first
                              FDA approval for the indication for which the drug has such
                              designation. Orphan drug exclusivity prevents approval of another
                              application for the same drug for the same orphan indication, for a
                              period of seven years, regardless of whether the application is a
                              full NDA or a Section 505(b)(2) NDA, except in limited circumstances,
                              such as a showing of clinical superiority to the product with orphan
                              exclusivity. Pediatric exclusivity, if granted, provides an
                              additional six months to an existing exclusivity or statutory delay
                              in approval resulting from a patent certification. This six-month
                              exclusivity, which runs from the end of other exclusivity protection
                              or patent delay, may be granted based on the completion of a
                              pediatric study in accordance with an FDA-issued "Written Request"
                              for such a&nbsp;study.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Section 505(b)(2) NDAs are similar to full NDAs filed under Section
                              505(b)(1) in that they are entitled to any of these forms of
                              exclusivity if they meet the qualifying criteria. They also are
                              entitled to the patent protections described above, based on patents
                              that are listed in the FDA's Orange Book, in the same manner as
                              patents claiming drugs and uses approved for NDAs submitted as
                              full&nbsp;NDAs.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; "><I>Other Regulatory Requirements.</I> Maintaining substantial compliance with appropriate federal, state
                              and local statutes and regulations requires the expenditure of
                              substantial time and financial resources. Drug manufacturers are
                              required to register their establishments with the FDA and certain
                              state agencies, and after approval, the FDA and these state agencies
                              conduct periodic unannounced inspections to ensure continued
                              compliance with ongoing regulatory requirements, including cGMP. In
                              addition, after approval, some types of changes to the approved
                              product, such as adding new indications, manufacturing changes and
                              additional labeling claims, are subject to further FDA review and
                              approval. The FDA may require post-approval testing and surveillance
                              programs to monitor safety and the effectiveness of approved products
                              that have been commercialized. Any drug products manufactured or
                              distributed by us pursuant to FDA approvals are subject to continuing
                              regulation by the FDA, including:
                           </P>
                           <DIV style="padding-left: 37pt; ">
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>record-keeping requirements;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>reporting of adverse experiences with the&nbsp;drug;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>providing the FDA with updated safety and efficacy information;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>reporting on advertisements and promotional labeling;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>drug sampling and distribution requirements; and
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>complying with electronic record and signature requirements.
                              </P>
                           </DIV>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In addition, the FDA strictly regulates labeling, advertising,
                              promotion and other types of information on products that are placed
                              on the market. There are numerous regulations and policies that
                              govern various means for disseminating information to health-care
                              professionals as well as consumers, including to industry sponsored
                              scientific and educational activities, information provided to the
                              media and information provided over the Internet. Drugs may be
                              promoted only for the approved indications and in accordance with the
                              provisions of the approved label.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The FDA has very broad enforcement authority and the failure to
                              comply with applicable regulatory requirements can result in
                              administrative or judicial sanctions being imposed on us or on the
                              manufacturers and distributors of our approved products, including
                              warning letters, refusals of government contracts, clinical holds,
                              civil penalties, injunctions, restitution, and disgorgement or
                              profits, recall or seizure of products, total or partial suspension
                              of production or distribution, withdrawal of approvals, refusal to
                              approve pending applications, and criminal prosecution resulting in
                              fines and incarceration. The FDA and other agencies actively enforce
                              the laws and regulations prohibiting the promotion of off-label uses,
                              and a company that is found to have improperly promoted off-label
                              uses may be subject to significant liability. In addition, even after
                              regulatory approval is obtained, later discovery of previously
                              unknown problems with a product may result in restrictions on the
                              product or even complete withdrawal of the product from the&nbsp;market.
                           </P>
                        </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Regulations Outside the United States</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In addition to regulations in the United States, we will be subject
                              to a variety of laws and regulations in other jurisdictions governing
                              clinical trials and commercial sales and distribution of our
                              products. Whether or not we obtain FDA approval for a product, we
                              must obtain the necessary approvals by the comparable regulatory
                              authorities of countries outside the United States before we can
                              commence clinical trials or
                           </P>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">13</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <DIV style="padding-top: 0px; text-align: left; ">
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 0pt; margin-top: 06.00pt; text-align: left; ">marketing of the product in those countries. The approval process
                              varies from country to country, and the time may be longer or shorter
                              than that required for FDA approval. The requirements governing the
                              conduct of clinical trials, product licensing, pricing and
                              reimbursement also vary between jurisdictions.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">To obtain regulatory approval of a drug under European Union
                              regulatory systems, we may submit applications for marketing
                              authorizations either under a centralized or decentralized procedure.
                              The centralized procedure is compulsory for medicines produced by
                              certain biotechnological processes, new active substances indicated
                              for the treatment of certain diseases such as AIDS, cancer,
                              neurodegenerative disorders and diabetes, and products designated as
                              orphan medicinal products, and optional for other new active
                              substances and those products which constitute a significant
                              therapeutic, scientific or technical innovation. The procedure
                              provides for the grant of a single marketing authorization that is
                              valid for all European Union member states, as well as for Iceland,
                              Liechtenstein, and Norway. The decentralized procedure provides for
                              approval by one or more other, or concerned, member states of an
                              assessment of an application performed by one member state, known as
                              the reference member state. Under this procedure, an applicant
                              submits an application, or dossier, and related materials including a
                              draft summary of product characteristics, and draft labeling and
                              package leaflet, to the reference member state and concerned member
                              states. The reference member state prepares a draft assessment and
                              drafts of the related materials within 120 days after receipt of a
                              valid application. Within 90 days of receiving the reference member
                              state's assessment report, each concerned member state must decide
                              whether to approve the assessment report and related materials. If a
                              member state cannot approve the assessment report and related
                              materials on the grounds of potential serious risk to the public
                              health, the disputed points may eventually be referred to the
                              European Commission, whose decision is binding on all member states.
                           </P>
                        </DIV>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Competition</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The pharmaceutical industry is characterized by intense competition
                           and rapidly evolving technology. Many large pharmaceutical and
                           biotechnology companies, academic institutions, governmental agencies
                           and other public and private research organizations are pursuing the
                           development of novel drugs and drug formulations that target
                           endocrine disorders. If approved, our product candidates will compete
                           against many products with similar indications.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">If approved, our GEM product candidate would face significant
                           competition. Eli Lilly and Novo Nordisk currently market injectable
                           glucagon rescue kit products. We are aware of several glucagon rescue
                           product candidates in early stage development, such as a potentially
                           competitive auto-injector device being developed by Enject
                           Corporation that integrates glucagon powder and a diluent into a
                           dual-chamber cartridge within that device. Xeris Corporation, or
                           Xeris, is developing glucagon formulations that are stabilized using
                           non-aqueous solvents to suppress glucagon fibrillation. At the 2014
                           Annual Meeting of the American Diabetes Association, Xeris presented
                           data from a Phase 2, double-blind, crossover, comparative
                           pharmacology study in healthy non-diabetic volunteers in which the
                           Xeris candidate formulation demonstrated pharmacodynamic
                           bioequivalence to a marketed comparator (although the pharmacokinetic
                           profiles of the 2 glucagon formulations were significantly
                           different). In addition, other companies with expertise in protein
                           stabilization, including Latitude Pharmaceuticals, have announced
                           that they have developed a stable glucagon formulation using
                           FDA-approved injectable ingredients. We believe that an intranasal
                           formulation of glucagon is being studied in one or more clinical
                           trials, as is a glucagon formulation delivered intra-dermally by a
                           micro needle patch. All of these programs utilize the same active
                           pharmaceutical ingredient as the stable glucagon presentations that
                           we are developing and offer, or may offer, presentations allowing for
                           room temperature storage. In addition, Eli Lilly, Novo Nordisk and
                           Zealand Pharma A/S, a pharmaceutical company based in Denmark, may be
                           developing glucagon analogs, which may also offer advantages over our
                           stable glucagon presentations.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">If approved, the primary competition for our BIOD-123
                           ultra-rapid-acting insulin product candidate will be rapid-acting
                           mealtime injectable insulins. There are several approved injectable
                           rapid-acting mealtime insulin analogs currently on the market
                           including Humalog&#174;, marketed by Eli Lilly and Company, NovoLog&#174;,
                           marketed by Novo Nordisk, and Apidra&#174;, marketed by Sanofi. These
                           rapid-acting insulin analogs provide improvement over "regular"
                           mealtime insulin, including faster subcutaneous absorption, an
                           earlier and greater insulin peak and more rapid post-peak decrease.
                           Both Humalog&#174; and NovoLog&#174; have limited remaining patent protection
                           in the United States and Europe. The possible introduction of lower
                           priced brands
                        </P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">14</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 0pt; margin-top: 06.00pt; text-align: left; ">or substitutable generic versions of these products could negatively
                           impact the revenue potential of our ultra-rapid-acting product
                           candidates should any be&nbsp;approved.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In addition, other development stage insulin formulations may be
                           approved and compete with BIOD-123. Halozyme Therapeutics, Inc. has
                           conducted a Phase 1 and multiple Phase 2 clinical trials of RHI,
                           lispro (the insulin analog in Humalog&#174;) and aspart (the insulin
                           analog in NovoLog&#174;) in combination with a recombinant human
                           hyaluronidase enzyme and has reported that in each case the
                           combination yielded pharmacokinetics and glucodynamics that better
                           mimicked physiologic mealtime insulin release and activity than RHI,
                           Humalog&#174; or NovoLog&#174; alone. Novo Nordisk has initiated clinical
                           development of an insulin analog intended to provide faster onset of
                           action than the currently available rapid-acting insulin analogs and
                           is studying candidate formulations in Phase 3 clinical trials. A
                           French biotechnology company, Adocia Inc., announced positive
                           preliminary results in September 2014 from a Phase 2a dose response
                           clinical trial evaluating an "ultra-fast" formulation of insulin
                           lispro. Furthermore, the company announced plans to develop a
                           concentrated formulation of insulin lispro using its absorption
                           enhancing technologies.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Our concentrated ultra-rapid acting insulin product candidate,
                           BIOD-531, if approved, would face significant competition from
                           insulin formulations currently on the market and, potentially, from
                           development stage insulin formulations and other treatment systems.
                           Humulin&#174; R U-500 is commonly used to treat diabetes patients with
                           severe insulin resistance, and pre-mixed insulins, such as Humalog&#174;
                           Mix 75/25, is commonly used to treat diabetes patients and lesser
                           degrees of insulin resistance. Newer combination products may also
                           compete with BIOD-531. For example, a combination of insulin
                           degludec, an ultra-long-acting basal insulin developed by Novo
                           Nordisk, and NovoLog&#174; is approved in Europe and may be approved in
                           the United States within the next few years. Also, combinations of
                           basal insulin and GLP-1 analogs have either been approved or are in
                           later stages of development; these products are believed to offer
                           some measure of postprandial glucose control in addition to the
                           control offered by a basal insulin. Furthermore, Thermalin Diabetes,
                           LLC, has announced plans to develop a novel concentrated
                           insulin-analog based formulation with fast absorption.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Several companies are also developing or marketing alternative
                           insulin systems for diabetes, including Afrezza&#174; an inhalable
                           mealtime insulin product from MannKind Corporation, which was
                           approved by the FDA in July 2014. In September 2014 MannKind
                           Corporation announced the closing of a worldwide exclusive
                           collaboration and licensing agreement with Sanofi for the development
                           and commercialization of Afrezza&#174; for adults with Type 1 and Type 2
                           diabetes. An inhaled insulin could reduce the overall market for
                           injectable mealtime insulin.
                        </P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Intellectual Property and Proprietary Technology</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The technologies for our ultra-rapid-acting insulin formulations have
                           been developed exclusively by our employees, without input from third
                           parties.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In October 2007 the United States Patent and Trademark Office issued
                           U.S. Patent No. 7,279,457 encompassing our ultra-rapid-acting insulin
                           formulations. If all maintenance fees are paid, the patent will
                           expire no earlier than January 2026. In addition, a related European
                           Patent, EP 1 740 154, was granted in June 2009 and expires in March
                           2025 in the designated countries if all annuity fees are paid. Two
                           additional European applications on this technology, EP2 319 500 and
                           EP2 106 790, have been issued and, in October 2014, were successfully
                           defended in a third party opposition before the Opposition Division
                           of the European Patent Office. Related applications have been granted
                           in Australia, Canada and Japan. Additional applications with claims
                           directed to formulations containing insulin, insulin derivatives or
                           analogs are currently pending in the U.S. and foreign patent offices.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Our pending patent applications, those we may file in the future, or
                           those we may license from third parties, may not result in patents
                           being issued.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The individual active and inactive ingredients in our
                           ultra-rapid-acting insulin formulations and our liquid glucagon
                           formulations have been known and used for many years and, therefore,
                           are no longer subject to patent protection, except in proprietary
                           combinations. Accordingly, our patent and pending applications are
                           directed to the particular formulations of these ingredients in our
                           products, and to their use. Although we believe our formulations and
                           their uses are or will be patented and provide a competitive
                           advantage, our patents may not prevent others from marketing
                           formulations using the same active and inactive ingredients in
                           similar but different formulations.
                        </P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">15</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We have entered into an agreement with Aegis Therapeutics, LLC, or
                           Aegis, to acquire an exclusive, sublicensable, worldwide license to
                           the protein stabilization technology that we are using in the
                           development of our liquid glucagon formulations. Under the terms of
                           the agreement, Aegis will prepare, file, prosecute and maintain
                           patents and patent applications that are specific to our liquid
                           glucagon formulations in jurisdictions that we may designate from
                           time to&nbsp;time.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We have entered into a customization and commercial supply agreement
                           with Unilife Medical Solutions, Inc., a wholly owned subsidiary of
                           Unilife Corporation, to acquire an exclusive, sublicensable,
                           worldwide license to a proprietary device platform of dual-chamber
                           devices for use with glucagon. Under the terms of the agreement,
                           Unilife Medical Solutions, Inc. will control the patent protection
                           relating to the devices and be the sole owner of improvements thereto.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We require our employees and consultants to execute confidentiality
                           agreements upon the commencement of employment, consulting or
                           collaborative relationships with us. These agreements provide that
                           all confidential information developed or made known during the
                           course of the relationship with us be kept confidential and not
                           disclosed to third parties except in specific circumstances. In the
                           case of employees, the agreements provide that all inventions
                           resulting from work performed for us, utilizing our property or
                           relating to our business and conceived or completed by the individual
                           during employment shall be our exclusive property to the extent
                           permitted by applicable law.
                        </P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Manufacturing</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We do not have the facilities required to manufacture our product
                           candidates for use in clinical trials. Therefore, we intend to
                           manufacture our product candidates by contracting with third parties
                           that operate manufacturing facilities in accordance with&nbsp;cGMP.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We have terminated an earlier supply agreement with N.V. Organon
                           (subsequently acquired by Amphastar Pharmaceuticals, Inc., a
                           specialty pharmaceutical development and manufacturing company),
                           under which we have purchased the RHI we have used to formulate all
                           of our RHI-based product candidates, including BIOD-123 and BIOD-531.
                           We intend to use existing supplies of RHI to support the further
                           development BIOD-531, as well as enter into one or more development
                           stage RHI supply agreements, as necessary.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">With regard to our insulin analog-based formulations, we have entered
                           into an agreement with a pharmaceutical company to acquire a limited
                           supply of an insulin analog for use as the active pharmaceutical
                           ingredient in our proprietary formulations. In addition, we have
                           conducted some development work and clinical trials of our insulin
                           analog-based formulations by combining our proprietary excipients
                           with a marketed presentation of an insulin analog.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We have entered into a commercial supply agreement with Bachem AG, a
                           Swiss corporation, for the supply of all of the glucagon we will need
                           for the testing and manufacturing of our GEM product candidate. The
                           initial term of our agreement with Bachem AG will expire in July
                           2017. We believe that the quantities of glucagon that we have rights
                           to acquire under this agreement will be sufficient to allow us to
                           complete our current and anticipated future clinical trials of our
                           glucagon rescue product candidates and to support the commercial
                           launch of our GEM product candidate.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We have entered into a customization and commercial supply agreement
                           with Unilife Medical Solutions, Inc., a wholly owned subsidiary of
                           Unilife Corporation, to acquire an exclusive, sublicensable,
                           worldwide license to a proprietary device platform of dual-chamber
                           devices for use with glucagon. Under the terms of the agreement,
                           Unilife will develop and be the sole supplier of the device intended
                           for use with our dual-chamber glucagon rescue product candidate.
                           Additionally, Unilife is responsible for delivering three
                           registration lots of the filled and finished GEM device required for
                           submitting an NDA to the FDA. The initial term of our agreement with
                           Unilife Medical Solutions, Inc. will expire in&nbsp;2028.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We have entered into manufacturing agreement with Cangene bioPharma
                           Inc., doing business as Emergent BioSolutions, or Emergent, under
                           which Emergent will fill and finish the GEM device, using lyophilized
                           glucagon and an aqueous diluent. During the term of the agreement
                           following validation of the manufacturing process, we are required to
                           purchase, and Emergent is obligated to deliver to us, one
                           manufactured lot of the GEM device every quarter. We would expect to
                           reserve and commit to additional
                        </P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">16</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 0pt; margin-top: 06.00pt; text-align: left; ">manufacturing capacity with Emergent following the commercial launch
                           of our GEM product candidate, if successful. Either party may
                           terminate the agreement without cause upon thirty-six months prior
                           written notice.
                        </P>
                     </DIV> <BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Sales and Marketing</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We currently have no sales and marketing capabilities and no
                           distribution capabilities. Our current strategy is to selectively
                           enter into collaboration agreements with leading pharmaceutical or
                           biotechnology companies for the commercialization of our product
                           candidates.
                        </P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Employees</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">At November 30, 2014 we had 30 full time-employees who perform
                           services for us on a regular basis. We consider our employee
                           relations to be&nbsp;good.
                        </P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Additional Information</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Our website is <U>www.biodel.com</U>. We are not including the information contained on our website as a
                           part of, or incorporating it by reference into, this Annual Report on
                           Form 10-K. We make available free of charge on our website our Annual
                           Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports
                           on Form 8-K and amendments to those reports filed or furnished
                           pursuant to Section 13(a) or 15(d) of the Exchange Act, as soon as
                           reasonably practicable after we electronically file such material
                           with, or furnished it to, the Securities and Exchange Commission. Our
                           reports filed with the Securities and Exchange Commission are also
                           available at the Securities and Exchange Commission's website at <U>www.sec.gov</U>.
                        </P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">17</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: center; ">
               <DIV style="padding-top: 0px; text-align: center; ">
                  <DIV style="padding-top: 0px; text-align: center; "><BR><DIV style="padding-top: 0px; text-align: center; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; "><A name="allpages_continue3"></A>Executive Officers of the Registrant</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The following table sets forth our executive officers, their
                           respective ages and positions as of November 30, 2014:
                        </P>
                        <P style="text-align: center; margin: 0pt; padding: 0pt; ">
                           <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                              <TR>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 36.57%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 1.44%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 5.77%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 1.44%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 54.78%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                              </TR>
                              <DIV style="padding-top: 3px; text-align: center; ">
                                 <TR cont_lvl="1" style="text-align: left; ">
                                    <TD style="vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: left; "><U><B style="text-align: left; font-size: 8.0pt; ">Name</B></U></TD>
                                    <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><U><B style="text-align: center; font-size: 8.0pt; ">Age</B></U></TD>
                                    <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><U><B style="text-align: center; font-size: 8.0pt; ">Position</B></U></TD>
                                    <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Dr. Errol B. De Souza </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; text-indent: -10.00pt; ">61</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">President and Chief Executive Officer</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Gary G. Gemignani </TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; text-indent: -10.00pt; ">49</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">Chief Financial Officer</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Dr. Alan S. Krasner </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; text-indent: -10.00pt; ">51</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">Chief Medical Officer</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Paul S. Bavier </TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; text-indent: -10.00pt; ">42</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">General Counsel and Secretary, Chief Administrative Officer and Vice
                                       President of Corporate Development
                                    </TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; ">&nbsp;</TD>
                                 </TR>
                              </DIV>
                           </TABLE>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; "><I>Dr. Errol De&nbsp;Souza</I> joined our management and board of directors in March 2010. Dr. De
                           Souza has over two decades of experience in the biopharmaceutical
                           industry. From March 2009 until March 2010, Dr. De Souza was a
                           pharmaceutical and biotechnology consultant. From April 2003 to
                           January 2009, Dr. De Souza was president and chief executive officer
                           of Archemix Corporation, a privately held biopharmaceutical company
                           focused on aptamer therapeutics. From September 2002 to March 2003,
                           he was president, chief executive officer and a director of Synaptic
                           Pharmaceuticals Corporation, a publicly traded biopharmaceutical
                           company that was acquired by H. Lundbeck A/S in March 2003. Dr. De
                           Souza is a member of the board of directors of each of the following
                           publicly traded companies: Bionomics Ltd. and Targacept, Inc. Dr. De
                           Souza received his B.A. (Honors) in physiology and his Ph.D. in
                           neuroendocrinology from the University of Toronto and he completed
                           his postdoctoral fellowship in neuroscience at The Johns Hopkins
                           University School of&nbsp;Medicine.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; "><I>Mr. Gary Gemignani</I> joined our company in September 2014. He has over 25 years of
                           experience in accounting, strategic planning and financing in the
                           life sciences industry and has held senior leadership and management
                           roles at Novartis, Prudential Financial, Wyeth and Arthur
                           Andersen.&nbsp;Mr. Gemignani was most recently with Champions Oncology
                           where he served as Chief Financial Officer and Executive Vice
                           President from 2011 to 2013, with responsibility for raising capital,
                           investor relations and all financial operations.&nbsp;From 2010 to 2011,
                           Mr. Gemignani was the Executive Vice President, Chief Operating
                           Officer and Chief Financial Officer for Coronado Biosciences Inc.,
                           responsible for financial operations, strategic planning and business
                           development activities.&nbsp;He also served as the Executive Vice
                           President, Chief Operating Officer and Chief Financial officer of
                           Gentium S.P.A from 2006 to 2010.&nbsp;Mr. Gemignani received a Bachelor's
                           Degree in Accounting from St. Peter's College.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; "><I>Dr. Alan Krasner</I> joined our company in May 2008 as Chief Medical Officer. From 2002
                           to 2008, Dr. Krasner served as Director in the Department of Clinical
                           Research Metabolic Diseases at Pfizer Global Research and Development
                           where he was responsible for the design, execution, clinical
                           analysis, and reporting of multiple, global clinical trials
                           supporting registration of late stage drug candidates. Dr. Krasner
                           currently serves as a consulting physician at the Joslin Diabetes and
                           Endocrinology Center of the Lawrence and Memorial Hospital in New
                           London, Connecticut. Dr. Krasner holds a B.S. from the Medical
                           Education Honors Program at Northwestern University and an M.D. from
                           Northwestern University Medical School. He completed his residency at
                           Johns Hopkins Hospital in internal medicine and subsequently
                           completed his fellowship at Johns Hopkins Hospital in endocrinology
                           and metabolism.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; "><I>Mr. Paul Bavier</I> is our General Counsel and Secretary, Chief Administrative Officer
                           and Vice President of Corporate Development. From December 2013 to
                           November 2014, he served as our General Counsel, Chief Compliance
                           Officer and Secretary. Mr. Bavier served as our General Counsel and
                           Secretary from 2008 to 2013, and as our Deputy General Counsel from
                           2007 to 2008. Prior to joining Biodel, Mr. Bavier was the Assistant
                           General Counsel at Gerber Scientific, Inc., a publicly held
                           integrated automation equipment and software company with global
                           operations. He also served as Associate Counsel in the corporate law
                           group of The Hartford Financial Services Group, Inc. Mr. Bavier began
                           his legal career as an associate in the corporate law department of
                           Ropes &amp; Gray LLP in Boston. He holds a B.A. from Middlebury College
                           and a J.D. from the University of Michigan Law&nbsp;School.
                        </P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">18</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; "><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; "><A name="Item1a"></A><A name="allpages_continue4"></A>ITEM 1A.&nbsp;<I><B>RISK FACTORS</B></I></B></DIV>
                        </P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Risks Related to Our Financial Position and Need for Additional Capital</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">We have incurred significant losses since our inception. We expect to
                                 incur losses for the foreseeable future and may never achieve or
                                 maintain profitability.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Since our inception in December 2003, we have incurred significant
                           operating losses. Our net losses were approximately $14.1 million for
                           the fiscal year ended September 30, 2014. As of September 30, 2014,
                           we had a deficit accumulated since inception of approximately $229.6
                           million. We have invested a significant portion of our efforts and
                           financial resources in the development of our RHI- and insulin
                           analog-based ultra-rapid-acting insulin product candidates, including
                           BIOD-123, BIOD-531, BIOD-238, BIOD-250, and our prior Linjeta&#153;
                           formulation. More recently, we have begun to invest an increasing
                           portion of our efforts and financial resources in the development of
                           our GEM product candidate.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We expect to continue to incur significant operating losses for at
                           least the next several years as we&nbsp;may:
                        </P>
                        <DIV style="padding-left: 37pt; ">
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>conduct the development work necessary to finalize the formulation
                              and design of our GEM product candidate and undertake manufacturing
                              activities in support our earlier stage clinical trials with that
                              product candidate;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>produce registration batches of our GEM product candidate to support
                              the submission of an NDA with the&nbsp;FDA;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>conduct later stage clinical trials with our GEM product candidate,
                              including at least one pivotal clinical trial required for FDA
                              approval of an NDA, and commence targeted commercialization
                              activities;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>conduct clinical trials with our BIOD-531 product candidate,
                              including a planned Phase 2, parallel group study in patients with
                              Type 2 diabetes over a six-month treatment period;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>conduct the required stability, preclinical and human factors and
                              user acceptability studies to support the approval of GEM device and
                              one or more insulin injection devices intended for use with BIOD-531;
                              and
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>purchase active pharmaceutical ingredients and other materials in
                              support of our product candidates.
                           </P>
                        </DIV>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">To become and remain profitable, we must succeed in developing and
                           eventually commercializing drugs with significant market potential.
                           This will require us to be successful in a range of challenging
                           activities, including developing proprietary insulin and glucagon
                           product candidates with desirable pharmacokinetic, pharmacodynamic,
                           stability and injection site toleration characteristics and then
                           successfully completing preclinical testing and clinical trials for
                           these formulations, obtaining regulatory approval for these
                           formulations and manufacturing, marketing and selling those products
                           for which we may obtain regulatory approval. We may never succeed in
                           these activities and may never generate revenues that are significant
                           or large enough to achieve profitability. Even if we do achieve
                           profitability, we may not be able to sustain or increase
                           profitability on a quarterly or annual basis. Our failure to become
                           and remain profitable could depress the market price of our common
                           stock and could impair our ability to raise capital, expand our
                           business or continue our operations. A decline in the market price of
                           our common stock could also cause you to lose all or a part of your
                           investment.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">We will need substantial additional funding and may be unable to
                                 raise capital when needed, which would force us to delay, reduce or
                                 eliminate our product development programs or commercialization
                                 efforts.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We are a development stage company with no commercial products. All
                           of our product candidates are in early stages of development. Our
                           product candidates will require significant additional clinical
                           development, regulatory approvals and related investment before they
                           can be commercialized. We expect to continue to incur significant
                           research and development expenses as we continue our formulation work
                           and advance these programs through clinical trials. Unless we are
                           successful in consummating a strategic partnership to develop and
                           commercialize an ultra-rapid-acting insulin formulation or a glucagon
                           rescue presentation, we would need to raise substantial additional
                           capital to develop and commercialize competitive products. Such
                           financing may
                        </P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">19</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 0pt; margin-top: 06.00pt; text-align: left; ">not be available on terms acceptable to us, or at all. If we are
                           unable to obtain financing on favorable terms, our business, results
                           of operations and financial condition may be materially adversely
                           affected.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Based upon our current plans, we believe that our existing cash, cash
                           equivalents and restricted cash will be sufficient to fund our
                           anticipated operating expenses and capital expenditures at least
                           through the third calendar quarter of 2015. However, we cannot assure
                           you that our plans will not change or that changed circumstances will
                           not result in the depletion of our capital resources more rapidly
                           than we currently anticipate. Our future capital requirements will
                           depend on many factors, including:
                        </P>
                        <DIV style="padding-left: 37pt; ">
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the progress, timing or success of our research and development and
                              clinical programs for our product candidates, particularly our GEM
                              product candidate and our BIOD-531 product candidate;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to conduct the development work necessary to finalize the
                              formulation and presentation of our GEM product candidate, as well as
                              the preclinical studies, clinical trials and manufacturing activities
                              necessary to support the submission of an NDA for that candidate;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the ability and willingness of our existing strategic partners,
                              service providers and suppliers, upon which we rely in the
                              advancement of our product candidates, to meet the obligations set
                              forth in our agreements with them, including Unilife, which is
                              responsible for designing and manufacturing the device intended for
                              use with our GEM product candidate, as well as delivering three
                              registration lots of the filled and finished GEM device required for
                              submitting an NDA to the&nbsp;FDA;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the success of our formulation development work to improve the
                              stability of our newer ultra-and rapid-acting insulin analog-based
                              formulations while maintaining the pharmacokinetic and injection site
                              toleration characteristics associated with earlier formulations;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the results of our real-time stability programs for our glucagon-,
                              RHI-, and insulin analog-based product candidates, including the
                              reproducibility of earlier, smaller scale, stability studies and our
                              ability to accurately project long term stability on the basis of
                              accelerated testing;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to accurately anticipate technical challenges that we may
                              face in the development of our glucagon-, RHI-, and insulin
                              analog-based product candidates;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to secure approval by the FDA for our product candidates
                              under Section 505(b)(2) of the&nbsp;FFDCA;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to enter into collaboration arrangements for the
                              commercialization of our product candidates and the success or
                              failure of any such collaborations into which we enter, or our
                              ability to commercialize our product candidates ourselves;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to enforce our patents for our product candidates and our
                              ability to secure additional patents for our product candidates;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to protect our intellectual property and operate our
                              business without infringing upon the intellectual property rights
                              of&nbsp;others;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the degree of clinical utility of our product candidates,
                              particularly with regard to our ultra-rapid-acting insulin
                              formulations, which have not yet been shown to be clinically superior
                              to existing rapid-acting insulin analogs;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the emergence of competing technologies and products and other
                              adverse market developments, such as advancements in glucagon
                              stabilization technologies that could enable a room-temperature
                              rescue product in a portable, easy to use presentation;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the ability of our contract manufacturing organizations or
                              collaborators to produce our products in our final dosage form and in
                              the quantities we may&nbsp;require;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to secure adequate supplies of active pharmaceutical
                              ingredients to support our product development programs and, if
                              successful, the commercialization one or more product candidates;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our capabilities and strategies for manufacturing, marketing and
                              commercializing a product candidate; and
                           </P>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">20</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <DIV style="padding-left: 37pt; ">
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to accurately estimate anticipated operating losses,
                              future revenues, capital requirements and our needs for additional
                              financing.
                           </P>
                        </DIV>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Until such time, if ever, as we can generate substantial product
                           revenues, we expect to finance our cash needs through public or
                           private equity offerings and debt financings, strategic
                           collaborations and licensing arrangements. If we raise additional
                           funds by issuing additional equity securities, our stockholders will
                           experience dilution. Debt financing, if available, may involve
                           agreements that include covenants limiting or restricting our ability
                           to take specific actions, such as incurring additional debt, making
                           capital expenditures or declaring dividends. Any debt financing or
                           additional equity that we raise may contain terms, such as
                           liquidation and other preferences, which are not favorable to us or
                           our stockholders. If we raise additional funds through collaboration,
                           strategic alliance or licensing arrangements with third parties, it
                           may be necessary to relinquish valuable rights to our technologies or
                           product candidates, future revenue streams, research programs or
                           product candidates or to grant licenses on terms that may not be
                           favorable to&nbsp;us.
                        </P>
                        <P style="padding-left: 0pt; padding-top: 6px; line-height: 1.3; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Our independent registered public accounting firm has expressed doubt
                                 about our ability to continue as a going concern, which may hinder
                                 our ability to obtain future financing.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 18.00pt; text-align: left; ">Our consolidated financial statements as of September 30, 2014 were
                           prepared under the assumption that we will continue as a going
                           concern for the next twelve months. Our independent registered public
                           accounting firm has issued a report that included an explanatory
                           paragraph referring to our recurring and expected continuing future
                           losses from operations and expressing substantial doubt in our
                           ability to continue as a going concern without additional capital
                           becoming available. While we have access to certain amounts of financing through our At-the-Market Issuance

Sales Agreement, or the sales agreement, with MLV &amp; Co., LLC, or MLV, and our stock purchase agreement with Lincoln Park
Capital Fund, LLC, or LPC, there are certain factors, such as volume of trading in our common stock, our stock price and the ability to terminate the
agreement with notice, which limit the amount that can be raised in a short period of time through our agreement with LPC.

Our ability to continue as a going concern is
                           dependent upon our ability to obtain additional equity or debt
                           financing, attain further operating efficiencies, reduce
                           expenditures, and, ultimately, to generate revenue. The financial
                           statements do not include any adjustments that might result from the
                           outcome of this uncertainty.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 0; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Our short operating history may make it difficult for you to evaluate
                                 the success of our business to date and to assess our future
                                 viability.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We commenced active operations in January 2004. Our operations to
                           date have been limited to organizing and staffing our company,
                           developing and securing our technology and undertaking preclinical
                           studies and clinical trials of our product candidates. We have
                           limited experience completing large-scale, pivotal clinical trials
                           and we have not yet demonstrated our ability to obtain regulatory
                           approval to market a product, manufacture a commercial scale product,
                           or arrange for a third party to do so on our behalf, or conduct sales
                           and marketing activities necessary for successful product
                           commercialization. Consequently, any predictions you make about our
                           future success or viability may not be as accurate as they could be
                           if we had a longer operating history.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In addition, as a relatively new business, we may encounter
                           unforeseen expenses, difficulties, complications, delays and other
                           known and unknown factors. We may need to transition from a company
                           with a research focus to a company capable of supporting commercial
                           activities. We may not be successful in such a transition.
                        </P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Risks Related to the Development and Commercialization of Our Product Candidates</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">We have depended heavily on the success of our ultra-rapid-acting
                                 mealtime insulin development program.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We have invested a significant portion of our efforts and financial
                           resources in the development of our ultra-rapid-acting insulin
                           product candidates. The FDA concluded that the results from our
                           completed pivotal Phase 3 clinical trials of Linjeta&#153; were not
                           sufficient to obtain marketing approval for the Linjeta&#153; formulation.
                           We therefore chose to study newer formulations in earlier stage
                           clinical trials. Clinical trials of our first two new RHI-based
                           formulations, BIOD-105 and BIOD-107, did not achieve satisfactory
                           results. If we are not able to develop alternative RHI- or
                           insulin-analog based formulations with desirable pharmacokinetic,
                           pharmacodynamic, stability and injection site toleration
                           characteristics, or experience significant delays in doing so, then
                           our business may be materially harmed. For example, while BIOD-531,
                           our lead candidate for a concentrated ultra-rapid-acting RHI-based
                           formulation, demonstrated pharmacokinetic, pharmacodynamic and
                           injection site toleration characteristics consistent with our target
                           product profile in two earlier stage, single-dose, clinical trials,
                           we have not studied BIOD-531 in multi-dose outpatient clinical
                           trials.
                        </P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">21</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The results of our earlier stage clinical trials may not be
                           predictive of results we may generate in later stage clinical trials,
                           which may be more representative of the product candidate's intended
                           use as a long-term therapy. Additionally, we have manufactured a
                           limited number of larger-scale batches of BIOD-531 from which to
                           generate real-time stability data.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Our development of an RHI- or insulin analog-based formulation may
                                 not be successful; some formulations may have different regulatory
                                 requirements to obtain marketing approval from the&nbsp;FDA.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">While we have significant experience with the technology we use to
                           develop ultra-rapid-acting insulin formulations, we cannot assure you
                           that our program to advance RHI- or insulin analog-based formulations
                           will be successful or will offer improvements over the Linjeta&#153;
                           formulation that we submitted to the FDA in our NDA. Some of our
                           formulations offer advantages in terms of injection site toleration,
                           but may not perform as well as the Linjeta&#153; formulation in terms of
                           the overall pharmacokinetic and pharmacodynamic profile. Some of our
                           insulin analog-based formulations under development appear to be
                           absorbed as rapidly as Linjeta&#153;, but are less stable in accelerated
                           testing. For example, BIOD-238 and BIOD-250 do not demonstrate
                           stability characteristics consistent with our target product profile.
                           Accordingly, we are continuing our formulation development work to
                           improve the stability characteristics of our ultra-rapid-acting
                           insulin analog-based formulations. We may be unable to develop new
                           RHI- or insulin analog-based formulations with pharmacokinetic,
                           pharmacodynamic, stability and injection site toleration
                           characteristics that are acceptable to us, a potential strategic
                           partner or the&nbsp;FDA.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Furthermore, the regulatory requirements for any alternate
                           formulation may not meet our expectations or may be different from
                           those applicable to the formulation of Linjeta&#153; submitted in our NDA.
                           For example, advancing any formulation based on an insulin analog may
                           necessitate our conducting additional toxicology work prior to
                           initiation of clinical trials in the United States. While BIOD-238
                           and BIOD 250, which are formulated by adding our proprietary
                           excipients to the marketed presentation of Humalog&#174;, were the subject
                           of a Phase 1 clinical trial in Australia, we expect that we would
                           need to conduct toxicology studies before advancing our insulin
                           analog-based formulations into a Phase 1 clinical trial in the United
                           States.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Our development of a glucagon rescue product candidate may not be
                                 successful; we have limited experience with developing drug-device
                                 combination products and rely heavily on the performance of third
                                 parties collaborators and consultants.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Our experience with the manufacture, testing and analysis of
                           pharmaceutical preparations of glucagon in preclinical studies is
                           limited, and we have not yet concluded any clinical trials using
                           glucagon as an active pharmaceutical ingredient. Additionally, we
                           have never prepared or submitted an NDA to the FDA for a drug-device
                           combination product, such as our GEM product candidate, and we
                           therefore rely heavily on the expertise of third-party collaborators
                           and consultants, such as Unilife, which is responsible for the design
                           and the development phase manufacturing of the GEM device, as well as
                           for the device-specific portions of any NDA we may submit to the FDA.
                           If we, or our consultants and collaborators, do not adequately
                           anticipate or address technical and regulatory challenges that we may
                           face in the development of our GEM product candidate, our business
                           may be significantly harmed. For example, we have recently
                           experienced delays in the development work for our GEM product
                           candidate due to the inability of Unilife to produce registration
                           lots of the final device according to previously projected timelines.
                           As a result, our plans to submit an NDA for our GEM product candidate
                           have been delayed, and we now anticipate filing an NDA for our GEM
                           product candidate in the first half of calendar year&nbsp;2016.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">The results of preclinical testing and clinical trials do not ensure
                                 success in future clinical trials or commercial success.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We have completed and released the results of our two pivotal Phase 3
                           clinical trials of Linjeta&#153;. We have not completed the development of
                           any products through commercialization. In October 2010, the FDA
                           notified us that it would not approve our NDA for the Linjeta&#153;
                           formulation, and we subsequently advanced alternate formulations,
                           including BIOD-105, BIOD-107, BIOD-123, BIOD-125, BIOD-238, BIOD-250
                           and BIOD-531into the clinic and discontinued development of earlier
                           formulations of Linjeta&#153;. The outcomes of preclinical testing and
                           clinical trials of our product candidates may not be predictive of
                           the success of future clinical. For example, despite promising
                           preclinical data, BIOD-105 and BIOD-107 did not meet our preferred
                           target product profile in Phase 1 clinical trials, and we
                           discontinued development of these formulations. In
                        </P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">22</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 0pt; margin-top: 06.00pt; text-align: left; ">addition, interim or preliminary results of a clinical trial do not
                           necessarily predict final results. We cannot assure you that the
                           clinical trials of any of our product candidates will ultimately be
                           successful. New information regarding the safety, efficacy,
                           toleration and stability may arise that may be less favorable than
                           the data observed to&nbsp;date.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">If we are not successful in commercializing any of our product
                           candidates, or are significantly delayed in doing so, our business
                           will be materially harmed. The commercial success of our product
                           candidates will depend on several factors, including the following:
                        </P>
                        <DIV style="padding-left: 37pt; ">
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>successful completion of preclinical development and clinical trials;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to identify and enroll patients who meet clinical trial
                              eligibility criteria;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>receipt of marketing approvals from the FDA and similar regulatory
                              authorities outside the United States;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>establishing that, with regard to our ultra-rapid-acting insulin
                              formulations, the formulations are well-tolerated in chronic&nbsp;use;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>establishing that, with regard to our GEM product candidate, the
                              commercial presentation can be administered effectively by patient
                              caregivers with limited or no&nbsp;training;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>establishing commercial manufacturing capabilities through
                              arrangements with third-party manufacturers;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>launching commercial sales of the products, whether alone or in
                              collaboration with&nbsp;others;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>competition from other products; and
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>continued acceptable safety profiles of the products following approval.
                           </P>
                        </DIV>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">If our clinical trials are delayed or do not produce positive
                                 results, we may incur additional costs and ultimately be unable to
                                 commercialize our product candidates.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Before obtaining regulatory approval for the sale of our product
                           candidates, we must conduct, at our own expense, extensive
                           preclinical tests to demonstrate the safety of our product candidates
                           in animals and clinical trials to demonstrate the safety and efficacy
                           of our product candidates in humans. Preclinical and clinical testing
                           is expensive, difficult to design and implement, can take many years
                           to complete and is uncertain as to outcome. A failure of one or more
                           of our clinical trials for ultra rapid acting insulin or GEM product
                           candidates could occur at any stage of testing. We may experience
                           numerous unforeseen events during our clinical trials that could
                           delay or prevent our ability to receive regulatory approval or
                           commercialize our product candidates, including:
                        </P>
                        <DIV style="padding-left: 37pt; ">
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the number of patients required for our clinical trials may be larger
                              than we anticipate, enrollment in our clinical trials may be slower
                              than we currently anticipate, or participants may drop out of our
                              clinical trials at a higher rate than we anticipate, any of which
                              would result in significant delays;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our third-party contractors may fail to comply with regulatory
                              requirements or meet their contractual obligations to us in a timely
                              manner;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>we might have to suspend or terminate our clinical trials if the
                              participants are being exposed to unacceptable health risks;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>regulators or institutional review boards may require that we hold,
                              suspend or terminate clinical research for various reasons, including
                              noncompliance with regulatory requirements;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the cost of our clinical trials may be greater than we anticipate;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the supply, stability or quality of our product candidates or other
                              materials necessary to conduct our clinical trials may be
                              insufficient or inadequate; and
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the effects of our product candidates may not be the desired effects,
                              may include undesirable side effects or the product candidates may
                              have other unexpected characteristics.
                           </P>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">23</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">If we are required to conduct additional clinical trials or other
                           testing of our product candidates beyond those that we currently
                           contemplate, if we are unable to successfully complete our clinical
                           trials or other testing, if the results of these trials or tests are
                           not positive or are only modestly positive or if there are safety
                           concerns, we&nbsp;may:
                        </P>
                        <DIV style="padding-left: 37pt; ">
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>be delayed in obtaining or discontinue our efforts to obtain marketing approval;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>not be able to obtain marketing approval;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>obtain approval for indications that are not as broad as intended;&nbsp;or
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>have the product removed from the market after obtaining marketing approval.
                           </P>
                        </DIV>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Our product development costs will also increase if we experience
                           delays in testing or approvals. We do not know whether any
                           preclinical tests or clinical trials will begin as planned, will need
                           to be redesigned or will be completed on schedule, if at all.
                           Significant preclinical or clinical trial delays also could shorten
                           any periods during which we may have the exclusive right to
                           commercialize our product candidates or allow our competitors to
                           bring products to market before we do and impair our ability to
                           commercialize our products or product candidates and may harm our
                           business and results of operations.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">If our product candidates are found to cause undesirable side effects
                                 we may need to delay or abandon our development and commercialization
                                 efforts.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Any undesirable side effects that might be caused by our product
                           candidates could interrupt, delay or halt clinical trials and could
                           result in the denial of regulatory approval by the FDA or other
                           regulatory authorities for any or all targeted indications. In
                           addition, if any of our product candidates receive marketing approval
                           and we or others later identify undesirable side effects caused by
                           the product, we could face one or more of the following:
                        </P>
                        <DIV style="padding-left: 37pt; ">
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>a change in the labeling statements or withdrawal of FDA or other
                              regulatory approval of the&nbsp;product;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>a change in the way the product is administered; or
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the need to conduct additional clinical trials.
                           </P>
                        </DIV>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Any of these events could prevent us from achieving or maintaining
                           market acceptance of the affected product or could substantially
                           increase the costs and expenses of commercializing the product, which
                           in turn could delay or prevent us from generating significant
                           revenues from its&nbsp;sale.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">The commercial success of any product candidates that we may develop
                                 will depend upon the degree of market acceptance by physicians,
                                 patients, healthcare payors and others in the medical community.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Any products that we bring to the market may not gain market
                           acceptance by physicians, patients, healthcare payors and others in
                           the medical community. If these products do not achieve an adequate
                           level of acceptance, we may not generate significant product revenues
                           and we may not become profitable. Physicians will not recommend our
                           product candidates until clinical data or other factors demonstrate
                           the safety and efficacy of our product candidates as compared to
                           other treatments. Even if the clinical safety and efficacy of our
                           product candidates are established, physicians may elect not to
                           recommend these product candidates for a variety of reasons including
                           the reimbursement policies of government and third-party payors, the
                           effectiveness of our competitors in marketing their products and the
                           possibility that patients may experience more injection site
                           discomfort than they experience with competing products.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The degree of market acceptance of our product candidates, if
                           approved for commercial sale, will depend on a number of factors,
                           including:
                        </P>
                        <DIV style="padding-left: 37pt; ">
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the willingness and ability of patients and the healthcare community
                              to adopt our products;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the ability to manufacture our product candidates in sufficient
                              quantities with acceptable quality and to offer our product
                              candidates for sale at competitive prices;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the perception of patients and the healthcare community, including
                              third-party payors, regarding the safety, efficacy and benefits of
                              our product candidates compared to those of competing products or
                              therapies;
                           </P>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">24</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <DIV style="padding-left: 37pt; ">
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the convenience and ease of administration of our product candidates
                              relative to existing treatment methods;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the label and promotional claims allowed by the FDA, such as, in the
                              case of an RHI- or insulin analog-based formulation, claims relating
                              to glycemic control, hypoglycemia, weight gain, injection site
                              discomfort, expiry dating and required handling conditions;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the pricing and reimbursement of our product candidates relative to
                              existing treatments; and
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>marketing and distribution support for our product candidates.
                           </P>
                        </DIV>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Our ultra-rapid-acting insulin formulations have not yet been shown
                           to be clinically superior to existing rapid-acting insulin analogs or
                           other marketed comparators, such as Humulin&#174; R U-500 and Humalog&#174; Mix
                           75/25. It may be difficult for us to demonstrate superiority in the
                           future because we anticipate that the primary endpoint of any pivotal
                           clinical trial that we might conduct with an ultra-rapid-acting
                           insulin product candidate would be non-inferiority to the comparator
                           drug product. In addition, we are aware of other companies with
                           expertise in protein stabilization that are developing liquid
                           presentations of stable glucagon. If these formulations are presented
                           in devices that are easier to use than our GEM device, our GEM
                           product candidate, even if approved by the FDA, may not achieve
                           commercial success.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">The successful development of our product candidates may depend upon
                                 our ability to collaborate with or license technology from third
                                 parties.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">BIOD-531 is at an early stage of development. In order for us to meet
                           our projected milestones for this program, we must obtain a reliable
                           source of active pharmaceutical ingredient and other related
                           materials and supplies, including insulin injection devices or
                           syringes that may be unique to BIOD-531 and its insulin
                           concentration. In addition, with regard to our GEM product candidate,
                           we are dependent upon proprietary licenses and supply arrangements we
                           have with third parties, such as Unilife, which is responsible for
                           designing and manufacturing the GEM device, as well as delivering
                           three registration lots of the filled and finished GEM device
                           required for submitting an NDA to the FDA. If we are unable to
                           establish or maintain these licenses and supply arrangements, our
                           efforts to commercialize our product candidates may be materially
                           harmed.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">If we fail to enter into strategic collaborations for the
                                 commercialization of our product candidates or if our collaborations
                                 are unsuccessful, we may be delayed in our commercialization efforts;
                                 we may be required to establish our own sales, marketing,
                                 manufacturing and distribution capabilities which will be expensive,
                                 require additional capital we do not currently have, and could delay
                                 the commercialization of our product candidates and have a material
                                 and adverse effect on our business; we cannot commercialize our
                                 insulin analog-based formulations until all applicable third-party
                                 patents have expired.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We cannot commercialize on our own any insulin analog-based
                           formulation in the United States until 2014 at the earliest, when the
                           patents covering the currently marketed insulin analogs first begin
                           to expire. Therefore, our current strategy for developing,
                           manufacturing and commercializing our product candidates includes
                           securing collaborations with leading pharmaceutical and biotechnology
                           companies, including those that hold patents covering the currently
                           marketed insulin analogs. To date, we have not entered into any
                           out-licensing collaborations with pharmaceutical or biotechnology
                           companies. We face significant competition in seeking appropriate
                           collaborators. In addition, collaboration agreements are complex and
                           time-consuming to negotiate, document and implement. For all these
                           reasons, it may be difficult for us to find third parties that are
                           willing to enter into collaborations on economic terms that are
                           favorable to us, or at all. Even if we do enter into any such
                           collaboration, the collaboration may not be successful. The success
                           of our collaboration arrangements will depend heavily on the efforts
                           and activities of our collaborators. It is likely that our
                           collaborators will have significant discretion in determining the
                           efforts and resources that they will apply to these collaborations.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">If we fail to enter into collaborations, or if our collaborations are
                           unsuccessful, we may be required to establish our own direct sales,
                           marketing, manufacturing and distribution capabilities. Establishing
                           these capabilities can be time-consuming and expensive and we have
                           little experience in doing so. Because of our size, we would be at a
                           disadvantage to our potential competitors to the extent they
                           collaborate with large pharmaceutical companies that have
                           substantially more resources than we do. As a result, we would not
                        </P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">25</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 0pt; margin-top: 06.00pt; text-align: left; ">initially be able to field a sales force as large as our competitors
                           or provide the same degree of market research or marketing support.
                           In addition, our competitors would have a greater ability to devote
                           research and development resources toward expansion of the
                           indications for their products. We cannot assure our investors that
                           we will succeed in entering into acceptable collaborations, that any
                           such collaboration will be successful or, if not, that we will
                           successfully develop our own sales, marketing and distribution
                           capabilities.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">If we are unable to obtain adequate reimbursement from governments or
                                 third-party payors for any products that we may develop or if we are
                                 unable to obtain acceptable prices for those products, they may not
                                 be purchased or used and our revenues and prospects for profitability
                                 will&nbsp;suffer.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Our future revenues and profits will depend heavily upon the
                           availability of adequate reimbursement for the use of any approved
                           product candidates from governmental and other third-party payors,
                           both in the United States and in other markets. Reimbursement by a
                           third-party payor may depend upon a number of factors, including the
                           third-party payor's determination that use of a product&nbsp;is:
                        </P>
                        <DIV style="padding-left: 37pt; ">
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>a covered benefit under its health&nbsp;plan;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>safe, effective and medically necessary;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>appropriate for the specific patient;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>cost-effective; and
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>neither experimental nor investigational.
                           </P>
                        </DIV>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Obtaining reimbursement approval for a product from each government
                           or other third-party payor is a time-consuming and costly process
                           that could require us to provide supporting scientific, clinical and
                           cost-effectiveness data for the use of our products to each payor. We
                           may not be able to provide data sufficient to gain acceptance with
                           respect to reimbursement. Even when a payor determines that a product
                           is eligible for reimbursement, the payor may impose coverage
                           limitations that preclude payment for some uses that are approved by
                           the FDA or comparable authorities. In addition, eligibility for
                           coverage does not imply that any product will be reimbursed in all
                           cases or at a rate that allows us to make a profit or even cover
                           our&nbsp;costs.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Interim payments for new products, if applicable, may also not be
                           sufficient to cover our costs and may not be made permanent.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Governments outside the United States tend to impose strict price
                                 controls, which may adversely affect our revenues, if&nbsp;any.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In some countries, particularly the countries of the European Union,
                           the pricing of prescription pharmaceuticals is subject to
                           governmental control. In these countries, pricing negotiations with
                           governmental authorities can take considerable time after the receipt
                           of marketing approval for a product. To obtain reimbursement or
                           pricing approval in some countries, we may be required to conduct a
                           clinical trial that compares the cost-effectiveness of our product
                           candidate to other available therapies. If reimbursement of our
                           products is unavailable or limited in scope or amount, or if pricing
                           is set at unsatisfactory levels, our business could be adversely
                           affected.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Product liability lawsuits against us could cause us to incur
                                 substantial liabilities and to limit commercialization of any
                                 products that we may&nbsp;develop.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We face an inherent risk of product liability exposure related to the
                           testing of our product candidates in human clinical trials and will
                           face an even greater risk if we commercially sell any products that
                           we may develop. If we cannot successfully defend ourselves against
                           claims that our product candidates or products caused injuries, we
                           will incur substantial liabilities. Regardless of merit or eventual
                           outcome, liability claims may result&nbsp;in:
                        </P>
                        <DIV style="padding-left: 37pt; ">
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>decreased demand for any product candidates or products that we may&nbsp;develop;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>injury to our reputation;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>withdrawal of clinical trial participants;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>costs to defend the related litigation;
                           </P>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">26</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <DIV style="padding-left: 37pt; ">
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>substantial monetary awards to trial participants or&nbsp;patients;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>loss of revenue;&nbsp;and
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the inability to commercialize any products that we may&nbsp;develop.
                           </P>
                        </DIV>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We currently carry global liability insurance that we believe is
                           sufficient to cover us from potential damages arising from past or
                           future clinical trials of our ultra-rapid-acting insulin formulations
                           and other product candidates that we may advance into the clinic. The
                           amount of insurance that we currently hold may not be adequate to
                           cover all liabilities that we may incur. We intend to expand our
                           insurance coverage to include the sale of commercial products if we
                           obtain marketing approval for any products. Insurance coverage is
                           increasingly expensive. We may not be able to maintain insurance
                           coverage at a reasonable cost. If losses from product liability
                           claims exceed our liability insurance coverage, we may ourselves
                           incur substantial liabilities. If we are required to pay a product
                           liability claim, we may not have sufficient financial resources to
                           complete development or commercialization of any of our product
                           candidates and, if so, our business and results of operations would
                           be&nbsp;harmed.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">We face substantial competition in the development of our product
                                 candidates which may result in others developing or commercializing
                                 products before or more successfully than we&nbsp;do.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We are engaged in segments of the pharmaceutical industry that are
                           characterized by intense competition and rapidly evolving technology.
                           Many large pharmaceutical and biotechnology companies, academic
                           institutions, governmental agencies and other public and private
                           research organizations are pursuing the development of novel drugs
                           that target endocrine disorders. We face, and expect to continue to
                           face, intense and increasing competition as new products enter the
                           market and advanced technologies become available.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">If approved, our GEM product candidate would face significant
                           competition. Eli Lilly and Novo Nordisk currently market injectable
                           glucagon rescue kit products. We are aware of several glucagon rescue
                           product candidates in early stage development, such as a potentially
                           competitive auto-injector device being developed by Enject
                           Corporation that integrates glucagon powder and a diluent into a
                           dual-chamber cartridge within that device. Xeris Corporation, or
                           Xeris, is developing glucagon formulations that are stabilized using
                           non-aqueous solvents to suppress glucagon fibrillation. At the 2014
                           Annual Meeting of the American Diabetes Association, Xeris presented
                           data from a Phase 2, double-blind, crossover, comparative
                           pharmacology study in healthy non-diabetic volunteers in which the
                           Xeris candidate formulation demonstrated pharmacodynamic
                           bioequivalence to a marketed comparator (although the pharmacokinetic
                           profiles of the 2 glucagon formulations were significantly
                           different). In addition, other companies with expertise in protein
                           stabilization, including Latitude Pharmaceuticals, have announced
                           that they have developed a stable glucagon formulation using
                           FDA-approved injectable ingredients. We believe that an intranasal
                           formulation of glucagon is being studied in one or more clinical
                           trials, as is a glucagon formulation delivered intra-dermally by a
                           micro needle patch. All of these programs utilize the same active
                           pharmaceutical ingredient as the stable glucagon presentations that
                           we are developing and offer, or may offer, presentations allowing for
                           room temperature storage. In addition, Eli Lilly, Novo Nordisk and
                           Zealand Pharma A/S, a pharmaceutical company based in Denmark, may be
                           developing glucagon analogs, which may also offer advantages over our
                           stable glucagon presentations.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">If approved, the primary competition for our BIOD-123
                           ultra-rapid-acting insulin product candidate will be rapid-acting
                           mealtime injectable insulins. There are several approved injectable
                           rapid-acting mealtime insulin analogs currently on the market
                           including Humalog&#174;, marketed by Eli Lilly and Company, NovoLog&#174;,
                           marketed by Novo Nordisk, and Apidra&#174;, marketed by Sanofi. These
                           rapid-acting insulin analogs provide improvement over "regular"
                           mealtime insulin, including faster subcutaneous absorption, an
                           earlier and greater insulin peak and more rapid post-peak decrease.
                           Both Humalog&#174; and NovoLog&#174; have limited remaining patent protection
                           in the United States and Europe. The possible introduction of lower
                           priced brands or substitutable generic versions of these products
                           could negatively impact the revenue potential of our
                           ultra-rapid-acting product candidates should any be&nbsp;approved.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In addition, other development stage insulin formulations may be
                           approved and compete with BIOD-123. Halozyme Therapeutics, Inc. has
                           conducted a Phase 1 and multiple Phase 2 clinical trials of RHI,
                           lispro (the insulin analog in Humalog&#174;) and aspart (the insulin
                           analog in NovoLog&#174;) in combination with a recombinant human
                           hyaluronidase enzyme and has reported that in each case the
                           combination yielded pharmacokinetics
                        </P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">27</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 0pt; margin-top: 06.00pt; text-align: left; ">and glucodynamics that better mimicked physiologic mealtime insulin
                           release and activity than RHI, Humalog&#174; or NovoLog&#174; alone. Novo
                           Nordisk has initiated clinical development of an insulin analog
                           intended to provide faster onset of action than the currently
                           available rapid-acting insulin analogs and is studying candidate
                           formulations in Phase 3 clinical trials. A French biotechnology
                           company, Adocia Inc., announced positive preliminary results in
                           September 2014 from a Phase 2a dose response clinical trial
                           evaluating an "ultra-fast" formulation of insulin lispro.
                           Furthermore, the company announced plans to develop a concentrated
                           formulation of insulin lispro using its absorption enhancing
                           technologies.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Our concentrated ultra-rapid acting insulin product candidate,
                           BIOD-531, if approved, would face significant competition from
                           insulin formulations currently on the market and, potentially, from
                           development stage insulin formulations and other treatment systems.
                           Humulin&#174; R U-500 is commonly used to treat diabetes patients with
                           severe insulin resistance, and pre-mixed insulins, such as Humalog&#174;
                           Mix 75/25, is commonly used to treat diabetes patients and lesser
                           degrees of insulin resistance. Newer combination products may also
                           compete with BIOD-531. For example, a combination of insulin
                           degludec, an ultra-long-acting basal insulin developed by Novo
                           Nordisk, and NovoLog&#174; is approved in Europe and may be approved in
                           the United States within the next few years. Also, combinations of
                           basal insulin and GLP-1 analogs have either been approved or are in
                           later stages of development; these products are believed to offer
                           some measure of postprandial glucose control in addition to the
                           control offered by a basal insulin. Furthermore, Thermalin Diabetes,
                           LLC, has announced plans to develop a novel concentrated
                           insulin-analog based formulation with fast absorption.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Several companies are also developing or marketing alternative
                           insulin systems for diabetes, including Afrezza&#174; an inhalable
                           mealtime insulin product from MannKind Corporation, which was
                           approved by the FDA in July 2014. In September 2014 MannKind
                           Corporation announced the closing of a worldwide exclusive
                           collaboration and licensing agreement with Sanofi for the development
                           and commercialization of Afrezza&#174; for adults with Type 1 and Type 2
                           diabetes. An inhaled insulin could reduce the overall market for
                           injectable mealtime insulin.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Potential competitors also include academic institutions, government
                           agencies and other public and private research organizations that
                           conduct research, seek patent protection and establish collaborative
                           arrangements for research, development, manufacturing and
                           commercialization. Our competitors may develop products that are more
                           effective, safer, more convenient or less costly than any that we are
                           developing or that would render our product candidates obsolete or
                           non-competitive. Our competitors may also obtain FDA or other
                           regulatory approval for their products more rapidly than we may
                           obtain approval for&nbsp;ours.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Many of our potential competitors have:</P>
                        <DIV style="padding-left: 37pt; ">
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>significantly greater financial, technical and human resources than
                              we have and may be better equipped to discover, develop, manufacture
                              and commercialize product candidates;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>more extensive experience in preclinical testing and clinical trials,
                              obtaining regulatory approvals and manufacturing and marketing
                              pharmaceutical products;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>product candidates that have been approved or are in late-stage
                              clinical development; or
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>collaborative arrangements in our target markets with leading
                              companies and research institutions.
                           </P>
                        </DIV>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Our product candidates may be rendered obsolete by technological change.</B></I></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The rapid rate of scientific discoveries and technological changes
                           could result in one or more of our product candidates becoming
                           obsolete or noncompetitive. For several decades, scientists have
                           attempted to improve the bioavailability of injected formulations and
                           to devise alternative non-invasive delivery systems for the delivery
                           of drugs such as insulin. Our product candidates will compete against
                           many products with similar indications. Our future success will
                           depend not only on our ability to develop our product candidates, but
                           also on our ability to maintain market acceptance against emerging
                           industry developments. We cannot assure current or prospective
                           stockholders that we will be able to do&nbsp;so.
                        </P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">28</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 0pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Our business activities involve the storage and use of hazardous
                                 materials, which require compliance with environmental and
                                 occupational safety laws regulating the use of such materials. If we
                                 violate these laws, we could be subject to significant fines,
                                 liabilities or other adverse consequences.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Our research and development work and manufacturing processes involve
                           the controlled storage and use of hazardous materials, including
                           chemical and biological materials. Our operations also produce
                           hazardous waste products. We are subject to federal, state and local
                           laws and regulations governing the use, manufacture, storage,
                           handling and disposal of these materials. Although we believe that
                           our safety procedures for handling and disposing of such materials
                           and waste products comply in all material respects with the standards
                           prescribed by federal, state and local laws and regulations, the risk
                           of accidental contamination or injury from hazardous materials cannot
                           be completely eliminated. In the event of an accident or failure to
                           comply with environmental laws, we could be held liable for any
                           damages that may result, and any such liability could fall outside
                           the coverage or exceed the limits of our insurance. In addition, we
                           could be required to incur significant costs to comply with
                           environmental laws and regulations in the future or pay substantial
                           fines or penalties if we violate any of these laws or regulations.
                           Finally, current or future environmental laws and regulations may
                           impair our research, development or production efforts.
                        </P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Risks Related to Our Dependence on Third Parties</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Use of third parties to manufacture our product candidates may
                                 increase the risks that we will not have sufficient quantities of our
                                 product candidates or such quantities at an acceptable cost, or that
                                 our contract manufacturers will not be able to manufacture our
                                 products in their final dosage form. In any such case, clinical
                                 development and commercialization of our product candidates could be
                                 delayed, prevented or&nbsp;impaired.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We do not currently own or operate manufacturing facilities for
                           commercial production of our product candidates. We have limited
                           experience in drug manufacturing and we lack the resources and the
                           capabilities to manufacture any of our product candidates on a
                           clinical or commercial scale. Our current strategy is to outsource to
                           third parties all of the manufacturing required for our product
                           candidates, including the component parts of the GEM device and
                           activities associated with assembling, filling, finishing and
                           packaging that&nbsp;device.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Under our customization and commercial supply agreement with Unilife,
                           Unilife will develop and be the sole supplier of the GEM device.
                           Additionally, Unilife is responsible for delivering three
                           registration lots of the filled and finished GEM device required for
                           submitting an NDA to the FDA. The initial term of our agreement with
                           Unilife will expire in&nbsp;2028.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We have entered into a manufacturing agreement with Emergent, under
                           which Emergent will fill and finish the GEM device, using lyophilized
                           glucagon and an aqueous diluent. During the term of our agreement
                           with Emergent following validation of the manufacturing process, we
                           are required to purchase, and Emergent is obligated to deliver to us,
                           one manufactured lot of the GEM device every quarter. However, we
                           would likely require additional manufacturing capacity in order for
                           any commercial launch of our GEM product candidate to be successful.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">With regard to our ultra-rapid-acting insulin formulations, including
                           BIOD-531, we have recently relied on the University of Iowa for
                           manufacturing services. We do not have any commercial manufacturing
                           agreements in place with third parties to support these product
                           candidates.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Reliance on third-party manufacturers entails risks to which we would
                           not be subject if we manufactured product candidates or products
                           ourselves, including:
                        </P>
                        <DIV style="padding-left: 37pt; ">
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>reliance on the third party for regulatory compliance and quality assurance;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the possible breach of the manufacturing agreement by the third party
                              because of factors beyond our control;&nbsp;and
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the possible refusal by or inability of the third party to support
                              our manufacturing programs in a time frame that we would otherwise
                              prefer.
                           </P>
                        </DIV>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Our manufacturers may not be able to comply with current good
                           manufacturing practice, or cGMP, regulations or other regulatory
                           requirements or similar regulatory requirements outside the United
                           States. Our
                        </P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">29</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 0pt; margin-top: 06.00pt; text-align: left; ">manufacturers are subject to unannounced inspections by the FDA,
                           state regulators and similar regulators outside the United States.
                           Our failure, or the failure of our third-party manufacturers, to
                           comply with applicable regulations could result in sanctions being
                           imposed on us, including fines, injunctions, civil penalties, failure
                           of regulatory authorities to grant marketing approval of our product
                           candidates, delays, suspension or withdrawal of approvals, license
                           revocation, seizures or recalls of product candidates or products,
                           operating restrictions and criminal prosecutions, any of which could
                           significantly and adversely affect supplies of our product candidates.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Our product candidates and any products that we may develop may
                           compete with other product candidates and products for access to
                           manufacturing facilities. There are a limited number of manufacturers
                           that operate under cGMP regulations and that are both capable of
                           manufacturing for us and willing to do so. If the third parties that
                           we engage to manufacture product for our clinical trials should cease
                           to continue to do so for any reason, we likely would experience
                           delays in advancing these trials while we identify and qualify
                           replacement suppliers and we may be unable to obtain replacement
                           supplies on terms that are favorable to us. In addition, if we are
                           not able to obtain adequate supplies of our product candidates or the
                           drug substances used to manufacture them, it will be more difficult
                           for us to develop our product candidates and compete effectively.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Our current and anticipated future dependence upon others for the
                           manufacture of our product candidates may adversely affect our future
                           profit margins and our ability to develop product candidates and
                           commercialize any products that receive regulatory approval on a
                           timely and competitive basis.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">We rely on third parties for design and engineering expertise
                                 relating to the development of devices we may use to administer the
                                 pharmaceutical preparations of our product candidates.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The success of certain of our product candidates is likely to depend
                           heavily on the design of the devices being used for the
                           administration of our pharmaceutical preparations. For example, the
                           GEM device, which is based on an existing technology platform
                           developed by Unilife Corporation, is being customized by Unilife for
                           use in an emergency situation. We do not have internal engineering
                           expertise relating to medical devices, and we therefore rely on
                           Unilife to provide such expertise. If our collaboration with Unilife
                           is not successful in this regard, our program to develop our GEM
                           product candidate will be materially harmed. Additionally, in order
                           to maximize the commercial potential of our ultra-rapid-acting
                           insulin product candidates, we will likely depend on one or more
                           manufacturers of insulin pen injection devices or syringes to supply
                           us with a commercially acceptable device. To date, we have not
                           entered into any agreements for the supply of insulin pen injection
                           devices or syringes, and we cannot assure you that any such devices
                           will be available on terms that will be acceptable to us, if at&nbsp;all.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">We rely on third parties to conduct our clinical trials and those
                                 third parties may not perform satisfactorily, including failing to
                                 meet established timelines for the completion of such&nbsp;trials.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We do not independently conduct clinical trials of our product
                           candidates. We rely on third parties, such as contract research
                           organizations, clinical data management organizations, medical
                           institutions and clinical investigators, to enroll qualified patients
                           and conduct our clinical trials. Our reliance on these third parties
                           for clinical development activities reduces our control over these
                           activities. We are responsible for ensuring that each of our clinical
                           trials is conducted in accordance with the general investigational
                           plan and protocols for the trial. Moreover, the FDA requires us to
                           comply with standards, commonly referred to as Good Clinical
                           Practices, for conducting, recording, and reporting the results of
                           clinical trials to assure that data and reported results are credible
                           and accurate and that the rights, integrity and confidentiality of
                           trial participants are protected. Our reliance on third parties that
                           we do not control does not relieve us of these responsibilities and
                           requirements. Furthermore, these third parties may also have
                           relationships with other entities, some of which may be our
                           competitors. If these third parties do not successfully carry out
                           their contractual duties, meet expected deadlines or conduct our
                           clinical trials in accordance with regulatory requirements or our
                           stated protocols, we will not be able to obtain, or may be delayed in
                           obtaining, regulatory approvals for our product candidates and will
                           not be able to, or may be delayed in our efforts to, successfully
                           commercialize our product candidates.
                        </P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">30</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">If our suppliers of active pharmaceutical ingredients and other
                                 production materials fail to deliver materials and provide services
                                 needed for the production of our product candidates in a timely and
                                 sufficient manner, or if they fail to comply with applicable
                                 regulations, clinical development or regulatory approval of our
                                 product candidates, commercialization of our products could be
                                 delayed, producing additional losses and depriving us of potential
                                 product revenue.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We need access to sufficient, reliable and affordable supplies of
                           insulin, glucagon and other materials, such as vials, cartridges,
                           prefilled syringes and, potentially, drug injection devices, for
                           which we rely on various suppliers. We also must rely on those
                           suppliers to comply with relevant regulatory and other legal
                           requirements, including the production of insulin and glucagon in
                           accordance with cGMP. We can make no assurances that our suppliers
                           will comply with&nbsp;cGMP.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We have entered into a commercial supply agreement with Bachem AG for
                           the supply of all of the glucagon we will need for the testing and
                           manufacturing of our GEM product candidate. The initial term of our
                           agreement with Bachem AG will expire in July 2017. We believe that
                           the quantities of glucagon that we have rights to acquire under this
                           agreement will be sufficient to allow us to complete our current and
                           anticipated future clinical trials of our GEM product candidate and
                           to support any commercial launch of the product candidate.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We have terminated an earlier supply agreement with N.V. Organon
                           (subsequently acquired by Amphastar Pharmaceuticals, Inc., a
                           specialty pharmaceutical development and manufacturing company),
                           under which we have purchased the RHI we have used to formulate all
                           of our RHI-based product candidates. We intend to use existing
                           supplies of RHI to support the further development of BIOD-531, as
                           well as enter into one or more development stage RHI supply
                           agreements, as necessary. We do not have any plans, however, to
                           commit to quantities of RHI that may be required to support the
                           commercial launch of one or more of our RHI-based product candidates.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">If we are unable to procure sufficient quantities of glucagon or
                           insulin from our current or any future supplier, if supply of RHI,
                           glucagon and other materials otherwise becomes limited, or if our
                           suppliers do not meet relevant regulatory requirements, and if we
                           were unable to obtain these materials in sufficient amounts, in a
                           timely manner and at reasonable prices, we could be delayed in the
                           manufacturing and possible commercialization of our product
                           candidates, which may have a material adverse effect on our business.
                           We would incur substantial costs and manufacturing delays if our
                           suppliers are unable to provide us with products or services approved
                           by the FDA or other regulatory agencies.
                        </P>
                     </DIV> <BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Risks Related to Our Intellectual Property</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">If we are unable to protect our intellectual property rights, our
                                 competitors may develop and market similar or identical products that
                                 may reduce demand for our products, and we may be prevented from
                                 establishing collaborative relationships on favorable terms.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The following factors are important to our&nbsp;success:</P>
                        <DIV style="padding-left: 37pt; ">
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>receiving patent protection for our product candidates;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>maintaining our trade secrets;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>not infringing on the proprietary rights of others;&nbsp;and
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>preventing others from infringing on our proprietary rights.
                           </P>
                        </DIV>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We will be able to protect our proprietary rights from unauthorized
                           use by third parties only to the extent that our proprietary rights
                           are covered by valid and enforceable patents or are effectively
                           maintained as trade secrets. We try to protect our proprietary
                           position by filing U.S. and foreign patent applications related to
                           our proprietary technology, inventions and improvements that are
                           important to the development of our business. Because the patent
                           position of pharmaceutical companies involves complex legal and
                           factual questions, the issuance, scope and enforceability of patents
                           cannot be predicted with certainty. Patents, if issued, may be
                           challenged, invalidated or circumvented. Thus, any patents that we
                           own or license from others may not provide any protection against
                           competitors.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In June 2012 we entered into an agreement with Aegis Therapeutics,
                           LLC, or Aegis, to acquire an exclusive, sublicensable, worldwide
                           license to the protein stabilization technology that we are using in
                           the
                        </P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">31</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 0pt; margin-top: 06.00pt; text-align: left; ">development of our stable liquid glucagon formulations. Under the
                           terms of the agreement, Aegis will prepare, file, prosecute and
                           maintain patents and patent applications that are specific to our
                           stable glucagon presentations in jurisdictions that we may designate
                           from time to&nbsp;time.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Our pending patent applications, those we may file in the future, or
                           those we may license from third parties, may not result in patents
                           being issued. If patents do not issue with claims encompassing our
                           products, our competitors may develop and market similar or identical
                           products that compete with ours. Even if patents are issued, they may
                           not provide us with proprietary protection or competitive advantages
                           against competitors with similar technology. Failure to obtain
                           effective patent protection for our technology and products may
                           reduce demand for our products and prevent us from establishing
                           collaborative relationships on favorable terms.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The individual active and inactive ingredients in our
                           ultra-rapid-acting insulin formulations and our stable glucagon
                           presentations have been known and used for many years and, therefore,
                           are no longer subject to patent protection, except in proprietary
                           combinations. Accordingly, our patent and pending applications are
                           directed to the particular formulations of these ingredients in our
                           products, and to their use. Although we believe our formulations and
                           their uses are or will be patented and provide a competitive
                           advantage, our patents may not prevent others from marketing
                           formulations using the same active and inactive ingredients in
                           different combinations.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We also rely on trade secrets, know-how and technology, which are not
                           protected by patents, to maintain our competitive position. We try to
                           protect this information by entering into confidentiality agreements
                           with parties that have access to it, such as potential corporate
                           partners, collaborators, employees and consultants. Any of these
                           parties may breach the agreements and disclose our confidential
                           information or our competitors may learn of the information in some
                           other way. Furthermore, others may independently develop similar
                           technologies or duplicate any technology that we have developed. If
                           any trade secret, know-how or other technology not protected by a
                           patent were to be disclosed to or independently developed by a
                           competitor, our business and financial condition could be materially
                           adversely affected.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The laws of many foreign countries do not protect intellectual
                           property rights to the same extent as do the laws of the United
                           States. Accordingly, the fact that we have obtained certain patent
                           rights in the United States does not guarantee that we will be able
                           to obtain the same or similar rights elsewhere. Even if we are
                           granted patents in foreign countries, we cannot guarantee that we
                           will be able to enforce our rights effectively.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">We may become involved in lawsuits and administrative proceedings to
                                 protect, defend or enforce our patents that would be expensive and
                                 time-consuming.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In order to protect or enforce our patent rights, we may initiate
                           patent litigation against third parties in the United States or in
                           foreign countries. In addition, we may be subject to certain
                           opposition proceedings conducted in patent and trademark offices
                           challenging the validity of our patents and may become involved in
                           future opposition proceedings challenging the patents of others. For
                           example, in late July 2013, a third party initiated administrative
                           proceedings to oppose two of our more recent patents that have been
                           granted by the European Patent Office in connection with our
                           ultra-rapid-acting insulin formulations. While we were successful in
                           defending the opposition before the Opposition Division of the
                           European Patent Office in October 2014, the decision in those
                           proceedings is subject to appeal. The defense of intellectual
                           property rights, including patent rights, through lawsuits,
                           interference or opposition proceedings, and other legal and
                           administrative proceedings can be costly and can divert our technical
                           and management personnel from their normal responsibilities. Such
                           costs increase our operating losses and reduce our resources
                           available for development activities. An adverse determination of any
                           litigation or defense proceedings could put one or more of our
                           patents at risk of being invalidated or interpreted narrowly and
                           could put our patent applications at risk of not&nbsp;issuing.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Furthermore, because of the substantial amount of discovery required
                           in connection with intellectual property litigation, there is a risk
                           that some of our confidential information could be compromised by
                           disclosure during this type of litigation. For example, during the
                           course of this kind of litigation and despite protective orders
                           entered by the court, confidential information may be inadvertently
                           disclosed in the form of documents or testimony in connection with
                           discovery requests, depositions or trial testimony. This disclosure
                           could materially adversely affect our business and financial results.
                        </P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">32</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Claims by other parties that we infringe or have misappropriated
                                 their proprietary technology may result in liability for damages,
                                 royalties, or other payments, or stop our development and
                                 commercialization efforts.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Competitors and other third parties may initiate patent litigation
                           against us in the United States or in foreign countries based on
                           existing patents or patents that may be granted in the future. Many
                           of our competitors may have obtained patents covering products and
                           processes generally related to our products and processes, and they
                           may assert these patents against us. Moreover, there can be no
                           assurance that these competitors have not sought or will not seek
                           additional patents that may cover aspects of our technology. As a
                           result, there is a greater likelihood of a patent dispute than would
                           be expected if our competitors were pursuing unrelated technologies.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">While we conduct patent searches to determine whether the
                           technologies used in our products infringe patents held by third
                           parties, numerous patent applications are currently pending and may
                           be filed in the future for technologies generally related to our
                           technologies, including many patent applications that remain
                           confidential after filing. Due to these factors and the inherent
                           uncertainty in conducting patent searches, there can be no guarantee
                           that we will not violate third-party patent rights that we have not
                           yet identified.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">There may be U.S. and foreign patents issued to third parties that
                           relate to aspects of our product candidates. There may also be patent
                           applications filed by these or other parties in the United States and
                           various foreign jurisdictions that relate to some aspects of our
                           product candidates, which, if issued, could subject us to
                           infringement actions. The owners or licensees of these and other
                           patents may file one or more infringement actions against us. In
                           addition, a competitor may claim misappropriation of a trade secret
                           by an employee hired from that competitor. Any such infringement or
                           misappropriation action could cause us to incur substantial costs
                           defending the lawsuit and could distract our management from our
                           business, even if the allegations of infringement or misappropriation
                           are unwarranted. A need to defend multiple actions or claims could
                           have a disproportionately greater impact. In addition, either in
                           response to or in anticipation of any such infringement or
                           misappropriation claim, we may enter into commercial agreements with
                           the owners or licensees of these rights. The terms of these
                           commercial agreements may include substantial payments, including
                           substantial royalty payments on revenues received by us in connection
                           with the commercialization of our products.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Payments under such agreements could increase our operating losses
                           and reduce our resources available for development activities.
                           Furthermore, a party making this type of claim could secure a
                           judgment that requires us to pay substantial damages, which would
                           increase our operating losses and reduce our resources available for
                           development activities. A judgment could also include an injunction
                           or other court order that could prevent us from making, using,
                           selling, offering for sale or importing our products or prevent our
                           customers from using our products. If a court determined or if we
                           independently concluded that any of our products or manufacturing
                           processes violated third-party proprietary rights, our clinical
                           trials could be delayed and there can be no assurance that we would
                           be able to reengineer the product or processes to avoid those rights,
                           or to obtain a license under those rights on commercially reasonable
                           terms, if at&nbsp;all.
                        </P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Risks Related to Regulatory Approval of Our Product Candidates</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">If the FDA does not believe that our product candidates satisfy the
                                 requirements for the Section 505(b)(2) approval procedure, or if the
                                 requirements for our product candidates under Section 505(b)(2) are
                                 not as we expect, the approval pathway will take longer and cost more
                                 than anticipated and in either case may not be successful.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We believe our ultra-rapid-acting insulin formulations and our stable
                           glucagon presentation for use as a rescue product qualify for
                           approval under Section 505(b)(2) of the FFDCA. Because we are
                           developing new formulations of previously approved chemical entities,
                           such as insulin and glucagon, our drug approval strategy is to submit
                           Section 505(b)(2) NDAs to the FDA. We plan to pursue similar routes
                           for submitting applications for our product candidates in foreign
                           jurisdictions if available. The FDA may not agree that our product
                           candidates are approvable pursuant to Section 505(b)(2) NDAs. There
                           is no specific guidance available for Section 505(b)(2) NDAs for
                           insulin or glucagon. In addition, while there is precedent for a
                           glucagon product being approved under a Section 505(b)(2) NDA, we are
                           not aware of any insulin product that has been approved under a
                           Section 505(b)(2) NDA. If the FDA determines that Section 505(b)(2)
                           NDAs
                        </P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">33</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 0pt; margin-top: 06.00pt; text-align: left; ">are not appropriate and that full NDAs are required for our product
                           candidates, the time and financial resources required to obtain FDA
                           approval for our product candidates could substantially and
                           materially increase, and our product candidates might be less likely
                           to be approved. If the FDA requires full NDAs for our product
                           candidates, or requires more extensive testing and development for
                           some other reason, our ability to compete with alternative products
                           that arrive on the market more quickly than our product candidates
                           would be adversely impacted.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Notwithstanding the approval of many products by the FDA pursuant to
                           Section 505(b)(2), over the last few years certain pharmaceutical
                           companies and others have objected to the FDA's interpretation of
                           Section 505(b)(2). If the FDA's interpretation of Section 505(b)(2)
                           is successfully challenged in court, the FDA may be required to
                           change its interpretation of Section 505(b)(2) which could delay or
                           even prevent the FDA from approving any Section 505(b)(2) NDA that we
                           submit. The pharmaceutical industry is highly competitive, and it is
                           not uncommon for a manufacturer of an approved product to file a
                           citizen petition with the FDA seeking to delay approval of, or impose
                           additional approval requirements for, pending competing products. If
                           successful, such petitions can significantly delay, or even prevent,
                           the approval of the new product. Moreover, even if the FDA ultimately
                           denies such a petition, the FDA may substantially delay approval
                           while it considers and responds to the petition.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Even if one of our product candidates is approved under Section
                           505(b)(2), the approval may be subject to limitations on the
                           indicated uses for which the product may be marketed or to other
                           conditions of approval, or may contain requirements for costly
                           post-marketing testing and surveillance to monitor the safety or
                           efficacy of the&nbsp;product.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Any product for which we obtain marketing approval could be subject
                                 to restrictions or withdrawal from the market and we may be subject
                                 to penalties if we fail to comply with regulatory requirements or if
                                 we experience unanticipated problems with our products, when and if
                                 any of them are approved.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Any product for which we obtain marketing approval, along with the
                           manufacturing processes, post-approval clinical data, labeling,
                           advertising and promotional activities for such product, will be
                           subject to continual requirements of and review by the FDA and other
                           state and federal regulatory authorities. These requirements include,
                           in the case of the FDA, submissions of safety and other
                           post-marketing information and reports, registration requirements,
                           cGMP requirements relating to quality control, quality assurance and
                           corresponding maintenance of records and documents, requirements
                           regarding the distribution of samples to physicians and
                           recordkeeping. Even if regulatory approval of a product is granted,
                           the approval may be subject to limitations on the indicated uses for
                           which the product may be marketed or to other conditions of approval,
                           or may contain requirements for costly post-marketing testing and
                           surveillance to monitor the safety or efficacy of the product. In
                           addition, if any of our product candidates are approved, our product
                           labeling, advertising and promotion would be subject to regulatory
                           requirements and continuing regulatory review. The FDA strictly
                           regulates the promotional claims that may be made about prescription
                           drug products. In particular, a drug may not be promoted in a
                           misleading manner or for uses that are not approved by the FDA as
                           reflected in the product's approved labeling. The FDA and other state
                           and federal entities actively enforce the laws and regulations
                           prohibiting misleading promotion and the promotion of off-label uses,
                           and a company that is found to have improperly promoted off-label
                           uses may be subject to significant liability.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Discovery after approval of previously unknown problems with our
                           products, manufacturers or manufacturing processes, or failure to
                           comply with state or federal regulatory requirements, may result in
                           actions such&nbsp;as:
                        </P>
                        <DIV style="padding-left: 37pt; ">
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>restrictions on such products' manufacturers or manufacturing processes;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>restrictions on the marketing or distribution of a&nbsp;product;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>requirements that we conduct new studies, make labeling changes, and
                              implement Risk Evaluation and Mitigation Strategies;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>warning letters;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>withdrawal of the products from the&nbsp;market;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>refusal to approve pending applications or supplements to approved
                              applications that we&nbsp;submit;
                           </P>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">34</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <DIV style="padding-left: 37pt; ">
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>recall of&nbsp;products;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>fines, restitution or disgorgement of profits or&nbsp;revenue;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>suspension or withdrawal of regulatory approvals;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>refusal to permit the import or export of our products;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>product embargo and/or seizure;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>injunctions; or
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>imposition of civil or criminal penalties.
                           </P>
                        </DIV>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Changes in law, regulations, and policies may preclude approval of
                                 our product under a 505(b)(2) or make it more difficult and costly
                                 for us to obtain regulatory approval of our product candidates and to
                                 produce, market and distribute our existing products.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In March 2010, the President signed into law legislation creating an
                           abbreviated pathway for approval under the Public Health Service, or
                           PHS Act, of biological products that are similar to other biological
                           products that are approved under the PHS Act. This legislation also
                           expanded the definition of biological product to include proteins
                           such as insulin. The new law contains transitional provisions
                           governing protein products such as insulin that, under certain
                           circumstances, might permit companies to seek approval for their
                           insulin products as biologics under the PHS Act and might require
                           that Biodel's product be approved under the PHS Act rather than in a
                           505(b)(2) NDA. We would be unlikely to pursue approval of our product
                           candidates if we were required to seek approval under the PHS Act
                           rather than in a 505(b)(2) NDA.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In addition, the federal and state laws, regulations, policies or
                           guidance may change in a manner that could prevent or delay
                           regulatory approval of our product candidates or further restrict or
                           regulate post-approval activities. It is impossible to predict
                           whether additional legislative changes will be enacted, or FDA
                           regulations, guidance or interpretations implemented or modified, or
                           what the impact of such changes, if any, may&nbsp;be.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Failure to obtain regulatory approval in international jurisdictions
                                 would prevent us from marketing our products abroad.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We intend to have our products marketed outside the United States. In
                           order to market our products in the European Union and many other
                           jurisdictions, we must obtain separate regulatory approvals and
                           comply with numerous and varying regulatory requirements of other
                           countries regarding safety and efficacy and governing, among other
                           things, clinical trials and commercial sales and distribution of our
                           products. The approval procedure varies among countries and can
                           involve additional testing. The time required to obtain approval may
                           differ from that required to obtain FDA approval. The regulatory
                           approval processes outside the United States may include all of the
                           risks associated with obtaining FDA approval, as well as additional
                           risks. In addition, in many countries outside the United States, it
                           is required that the product be approved for reimbursement before the
                           product can be approved for sale in that country. We may not obtain
                           approvals from regulatory authorities outside the United States on a
                           timely basis, if at all. Approval by the FDA does not ensure approval
                           by regulatory authorities in other countries or jurisdictions, and
                           approval by one regulatory authority outside the United States does
                           not ensure approval by regulatory authorities in other countries or
                           jurisdictions or by the FDA. We may not be able to file for
                           regulatory approvals and may not receive necessary approvals to
                           commercialize our products in any&nbsp;market.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Reports of side effects or safety concerns in related technology
                                 fields or in other companies' clinical trials could delay or prevent
                                 us from obtaining regulatory approval or negatively impact public
                                 perception of our product candidates.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">At present, there are a number of clinical trials being conducted by
                           us and by other pharmaceutical companies involving insulin or insulin
                           delivery systems. The major safety concern with patients taking
                           insulin is the occurrence of hypoglycemic events. If we discover that
                           our product is associated with a significantly increased frequency of
                           hypoglycemic or other adverse events, or if other pharmaceutical
                           companies announce that they observed frequent or significant adverse
                           events in their trials involving insulin or insulin delivery systems,
                           we could encounter delays in the commencement or completion of our
                           clinical trials or difficulties in
                        </P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">35</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 0pt; margin-top: 06.00pt; text-align: left; ">obtaining the approval of our product candidates. In addition, the
                           public perception of our products might be adversely affected, which
                           could harm our business and results of operations, even if the
                           concern relates to another company's product.
                        </P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Risks Related to Employee Matters and Managing Growth</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Our future success depends on our ability to retain our chief
                                 executive officer and other key executives and to attract, retain and
                                 motivate qualified personnel.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We are highly dependent on Errol De Souza, our President and Chief
                           Executive Officer, Gary Gemignani, our Chief Financial Officer and
                           Dr. Alan Krasner, our Chief Medical Officer. The loss of the services
                           of any of these persons might impede the achievement of our research,
                           development and commercialization objectives. Replacing key employees
                           may be difficult and time-consuming because of the limited number of
                           individuals in our industry with the skills and experiences required
                           to develop, gain regulatory approval of and commercialize our product
                           candidates successfully. We generally do not maintain key person life
                           insurance to cover the loss of any of our employees.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Recruiting and retaining qualified scientific personnel, clinical
                           personnel and sales and marketing personnel will also be critical to
                           our success. We may not be able to attract and retain these personnel
                           on acceptable terms, if at all, given the competition among numerous
                           pharmaceutical and biotechnology companies for similar personnel. We
                           also experience competition for the hiring of scientific and clinical
                           personnel from other companies, universities and research
                           institutions. In addition, we rely on consultants and advisors,
                           including scientific and clinical advisors, to assist us in
                           formulating our research and development and commercialization
                           strategy. Our consultants and advisors may be employed by employers
                           other than us and may have commitments under consulting or advisory
                           contracts with other entities that may limit their availability to&nbsp;us.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">We may expand our development, regulatory and sales and marketing
                                 capabilities, and as a result, we may encounter difficulties in
                                 managing our growth, which could disrupt our operations.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">If our development and commercialization plans for any of our product
                           candidates are successful, we may experience significant growth in
                           the number of our employees and the scope of our operations,
                           particularly in the areas of manufacturing, clinical trials
                           management, and regulatory affairs. To manage our possible future
                           growth, we must continue to implement and improve our managerial,
                           operational and financial systems and continue to recruit and train
                           additional qualified personnel. Due to our limited financial
                           resources we may not be able to effectively manage the expansion of
                           our operations or recruit and train additional qualified personnel.
                           Any inability to manage growth could delay the execution of our
                           business plans or disrupt our operations.
                        </P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Risks Related to Our Common Stock</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Provisions in our corporate charter documents and under Delaware law
                                 could make an acquisition of us, which may be beneficial to our
                                 stockholders, more difficult and may prevent attempts by our
                                 stockholders to replace or remove our current management.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Provisions in our corporate charter and bylaws may discourage, delay
                           or prevent a merger, acquisition or other change in control of us
                           that stockholders may consider favorable, including transactions in
                           which you might otherwise receive a premium for your shares. These
                           provisions could also limit the price that investors might be willing
                           to pay in the future for shares of our common stock, thereby
                           depressing the market price of our common stock. In addition, these
                           provisions may frustrate or prevent any attempts by our stockholders
                           to replace or remove our current management by making it more
                           difficult for stockholders to replace members of our board of
                           directors. Because our board of directors is responsible for
                           appointing the members of our management team, these provisions could
                           in turn affect any attempt by our stockholders to replace current
                           members of our management team.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Among others, these provisions:</P>
                        <DIV style="padding-left: 37pt; ">
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>establish a classified board of directors such that not all members
                              of the board are elected at one&nbsp;time;
                           </P>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">36</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <DIV style="padding-left: 37pt; ">
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>allow the authorized number of our directors to be changed only by
                              resolution of our board of directors;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>limit the manner in which stockholders can remove directors from the&nbsp;board;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>establish advance notice requirements for stockholder proposals that
                              can be acted on at stockholder meetings and nominations to our board
                              of directors;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>require that stockholder actions must be effected at a duly called
                              stockholder meeting and prohibit actions by our stockholders by
                              written consent;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>limit who may call stockholder meetings;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>authorize our board of directors to issue preferred stock without
                              stockholder approval, which could be used to institute a stockholder
                              rights plan or "poison pill" that would work to dilute the stock
                              ownership of a potential hostile acquirer, effectively preventing
                              acquisitions that have not been approved by our board of directors;
                              and
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>require the approval of the holders of at least 75% of the votes that
                              all our stockholders would be entitled to cast to amend or repeal
                              certain provisions of our charter or&nbsp;bylaws.
                           </P>
                        </DIV>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In addition, because we are incorporated in Delaware, we are governed
                           by the provisions of Section 203 of the Delaware General Corporation
                           Law, which generally prohibits a person who owns in excess of 15% of
                           our outstanding voting stock from merging or combining with us for a
                           period of three years after the date of the transaction in which the
                           person acquired in excess of 15% of our outstanding voting stock,
                           unless the merger or combination is approved in a prescribed manner.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Because our stock price is volatile, purchasers of our common stock
                                 could incur substantial losses.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Our stock price has been and may continue to be volatile. The stock
                           market in general and the market for biotechnology companies in
                           particular have experienced extreme volatility that has often been
                           unrelated to the operating performance of particular companies. The
                           market price for our common stock may be influenced by many factors,
                           including:
                        </P>
                        <DIV style="padding-left: 37pt; ">
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>results of clinical trials of our product candidates or those of our
                              competitors;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>regulatory or legal developments in the United States and other countries;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>variations in our financial results or those of companies that are
                              perceived to be similar to&nbsp;us;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>developments or disputes concerning patents or other proprietary rights;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the recruitment or departure of key personnel;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>changes in the structure of healthcare payment systems;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>market conditions in the pharmaceutical and biotechnology sectors and
                              issuance of new or changed securities analysts' reports or
                              recommendations;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>general economic, industry and market conditions; and
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the other factors described in this "Risk Factors" section.
                           </P>
                        </DIV>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Our outstanding warrants may be exercised, and our outstanding shares
                                 of preferred stock may be converted, in the future, which would
                                 increase the number of shares in the public market and result in
                                 dilution to our stockholders.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">As a result of our May 2011 registered direct offering and June 2012
                           private placement, we have outstanding warrants to purchase 2,256,929
                           shares of our common stock at $9.92 per share and 2,749,469 shares of
                           our common stock at $2.66 per share. The $9.92 per share warrants
                           expire in May 2016 and the $2.66 per share warrants expire in June
                           2017. We also have outstanding shares of Series B preferred stock
                           that are convertible into 1,950,000 shares of common stock. In June
                           and September 2013 an aggregate of 1,655,607 shares of Series B
                           preferred stock were converted into an equal number of shares of
                           common stock. The exercise of these warrants for, or the conversion
                           of shares of Series B preferred stock into, shares of
                        </P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">37</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 0pt; margin-top: 06.00pt; text-align: left; ">common stock would be substantially dilutive to the outstanding
                           shares of common stock. Any dilution or potential dilution may cause
                           our stockholders to sell their shares, which would contribute to a
                           downward movement in the stock price of our common stock.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">We have never paid any cash dividends on our common stock and we do
                                 not anticipate paying any cash dividends in the foreseeable future.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We have paid no cash dividends on our common stock to date. We
                           currently intend to retain our future earnings, if any, to fund the
                           development and growth of our business. In addition, the terms of any
                           future debt agreements may preclude us from paying dividends. As a
                           result, we do not expect to pay any cash dividends in the foreseeable
                           future, and payment of cash dividends, if any, will depend on our
                           financial condition, results of operations, capital requirements and
                           other factors and will be at the discretion of our board of
                           directors. Furthermore, we may in the future become subject to
                           contractual restrictions on, or prohibitions against, the payment of
                           dividends. Capital appreciation, if any, of our common stock will be
                           investors' sole source of gain for the foreseeable future.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 09.95pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">We incur substantial costs as a result of operating as a public
                                 company, and our management is required to devote substantial time to
                                 comply with public company regulations.</B></I></P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We are subject to the reporting requirements of the Exchange Act, the
                           Sarbanes-Oxley Act of 2002 as well as other federal and state laws.
                           These requirements may place a strain on our people, systems and
                           resources. The Exchange Act requires that we file annual, quarterly
                           and current reports with respect to our business and financial
                           condition. The Sarbanes-Oxley Act requires that we maintain effective
                           disclosure controls and procedures and internal controls over
                           financial reporting. In order to maintain and improve the
                           effectiveness of our disclosure controls and procedures and internal
                           controls over financial reporting, significant resources and
                           management oversight are required. This may divert management's
                           attention from other business concerns, which could have a material
                           adverse effect on our business, financial condition, results of
                           operations and cash&nbsp;flows.
                        </P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; "><B>ITEM 1B.</B><B>&nbsp;</B>UNRESOLVED STAFF COMMENTS</B></I></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Not applicable.</P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; "><B>ITEM 2.</B><B>&nbsp;</B>PROPERTIES</B></I></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; margin-top: 06.00pt; text-align: left; ">We lease approximately 29,300 square feet of office space and
                           laboratory facilities in Danbury, Connecticut. Our corporate
                           headquarters are located at 100 Saw Mill Road, Danbury, Connecticut,
                           in approximately 19,500 square feet of rentable office space. The
                           lease for our corporate headquarters expires in July, 2019. Our
                           laboratory facilities are located at 6 and 8 Christopher Columbus
                           Avenue, Danbury, Connecticut, in approximately 7,200 and 2,600 square
                           feet of rentable laboratory and office space, respectively. The
                           leases for our facilities at 6 and 8 Christopher Columbus expire in
                           January 2016.
                        </P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">ITEM 3.&nbsp;<I><B>LEGAL PROCEEDINGS</B></I></B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In July 2013, a third party initiated administrative proceedings in
                           Munich, Germany before the European Patent Office to oppose two of
                           our patents that have been granted in connection with our
                           ultra-rapid-acting insulin formulations&#151;EP 2 319 500 and EP2 106 790.
                           The opponent was listed as Dr. Armin K. Bohmann. The opponent
                           requested that the patents be revoked, alleging that the subject
                           matter was not patentable, the inventions were not adequately
                           disclosed and the subject matter extended beyond the subject of the
                           applications. In an October 2014 ruling that may be subject to
                           appeal, the Opposition Division of the European Patent Office found
                           that all claims of both patents are novel and inventive.
                        </P>
                     </DIV> <BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; "><A name="Item4"></A>ITEM 4.&nbsp;<I><B>MINE SAFETY DISCLOSURES</B></I></B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Not applicable.</P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">38</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: center; ">
               <DIV style="padding-top: 0px; text-align: center; "><BR><DIV style="padding-top: 0px; text-align: center; ">
                     <P>
                        <DIV style="padding-top: 0px; text-align: center; "><B style="text-align: center; font-size: 10.0pt; "><A name="allpages_continue5"></A>PART II</B></DIV>
                     </P> <BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; "><A name="Item5"></A>ITEM 5&nbsp;<I><B>MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS
                                       AND ISSUER PURCHASES OF EQUITY SECURITIES</B></I></B></DIV>
                        </P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: center; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Market Information</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">From May 2007 through May 10, 2012, our common stock traded on the
                           NASDAQ Global Market, and, since May 11, 2012, our common stock has
                           traded on the NASDAQ Capital Market, in each case under the symbol
                           "BIOD."
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The following table sets forth the high and low sale prices per share
                           for our common stock on the applicable exchange in each of the
                           quarters within our two most recent fiscal years. All prices shown in
                           the table reflect the one-for-four reverse split of our outstanding
                           common stock that we effected on June 11, 2012.
                        </P>
                        <P style="text-align: center; margin: 0pt; padding: 0pt; ">
                           <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                              <TR>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 76.93%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 2.88%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 8.41%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 3.12%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 8.65%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                              </TR>
                              <DIV style="padding-top: 3px; text-align: center; ">
                                 <TR cont_lvl="1" style="text-align: left; ">
                                    <TD style="vertical-align: top; line-height: 1.2; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: top; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: left; "><U><B style="text-align: left; font-size: 8.0pt; ">Fiscal Quarter Ended</B></U></TD>
                                    <TD style="vertical-align: top; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: top; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: top; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><U><B style="text-align: center; font-size: 8.0pt; ">High</B></U></TD>
                                    <TD style="vertical-align: top; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: top; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: top; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><U><B style="text-align: center; font-size: 8.0pt; ">Low</B></U></TD>
                                    <TD style="vertical-align: top; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">December 31, 2012 </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">2.98</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">2.13</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">March 31, 2013 </TD>
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">2.97</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">2.29</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">June 30, 2013 </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">5.11</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">2.48</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">September 30, 2013 </TD>
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">6.08</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">3.05</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">December 31, 2013 </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">3.23</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1.93</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">March 31, 2014 </TD>
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">3.71</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">2.23</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">June 30, 2014 </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">2.94</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1.97</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">September 30, 2014 </TD>
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">2.21</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1.61</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                              </DIV>
                           </TABLE>
                        </P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Holders</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">As of November 28, 2014, the number of holders of record of our
                           common stock was&nbsp;33.
                        </P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Dividends</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We have never paid or declared any cash dividends on our common
                           stock. We currently intend to retain earnings, if any, to finance the
                           growth and development of our business. Payment of future dividends,
                           if any, will be at the discretion of our board of directors.
                        </P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">39</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; "><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; "><A name="Item7"></A><A name="allpages_continue6"></A>ITEM 7. &nbsp;<I><B>MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
                                       OF OPERATIONS</B></I></B></DIV>
                        </P>
                        <P style="padding-left: 0pt; padding-top: 6px; line-height: 1.3; text-indent: 20.05pt; text-align: left; "><I style="text-align: left; font-size: 10.0pt; ">You should read the following discussion and analysis of our
                              financial condition and results of operations together with our
                              financial statements and the related notes included elsewhere in this
                              Annual Report on Form 10-K. Some of the information contained in this
                              discussion and analysis or set forth elsewhere in this Form 10-K,
                              including information with respect to our plans and strategy for our
                              business and related financing, includes forward-looking statements
                              that involve risks and uncertainties. You should read the "Risk
                              Factors" section of this Form 10-K (see Part I-Item 1A above) for a
                              discussion of important factors that could cause actual results to
                              differ materially from the results described in or implied by the
                              forward-looking statements contained in the following discussion and
                              analysis.</I></P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Overview</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We are a specialty biopharmaceutical company focused on the
                           development and commercialization of innovative treatments for
                           diabetes that may be safer, more effective and more convenient for
                           patients. We develop our product candidates by applying our
                           formulation technologies to existing drugs in order to improve their
                           therapeutic profiles. Our glucagon formulations and presentations are
                           designed to be stable at room temperature and are intended for use by
                           caregivers with little to no medical training as a rescue treatment
                           for diabetes patients experiencing severe hypoglycemia. Our
                           proprietary insulin formulations are designed to be more rapid-acting
                           than the formulations currently available to Type 1 and Type 2
                           diabetes patients. We refer to these as "ultra-rapid-acting" insulin
                           formulations.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; background-color: white; color: black; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Our lead product candidate is a glucagon emergency management, or
                           GEM, device that is intended to treat diabetes patients experiencing
                           severe hypoglycemia, or very low concentrations of blood glucose. GEM
                           is comprised of lyophilized glucagon and an aqueous diluent in a
                           proprietary injection device from Unilife Medical Solutions, Inc., or
                           Unilife. The GEM device is a dual-chamber design that automatically
                           reconstitutes lyophilized glucagon immediately prior to injection and
                           features automatic needle retraction on full dose delivery. We have
                           designed the GEM device with the goal of optimizing its ease of use
                           for patient caregivers in an emergency.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; background-color: white; color: black; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In the third quarter of calendar year 2014, we submitted an
                           Investigational New Drug application, or IND, to the U.S. Food and
                           Drug Administration, or FDA, for our GEM product candidate. We have
                           initiated a Phase 1 clinical trial to assess the pharmacokinetic and
                           pharmacodynamic profiles of BIOD-961, the reconstituted glucagon
                           formulation intended for use in the GEM device, in the fourth
                           calendar quarter of 2014. If the Phase 1 clinical trial is
                           successful, we intend to complete the pivotal trial for our GEM
                           product candidate by the end of calendar year 2015 and submit a New
                           Drug Application, or NDA, to the FDA in calendar year&nbsp;2016.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; background-color: white; color: black; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In addition to our GEM product candidate, we are developing
                           ultra-rapid-acting proprietary insulin formulations that are designed
                           to be more rapid-acting than the formulations currently available to
                           Type 1 and Type 2 diabetes patients. For example, BIOD-123, which was
                           evaluated in a Phase 2 clinical trial, combines recombinant human
                           insulin, or RHI, with our proprietary combination of excipients to
                           increase the rate of absorption following subcutaneous injection when
                           compared to other commercially available insulin formulations,
                           including "rapid-acting" mealtime insulin analogs such as Humalog&#174;,
                           marketed by Eli Lilly, NovoLog&#174;, marketed by Novo Nordisk, and
                           Apidra&#174;, marketed by Sanofi. Similarly, we have developed BIOD-531, a
                           concentrated ultra-rapid-acting insulin formulation. BIOD-531
                           contains 400 units of RHI per milliliter (instead of the standard 100
                           units per milliliter), and, like BIOD-123, is formulated with EDTA,
                           citrate and magnesium sulfate. When delivered by subcutaneous
                           injection, BIOD-531 is characterized by a rapid onset of action and a
                           prolonged duration of action, which we believe could address an unmet
                           medical need for an insulin with an initial rate of absorption
                           superior to that of existing concentrated insulins and prandial/basal
                           premixed insulins.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; background-color: white; color: black; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In addition to our RHI-based ultra-rapid-acting insulin formulations,
                           we are using our proprietary excipients to develop analog-based
                           ultra-rapid-acting insulin formulations using either insulin lispro,
                           the active pharmaceutical ingredient in Humalog&#174;, or insulin aspart,
                           the active pharmaceutical ingredient in&nbsp;NovoLog&#174;.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We were incorporated in December 2003 and commenced active operations
                           in January 2004. To date, we have generated no revenues and have
                           incurred significant losses. We expect to continue to incur operating
                        </P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">40</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 0pt; margin-top: 06.00pt; text-align: left; ">losses as we continue our efforts to develop and commercialize our
                           product candidates. We have financed our operations and internal
                           growth through various financing transactions, including our initial
                           public offering in May 2007 and several subsequent transactions,
                           including, most recently, our June 2013 underwritten public offering.
                           In addition, we recently raised funds pursuant to our At-the-Market
                           Issuance Sales Agreement, or the sales agreement, with MLV &amp; Co. LLC,
                           or MLV, and our stock purchase agreement with Lincoln Park Capital
                           Fund, LLC, or LPC, and we may issue shares of our common stock
                           pursuant to these agreements in the future. We have devoted
                           substantially all of our efforts to research and development
                           activities, including clinical trials. Our net loss was $14.1 million
                           for the year ended September 30, 2014. As of September 30, 2014 we
                           had an accumulated deficit of $229.6 million.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">As of September 30, 2014 we had approximately $24.6 million in cash
                           and cash equivalents compared to $39.8 million in cash and cash
                           equivalents as of September 30, 2013. We believe that our existing
                           cash and cash equivalents will be sufficient to fund our anticipated
                           operating expenses and capital expenditures at least until the third
                           calendar quarter of 2015. We believe that future cash expenditures
                           will be partially offset by raising additional capital from capital
                           markets, revenues from research grants and proceeds derived from
                           potential collaborations, including, but not limited to, upfront
                           fees, research and development funding, milestone payments and
                           royalties. We can give no assurances that such funding will, in fact,
                           be realized in the time frames we expect, or at all. We may be
                           required to secure alternative financing arrangements or defer or
                           limit some or all of our research, development or clinical projects.
                        </P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; "><A name="allpages_continue7"></A>Financial Operations Overview</B></DIV>
                        </P><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Revenues</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">To date, we have generated no revenues. We do not expect to begin
                              generating any revenues unless any of our product candidates receive
                              marketing approval, or if we receive payments in connection with
                              strategic collaborations that we may enter into for the
                              commercialization of our product candidates.
                           </P>
                        </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Research and Development Expenses</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Research and development expenses consist of the costs associated
                              with our basic research activities, as well as the costs associated
                              with our drug development efforts, conducting preclinical studies and
                              clinical trials, manufacturing development efforts and activities
                              related to regulatory filings. Our research and development expenses
                              consist&nbsp;of:
                           </P>
                           <DIV style="padding-left: 37pt; ">
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>external research and development expenses incurred under agreements
                                 with third-party contract research organizations and investigative
                                 sites, third-party manufacturing organizations and consultants;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>employee-related expenses, which include salaries and benefits for
                                 the personnel involved in our preclinical and clinical drug
                                 development and manufacturing activities; and
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>facilities, depreciation and other allocated expenses, which include
                                 direct and allocated expenses for rent and maintenance of facilities,
                                 depreciation of leasehold improvements and equipment and laboratory
                                 and other supplies.
                              </P>
                           </DIV>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We intend to focus our research and development efforts on conducting
                              preclinical studies and Phase 1 and Phase 2 clinical trials to
                              determine our preferred development, clinical and regulatory program
                              for our ultra-rapid-acting insulin formulations and our glucagon
                              formulations and presentations. We also expect to conduct a pivotal
                              clinical trial in support of an NDA for our GEM product candidate. We
                              anticipate that our research and development expenses for the fiscal
                              year ending September 30, 2015 will increase as compared to the
                              fiscal year ended September 30, 2014, as we continue&nbsp;to:
                           </P>
                           <DIV style="padding-left: 37pt; ">
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>conduct the development work necessary to finalize the formulation
                                 and design of our GEM product candidate and undertake manufacturing
                                 activities in support of clinical trials with that product candidate;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>produce validation and registration batches of our GEM product
                                 candidate to support the submission of an NDA with the&nbsp;FDA;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>conduct clinical trials with our GEM product candidate, including at
                                 least one pivotal clinical trial required for FDA approval of an&nbsp;NDA;
                              </P>
                           </DIV>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">41</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: center; ">
               <DIV style="padding-top: 0px; text-align: center; ">
                  <DIV style="padding-top: 0px; text-align: center; ">
                     <DIV style="padding-top: 0px; text-align: center; ">
                        <DIV style="padding-top: 0px; text-align: center; ">
                           <DIV style="padding-left: 37pt; ">
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>conduct clinical trials with our BIOD-531 product candidate,
                                 including a planned Phase 2, parallel group study in patients with
                                 Type 2 diabetes over a six-month treatment period;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>conduct the required stability, preclinical and human factors and
                                 user acceptability studies to support the approval of our GEM device
                                 and one or more insulin injection devices intended for use with
                                 BIOD-531; and
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>purchase active pharmaceutical ingredients and other materials
                                 consistent in support of our product candidates.
                              </P>
                           </DIV>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Over the longer term, we anticipate that these expenses will increase
                              further as&nbsp;we:
                           </P>
                           <DIV style="padding-left: 37pt; ">
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>prepare and file an NDA for our GEM product candidate; and
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>conduct later stage clinical trials of BIOD-531, including,
                                 potentially, pivotal clinical trials required for FDA approval of
                                 an&nbsp;NDA.
                              </P>
                           </DIV>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We have used our employee and infrastructure resources across
                              multiple research projects and our drug development programs. A
                              substantial majority of our research and development expenses
                              incurred to date are attributable to our ultra-rapid-acting insulin
                              program.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In July and September 2012, we were awarded two National Institutes
                              of Health grants for the development of a concentrated
                              ultra-rapid-acting insulin formulation and a stable glucagon
                              formulation, respectively, for use in an artificial pancreas. The
                              July 2012 award is intended to fund research to develop a proprietary
                              ultra-rapid-insulin product candidate at high concentrations suited
                              to provide sufficient quantities of insulin in an external artificial
                              pancreas pump device that has limited volume capacity. The July 2012
                              award is for two years and totals $582 thousand. The September 2012
                              award is intended to fund research to develop a proprietary glucagon
                              product candidate optimized to algorithmically deliver glucagon as
                              part of a bi-hormonal closed loop system to mitigate hypoglycemic
                              events. The September 2012 award is for two years and totals $583
                              thousand. As of September 30, 2014, all grant income was earned and
                              recorded.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The following table illustrates, for each period presented, our
                              research and development costs by nature of the&nbsp;cost.
                           </P>
                           <P style="text-align: center; margin: 0pt; padding: 0pt; ">
                              <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                                 <TR>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 73.89%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 1.23%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 1.23%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 9.84%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 1.23%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 12.31%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 0.27%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                 </TR>
                                 <DIV style="padding-top: 3px; text-align: center; ">
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="7" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; ">
                                          <P style=" line-height: 1.3; margin-top: 0pt; text-align: center; "><B>Year Ended</B><BR></P>
                                          <P style=" line-height: 1.3; margin-top: 0pt; text-align: center; "><B>September 30, 2014</B><BR></P>
                                          <P style=" line-height: 1.3; margin-top: 0pt; text-align: left; "></P>
                                       </TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2013</B></TD>
                                       <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2014</B></TD>
                                       <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="7" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center; "><B>(In thousands)</B></TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 00.00pt; text-indent: 0pt; text-align: left; ">Preclinical expenses </TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 00.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">4,640</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">4,734</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 00.00pt; text-indent: 0pt; text-align: left; ">Manufacturing expenses </TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 00.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">2,428</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">3,403</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 00.00pt; text-indent: 0pt; text-align: left; ">Clinical/regulatory expenses </TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 00.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">7,228</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">6,057</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 30.00pt; text-indent: -9.95pt; text-align: left; ">Total </TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 30.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">14,296</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">14,194</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                                    </TR>
                                 </DIV>
                              </TABLE>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The following table illustrates, for each period presented, our
                              research and development costs by&nbsp;project.
                           </P>
                           <P style="text-align: center; margin: 0pt; padding: 0pt; ">
                              <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                                 <TR>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 68.31%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 0.24%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 3.22%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 0.24%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 11.82%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 0.88%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 8.59%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 6.70%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                 </TR>
                                 <DIV style="padding-top: 3px; text-align: center; ">
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="10" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; ">
                                          <P style=" line-height: 1.3; margin-top: 0pt; text-align: center; "><B>Year Ended</B><BR></P>
                                          <P style=" line-height: 1.3; margin-top: 0pt; text-align: center; "><B>September 30, 2014</B><BR></P>
                                          <P style=" line-height: 1.3; margin-top: 0pt; text-align: left; "></P>
                                       </TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2013</B></TD>
                                       <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 06.35pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 06.35pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 06.35pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: left; "><B>2014</B></TD>
                                       <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="10" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>(In thousands)</B></TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">Ultra-rapid-acting insulin formulations:</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">RHI-based </TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">5,390</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">442</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Insulin analog-based </TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1,694</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1,377</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Stable Glucagon </TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1,848</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">5,569</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Concentrated RHI-based formulations </TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1,181</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">3,715</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Other </TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">4,183</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">3,091</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 30.00pt; text-indent: -9.95pt; text-align: left; ">Total </TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 30.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">14,296</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">14,194</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 00.00pt; ">&nbsp;</TD>
                                    </TR>
                                 </DIV>
                              </TABLE>
                           </P>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">42</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <DIV style="padding-top: 0px; text-align: left; ">
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The successful development of our product candidates is highly
                              uncertain. At this time, we cannot reasonably estimate or know the
                              nature, specific timing and estimated costs of the efforts that will
                              be necessary to complete the remainder of the development of, or the
                              period, if any, in which material net cash inflows may commence from
                              our product candidates. This is due to the numerous risks and
                              uncertainties associated with developing drugs, including the
                              uncertainty of:
                           </P>
                           <DIV style="padding-left: 37pt; ">
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the progress, timing or success of our research and development and
                                 clinical programs for our product candidates, particularly our GEM
                                 product candidate and our BIOD-531 product candidate;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to conduct the development work necessary to finalize the
                                 formulation and presentation of our GEM product candidate, as well as
                                 the preclinical studies, clinical trials and manufacturing activities
                                 necessary to support the submission of an NDA for that candidate;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the ability and willingness of our existing strategic partners,
                                 service providers and suppliers, upon which we rely in the
                                 advancement of our product candidates, to meet the obligations set
                                 forth in our agreements with them, including Unilife, which is
                                 responsible for designing and manufacturing the device intended for
                                 use with our GEM product candidate, as well as delivering three
                                 registration lots of the filled and finished GEM device required for
                                 submitting an NDA to the&nbsp;FDA;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the success of our formulation development work to improve the
                                 stability of our newer ultra-and rapid-acting insulin analog-based
                                 formulations while maintaining the pharmacokinetic and injection site
                                 toleration characteristics associated with earlier formulations;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the results of our real-time stability programs for our glucagon-,
                                 RHI-, and insulin analog-based product candidates, including the
                                 reproducibility of earlier, smaller scale, stability studies and our
                                 ability to accurately project long term stability on the basis of
                                 accelerated testing;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to accurately anticipate technical challenges that we may
                                 face in the development of our glucagon-, RHI-, and insulin
                                 analog-based product candidates;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to secure approval by the FDA for our product candidates
                                 under Section 505(b)(2) of the&nbsp;FFDCA;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to enter into collaboration arrangements for the
                                 commercialization of our product candidates and the success or
                                 failure of any such collaborations into which we enter, or our
                                 ability to commercialize our product candidates ourselves;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to enforce our patents for our product candidates and our
                                 ability to secure additional patents for our product candidates;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to protect our intellectual property and operate our
                                 business without infringing upon the intellectual property rights
                                 of&nbsp;others;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the degree of clinical utility of our product candidates,
                                 particularly with regard to our ultra-rapid-acting insulin
                                 formulations, which have not yet been shown to be clinically superior
                                 to existing rapid-acting insulin analogs;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the emergence of competing technologies and products and other
                                 adverse market developments, such as advancements in glucagon
                                 stabilization technologies that could enable a room-temperature
                                 rescue product in a portable, easy to use presentation;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the ability of our contract manufacturing organizations or
                                 collaborators to produce our products in our final dosage form and in
                                 the quantities we may&nbsp;require;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to secure adequate supplies of active pharmaceutical
                                 ingredients to support our product development programs and, if
                                 successful, the commercialization of one or more product candidates;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our capabilities and strategies for manufacturing, marketing and
                                 commercializing a product candidate; and
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to accurately estimate anticipated operating losses,
                                 future revenues, capital requirements and our needs for additional
                                 financing.
                              </P>
                           </DIV>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">43</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <DIV style="padding-top: 0px; text-align: left; ">
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">A change in the outcome of any of these variables with respect to the
                              development of ultra-rapid-acting insulin formulations or our liquid
                              glucagon formulation, could mean a significant change in the costs
                              and timing associated with product development.
                           </P>
                        </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">General and Administrative Expenses</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">General and administrative expenses consist primarily of salaries and
                              related expenses for personnel, including stock-based compensation
                              expenses, relating to our internal executive, legal, accounting,
                              finance and information technology departments. Other general and
                              administrative expenses include facility-related costs not otherwise
                              allocated to research and development expense, patent expenses,
                              travel expenses, costs associated with industry conventions and
                              professional fees, such as legal and accounting fees and consulting
                              costs.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We anticipate that our general and administrative expenses in the
                              fiscal year ending September 30, 2015 will remain substantially the
                              same as in the fiscal year ended September 30, 2014 as we continue to
                              focus our efforts on product formulation activities and begin
                              advancing our product candidates into later stage clinical trials,
                              including Phase 3 pivotal trials. Over the longer term, however,
                              these expenses could increase as we prepare to file an NDA in support
                              of our GEM product candidate and, possibly, commence
                              pre-commercialization activities.
                           </P>
                        </DIV> <BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Warrant Liability</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In June 2012, we issued warrants to purchase 2,749,469 shares of our
                              common stock at an exercise price of $2.66 per share in connection
                              with our June 2012 private placement. These warrants will expire on
                              June 26, 2017, five years from the original issuance date of June 27,
                              2012. In May 2011, we issued warrants to purchase 2,256,929 shares of
                              our common stock at an exercise price of $9.92 per share in
                              connection with our May 2011 registered direct offering. These
                              warrants will expire on May 17, 2016, five years from the original
                              issuance date of May 18, 2011. Under the terms of both the 2012
                              warrants and the 2011 warrants, if we enter into a merger or change
                              of control transaction, the holders of the warrants will be entitled
                              to receive consideration as if they had exercised the warrants
                              immediately prior to such transaction, or they may require us to
                              purchase the unexercised warrants at the Black-Scholes value (as
                              defined in the applicable warrant) of the warrant on the date of such
                              transaction. The holders have up to 30 days following any such
                              transaction to exercise this right. As a result of this provision, we
                              recognize the 2012 and 2011 warrants as liabilities at their fair
                              value on each reporting date.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We use the Black-Scholes valuation model to estimate the fair value
                              of the warrants. The Black-Scholes valuation model takes into
                              account, as of the valuation date, factors including the current
                              exercise price, the expected life of the warrant, the current price
                              of the underlying stock and its expected volatility, expected
                              dividends on the stock, and the risk-free interest rate for the term
                              of the warrant. Using this model, we recorded an initial warrant
                              liability of $4.8 million for the 2012 warrants and $9.4 million for
                              the 2011 warrants, in each case as of the initial warrant issuance
                              date. The significant assumptions for the model used for the 2012
                              warrants were remaining terms of the warrants, the common stock price
                              of $3.15 per share, the warrant exercise price of $2.66 per share, a
                              risk-free interest rate of 0.63% and an expected volatility rate of
                              82%. The significant assumptions for the model used for the 2011
                              warrants were remaining terms of the warrants, the common stock price
                              of $3.15 per share, the warrant exercise price of $9.92 per share, a
                              risk-free interest rate of 0.63% and an expected volatility rate of
                              77%. The liability for both the 2012 and 2011 warrants is revalued at
                              each reporting period and changes in fair value are recognized
                              currently in the statements of operations under the caption
                              "Adjustments to fair value of common stock warrant liability."
                           </P>
                        </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Interest Income</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Interest income consists of interest earned on our cash and cash
                              equivalents. In November 2007, our board of directors approved
                              investment policy guidelines, the primary objectives of which are the
                              preservation of capital, the maintenance of liquidity and maintenance
                              of appropriate fiduciary control, subject to our business objectives
                              and tax situation. We have maintained an investment strategy of
                              investing primarily in a premier commercial money market account,
                              which consists primarily of short-term debt securities issued by the
                              U.S. government, Treasury securities and U.S. government agencies. We
                              intend to maintain this conservative strategy in fiscal year ending
                              September 30, 2015.
                           </P>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">44</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Critical Accounting Policies and Significant Judgments and Estimates</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Our management's discussion and analysis of our financial condition
                           and results of operations is based on our audited financial
                           statements that have been prepared in accordance with accounting
                           principles generally accepted in the United States. The preparation
                           of these financial statements requires us to make estimates and
                           assumptions that affect the reported amounts of assets and
                           liabilities and the disclosure of contingent assets and liabilities
                           at the date of the financial statements, as well as the reported
                           expenses during the reporting periods. On an ongoing basis, we
                           evaluate our estimates and assumptions. We base our estimates on
                           historical experience and on various assumptions that we believe are
                           reasonable under the circumstances, the results of which form the
                           basis for making judgments about the carrying values of assets and
                           liabilities that are not readily apparent from other sources. Actual
                           results may differ from these estimates under different assumptions
                           or conditions.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">While our significant accounting policies are more fully described in
                           Note 2 to our financial statements appearing at the end of this
                           Annual Report on Form 10-K, we believe that the following accounting
                           policies, which we have discussed with our audit committee, are the
                           most critical to aid you in fully understanding and evaluating our
                           financial condition and results of operations.
                        </P><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Preclinical Study and Clinical Trial Accruals</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In preparing our financial statements, we must estimate accrued
                              expenses pursuant to contracts with multiple research institutions,
                              clinical research organizations and contract manufacturers that
                              conduct and manage preclinical studies, clinical trials and
                              manufacture product for these trials on our behalf. This process
                              involves communicating with relevant personnel to identify services
                              that have been performed on our behalf and estimating the level of
                              services performed and the associated costs incurred for services
                              when we have not yet been invoiced for or otherwise notified of the
                              actual cost. We make estimates of our accrued expenses as of each
                              balance sheet date in our financial statements based on facts and
                              circumstances known to us. The financial terms of these agreements
                              vary and may result in uneven payment flows. To date, we have not
                              adjusted our estimates at any balance sheet date in any material
                              amount. Examples of preclinical study, clinical trial and
                              manufacturing expenses include the following:
                           </P>
                           <DIV style="padding-left: 37pt; ">
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>fees paid to contract research organizations in connection with
                                 preclinical and toxicology studies and clinical trials;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>fees paid to investigative sites in connection with clinical trials;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>fees paid to contract manufacturers in connection with the production
                                 of clinical trial materials; and
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>professional service fees.
                              </P>
                           </DIV>
                        </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Government Grants</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Grants received are recognized as grant income when the grants become
                              receivable, provided there is reasonable assurance that we will
                              comply with the conditions attached to the grant and there is
                              reasonable assurance the grant will be received. We request cash
                              funding under approved grants as expenses are incurred (not in
                              advance) and report these receipts on the statement of operations as
                              a separate line item entitled "Government Grants." The corresponding
                              expenses are included in research and development expenses. In July
                              and September 2012, we were awarded two National Institutes of Health
                              grants for the development of a concentrated ultra-rapid-acting
                              insulin formulations and a stable glucagon formulation, respectively,
                              for use in an artificial pancreas. Both awards were for two years and
                              totaled approximately $580 thousand each. Work on the grant for the
                              development of concentrated ultra-rapid-acting insulin formulation
                              started in August 2012 and completed in June 2014. Expenses incurred
                              were $167 thousand during the twelve months ended September 30, 2014.
                              Work on the grant for the development of novel and stable glucagon
                              formulations for closed loop systems started in January 2013 and
                              completed in June 2014. Expenses incurred were $364 thousand during
                              the twelve months ended September 30, 2014. As of September 30, 2014,
                              all grant income was earned and recorded.
                           </P>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">45</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Share-Based Compensation</B></DIV>
                        </P><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Stock Incentive Plan</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In March 2013, our stockholders approved the amended and restated
                              2010 Stock Incentive Plan (the "2010 Plan"). Up to 3,750,000 shares
                              of common stock may be issued pursuant to awards granted under the
                              2010 Plan, plus 1,540,739 shares of common stock underlying already
                              outstanding awards under the Company's prior plans. As of September
                              30, 2014, we had 2,643,523shares of common stock subject to
                              outstanding awards. The contractual life of options granted under the
                              2010 Plan may not exceed seven years. The 2010 Plan uses a "fungible
                              share" concept under which any awards that are not a full-value award
                              will be counted against the share limit as one (1) share for each
                              share of common stock and any award that is a full-value award will
                              be counted against the share limit as 1.5 shares for each one share
                              of common stock. We have not made any new awards under any prior
                              equity plans after March 2, 2010, the effective date the 2010 Plan
                              was approved by the stockholders. The 2010 Plan replaces the 2004
                              Stock Incentive Plan and 2005 Non-Employee Directors Stock
                              Option&nbsp;Plan.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We use the Black-Scholes pricing model to calculate the fair value of
                              stock options. The expected life for these grants was calculated in
                              accordance with the simplified method described in the Securities and
                              Exchange Commission Staff Accounting Bulletin (SAB) Topic 14.D.2 in
                              accordance with SAB No.&nbsp;110.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We recognize compensation costs related to share-based transactions,
                              including employee stock options, in the financial statements based
                              on fair value. The fair value of the stock underlying the options is
                              a significant factor in determining credits or charges to operations
                              appropriate for the share-based payments to both employees and
                              non-employees.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We base our estimate of expected volatility on the historical
                              volatility of our stock. The risk free rate of interest for periods
                              within the contractual life of the stock option is based on the yield
                              of a U.S. Treasury strip on the date the award is granted with a
                              maturity equal to the expected term of the award. We estimate
                              forfeitures based on actual forfeitures during our limited history.
                              Additionally, we have assumed that dividends will not be&nbsp;paid.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We grant restricted stock units, or RSUs, to executive officers and
                              employees pursuant to the 2010 Plan, from time to time. Each RSU
                              represents one share of common stock. There is no direct cost to the
                              recipients of RSUs, except for any applicable taxes. Each award vests
                              in installments on each anniversary of the date of grant, and the
                              costs of the awards are determined as the fair market value of the
                              shares on the date of grant. In all cases, costs are expensed per the
                              vesting schedule outlined in the award. For example, RSUs awarded in
                              December 2010 vest annually over three years, with 50% vesting on the
                              first anniversary of the date of grant and the remainder vesting in
                              two equal installments on each anniversary thereafter, and therefore
                              are expensed 50% in the first year and 25% each year in the next two
                              years. Each year following the annual vesting date, between January
                              1st and March 15th, we will issue common stock for each vested RSU.
                              During the period when the RSU is vested but not distributed, the
                              RSUs cannot be transferred and the grantee has no voting rights. If
                              we declare a dividend, RSU recipients will receive payment based upon
                              the percentage of RSUs that have vested prior to the date of
                              declaration.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">For the year ended September 30, 2014, the share-based compensation
                              expense, including expenses associated with stock options and RSUs,
                              was $0.8 million, of which $0.3 million is reflected in research and
                              development expenses and $0.5 million is reflected in general and
                              administrative expenses. For the year ended September 30, 2013, the
                              share-based compensation expense, including expenses associated with
                              stock options and RSUs, was $1.5 million, of which $0.7 million is
                              reflected in research and development expenses and $0.8 million is
                              reflected in general and administrative expenses.
                           </P>
                        </DIV> <BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Income Taxes</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">As part of the process of preparing our financial statements, we are
                              required to estimate our income taxes in each of the jurisdictions in
                              which we operate. This process involves estimating our actual current
                              tax expense together with assessing temporary differences resulting
                              from differing treatments of items for tax and accounting purposes.
                              These differences result in deferred tax assets and liabilities.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">At September 30, 2013 and 2014, we recorded a 100% valuation
                              allowance against our net deferred tax asset of approximately $55.0
                              million and $62.4 million, respectively, as our management believes
                              it is
                           </P>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">46</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: center; ">
               <DIV style="padding-top: 0px; text-align: center; ">
                  <DIV style="padding-top: 0px; text-align: center; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <DIV style="padding-top: 0px; text-align: left; ">
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 0pt; margin-top: 06.00pt; text-align: left; ">uncertain that it will be fully realized. If we determine in the
                              future that we will be able to realize all or a portion of our net
                              deferred tax asset, an adjustment to the deferred tax valuation
                              allowance would increase net income in the period in which we make
                              such a determination.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">As of September 30, 2014, we had net operating loss carry-forwards of
                              approximately $71.9 million for U.S. federal and $126.5 million for
                              state tax purposes. These loss carry-forwards expire between 2024 and
                              2034. To the extent these net operating loss carry-forwards are
                              available, we intend to use them to reduce the corporate income tax
                              liability associated with our operations. Section 382 of the U.S.
                              Internal Revenue Code generally imposes an annual limitation on the
                              amount of net operating loss carry-forwards that might be used to
                              offset taxable income when a corporation has undergone significant
                              changes in stock ownership. Based on a Section 382 analysis review,
                              we determined that an ownership change under Section 382 occurred on
                              May 12, 2011. We also completed an additional study of the impact of
                              Section 382 limitation on future payments in November 2013 and
                              determined that there were no additional limitations on the Company's
                              existing NOLs.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We believe that approximately $55.9 million of the $127.8 million
                              federal losses will expire unused as a result of Section 382
                              limitations. The maximum annual limitation under Section 382 is
                              approximately $2.5 million for 20 years. To the extent our use of net
                              operating loss carry-forwards is limited, future income could be
                              subject to corporate income tax earlier than it would if we were able
                              to use net operating loss carry-forwards, which could result in
                              decreased net&nbsp;income.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We also have state research and development credit carry-forwards of
                              approximately $0.3 million, which expire commencing in fiscal&nbsp;2022.
                           </P>
                        </DIV>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: center; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Results of Operations</B></DIV>
                        </P><BR><DIV style="padding-top: 0px; text-align: center; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Year Ended September 30, 2014 Compared to Year Ended September 30, 2013</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; "><I>Revenue.</I>&nbsp;We did not recognize any revenue during the years ended September
                              30, 2014 or 2013.
                           </P><BR><DIV style="padding-top: 0px; text-align: center; ">
                              <P>
                                 <DIV style="padding-top: 0px; text-align: left; "><I style="text-align: left; font-size: 10.0pt; ">Research and Development Expenses.</I></DIV>
                              </P>
                              <P style="text-align: center; margin: 0pt; padding: 0pt; ">
                                 <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                                    <TR>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 57.69%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 1.44%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 10.09%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 1.44%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 10.09%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 1.44%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 10.09%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 1.44%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 6.26%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                    </TR>
                                    <DIV style="padding-top: 3px; text-align: center; ">
                                       <TR style="text-align: left; ">
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="7" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Year Ended<BR>September 30,</B></TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="7" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Decrease</B></TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                       </TR>
                                       <TR style="text-align: left; ">
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                          <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2013</B></TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2014</B></TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">$</TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">%</TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       </TR>
                                       <TR style="text-align: left; ">
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="19" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>In thousands, except per share amounts</B></TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                       </TR>
                                       <TR style="text-align: left; ">
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                          <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Research and Development </TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">14,296</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">14,194</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">102</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">0.7</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">%</TD>
                                       </TR>
                                       <TR style="text-align: left; ">
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Percentage of net loss </TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">73.9</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">%</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">100.4</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">%</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                                       </TR>
                                    </DIV>
                                 </TABLE>
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Research and development expenses were $14.2 million for the year
                                 ended September 30, 2014, a decrease of $0.1 million, or
                                 approximately 0.7%, from $14.3 million for the year ended September
                                 30, 2013. This decrease was primarily attributable to decreases of
                                 $1.0 million in external expenses associated with our clinical
                                 trials, $0.6 million in personnel and stock-based compensation
                                 expenses, and $0.1 million in consulting fees, offset by an increase
                                 of $1.6 million in expenses associated with payments to Unilife and
                                 other external contract manufacturers for the development of our GEM
                                 product candidate.
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Research and development expenses for the years ended September 30,
                                 2014 and 2013 include $0.3 million and $0.7 million, respectively, in
                                 stock-based compensation expense related to options granted to
                                 employees.
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In July and September 2012, we received two National Institutes of
                                 Health awards for the development of concentrated ultra-rapid-acting
                                 insulin formulation and glucagon formulation for use in an artificial
                                 pancreas. The July 2012 award was intended to fund research to
                                 develop a proprietary ultra-rapid-insulin product candidate at high
                                 concentrations suited to provide sufficient quantities of insulin in
                                 an external artificial pancreas pump device that has limited volume
                                 capacity. The July award was for two years and totaled $582 thousand.
                                 The September 2012 award was intended to fund research to develop a
                                 proprietary glucagon product candidate optimized to algorithmically
                                 deliver glucagon as part of a bi-hormonal closed loop system to
                                 mitigate hypoglycemic events. The September 2012 award was for two
                                 years and totaled $583 thousand. For the year ended September 30,
                                 2014, we reported $167 thousand in government grants for the high
                                 concentration ultra-rapid-insulin product candidate and $364 thousand
                                 for the glucagon formulation work.
                              </P>
                           </DIV>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">47</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: center; ">
               <DIV style="padding-top: 0px; text-align: center; ">
                  <DIV style="padding-top: 0px; text-align: center; ">
                     <DIV style="padding-top: 0px; text-align: center; ">
                        <DIV style="padding-top: 0px; text-align: center; ">
                           <DIV style="padding-top: 0px; text-align: left; ">
                              <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">For the year ended September 30, 2013, we reported $327 thousand in
                                 government grants for the high concentration ultra-rapid-insulin
                                 product candidate and $219 thousand for the glucagon formulation work.
                              </P>
                           </DIV><BR><DIV style="padding-top: 0px; text-align: center; ">
                              <P>
                                 <DIV style="padding-top: 0px; text-align: left; "><I style="text-align: left; font-size: 10.0pt; ">General and Administrative Expenses.</I></DIV>
                              </P>
                              <P style="text-align: center; margin: 0pt; padding: 0pt; ">
                                 <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                                    <TR>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 57.69%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 1.44%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 10.09%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 1.44%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 10.09%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 1.44%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 10.09%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 1.44%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 6.26%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                    </TR>
                                    <DIV style="padding-top: 3px; text-align: center; ">
                                       <TR style="text-align: left; ">
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="7" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Year Ended<BR>September 30,</B></TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="7" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Decrease</B></TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                       </TR>
                                       <TR style="text-align: left; ">
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                          <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2013</B></TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2014</B></TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">$</TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">%</TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       </TR>
                                       <TR style="text-align: left; ">
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="19" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>In thousands, except per share amounts</B></TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                       </TR>
                                       <TR style="text-align: left; ">
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                          <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">General and Administrative </TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">6,843</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">5,598</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1,245</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">18.2</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">%</TD>
                                       </TR>
                                       <TR style="text-align: left; ">
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Percentage of net loss </TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">35.4</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">%</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">39.6</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">%</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                                       </TR>
                                    </DIV>
                                 </TABLE>
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">General and administrative expenses were $5.6 million for the year
                                 ended September 30, 2014, a decrease of $1.2 million, or 18.2%, from
                                 $6.8 million for the year ended September 30, 2013. This decrease is
                                 primarily attributable to a decrease in personnel and stock-based
                                 compensation expenses of $1.1 million.
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">General and administrative expenses for the years ended September 30,
                                 2014 and 2013 include $0.5 million and $0.8 million, respectively, in
                                 stock-based compensation expense related to options granted to
                                 employees and non-employee directors.
                              </P>
                           </DIV><BR><DIV style="padding-top: 0px; text-align: center; ">
                              <P>
                                 <DIV style="padding-top: 0px; text-align: left; "><I style="text-align: left; font-size: 10.0pt; ">Interest and Other Income.</I></DIV>
                              </P>
                              <P style="text-align: center; margin: 0pt; padding: 0pt; ">
                                 <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                                    <TR>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 57.69%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 1.44%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 10.09%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 1.44%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 10.09%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 1.44%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 10.09%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 1.44%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 6.26%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                    </TR>
                                    <DIV style="padding-top: 3px; text-align: center; ">
                                       <TR style="text-align: left; ">
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="7" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Year Ended<BR>September 30,</B></TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="7" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Decrease</B></TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                       </TR>
                                       <TR style="text-align: left; ">
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                          <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2013</B></TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2014</B></TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">$</TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">%</TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       </TR>
                                       <TR style="text-align: left; ">
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="19" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>In thousands, except per share amounts</B></TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                       </TR>
                                       <TR style="text-align: left; ">
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                          <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Interest and Other Income </TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">56</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">49</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">7</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">12.5</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">%</TD>
                                       </TR>
                                       <TR style="text-align: left; ">
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Percentage of net loss </TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">0.29</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">%</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">0.35</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">%</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                                       </TR>
                                    </DIV>
                                 </TABLE>
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Interest and other income decreased to $0.05 million for the year
                                 ended September 30, 2014, from $0.06 million for the year ended
                                 September 30, 2013. The decrease is primarily due to lower cash
                                 balances during the&nbsp;year.
                              </P>
                           </DIV> <BR><DIV style="padding-top: 0px; text-align: center; ">
                              <P>
                                 <DIV style="padding-top: 0px; text-align: left; "><I style="text-align: left; font-size: 10.0pt; ">Adjustments to Fair Value of Common Stock Warrant Liability.</I></DIV>
                              </P>
                              <P style="text-align: center; margin: 0pt; padding: 0pt; ">
                                 <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                                    <TR>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 57.69%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 1.44%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 10.09%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 1.44%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 8.91%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 2.16%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 8.65%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 1.08%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 0.24%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 8.29%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                    </TR>
                                    <DIV style="padding-top: 3px; text-align: center; ">
                                       <TR style="text-align: left; ">
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="7" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Year Ended<BR>September 30,</B></TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="10" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Increase</B></TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                       </TR>
                                       <TR style="text-align: left; ">
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                          <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2013</B></TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2014</B></TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">$</TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="4" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">%</TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       </TR>
                                       <TR style="text-align: left; ">
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="22" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>In thousands, except per share amounts</B></TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                       </TR>
                                       <TR style="text-align: left; ">
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                          <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Adjustments to fair value of common stock warrant<BR> liability
                                          </TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD colspan="4" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                                       </TR>
                                       <TR style="text-align: left; ">
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">May 2011 Warrants </TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                          <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(542</TD>
                                          <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                          <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(1,143</TD>
                                          <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                          <TD bgcolor="#CCEEFF" colspan="4" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(601</TD>
                                          <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                                       </TR>
                                       <TR style="text-align: left; ">
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                          <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">June 2012 Warrants </TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(675</TD>
                                          <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(3,964</TD>
                                          <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="4" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(3,289</TD>
                                          <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                                       </TR>
                                       <TR style="text-align: left; ">
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Total </TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(1,217</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(5,107</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                          <TD bgcolor="#CCEEFF" colspan="4" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">3,890</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">319.6</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">%</TD>
                                       </TR>
                                       <TR style="text-align: left; ">
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                          <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Percentage of net loss </TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">62.9</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">%</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">36.1</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">%</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD colspan="4" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                                       </TR>
                                    </DIV>
                                 </TABLE>
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The change in fair value of derivative instruments-warrants of
                                 $(1,217) during the year ended September 30, 2013 was primarily due
                                 to shorter terms and reduced volatility. The change in fair value of
                                 common stock warrant liability of $(5,107) during the year ended
                                 September 30, 2014 was primarily a result of the decrease in the
                                 price of the common stock from $3.15 per share at September 30, 2013
                                 to $1.67 per share on September 30, 2014.
                              </P>
                           </DIV> <BR><DIV style="padding-top: 0px; text-align: center; ">
                              <P>
                                 <DIV style="padding-top: 0px; text-align: left; "><I style="text-align: left; font-size: 10.0pt; ">Net Loss and Net Loss per Share.</I></DIV>
                              </P>
                              <P style="text-align: center; margin: 0pt; padding: 0pt; ">
                                 <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                                    <TR>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 57.69%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 1.44%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 10.09%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 1.44%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 10.09%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 1.44%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 10.09%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 1.44%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 6.26%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                    </TR>
                                    <DIV style="padding-top: 3px; text-align: center; ">
                                       <TR style="text-align: left; ">
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="7" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Year Ended<BR>September 30,</B></TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="7" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Decrease</B></TD>
                                          <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                       </TR>
                                       <TR style="text-align: left; ">
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                          <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2013</B></TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2014</B></TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">$</TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">%</TD>
                                          <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       </TR>
                                       <TR style="text-align: left; ">
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                          <TD bgcolor="#CCEEFF" colspan="19" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>In thousands, except per share amounts</B></TD>
                                          <TD bgcolor="#CCEEFF" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                       </TR>
                                       <TR style="text-align: left; ">
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                          <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Net loss </TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(19,335</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(14,131</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">5,204</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                          <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">26.9</TD>
                                          <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">%</TD>
                                       </TR>
                                    </DIV>
                                 </TABLE>
                              </P>
                           </DIV>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">48</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <DIV style="padding-top: 0px; text-align: left; ">
                           <DIV style="padding-top: 0px; text-align: left; ">
                              <P style="text-align: center; margin: 0pt; padding: 0pt; ">
                                 <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; ">
                                    <TR>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 57.69%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 1.44%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 10.09%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 1.44%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 10.09%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 1.44%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 10.09%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 1.44%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                       <TD style="width: 6.26%; font-size: 1pt;">&nbsp;</TD>
                                       <TD style="font-size: 1pt;">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Net loss per share </TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(1.24</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(0.66</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                                    </TR>
                                 </TABLE>
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Net loss was $14.1 million, or $(0.66) per share, for the year ended
                                 September 30, 2014, compared to $19.3 million, or $(1.24) per share,
                                 for the year ended September 30, 2013. The decrease in net loss was
                                 primarily due to an increase in adjustments to fair value of common
                                 stock warrant liability and a decrease in general and administrative
                                 expenses as noted&nbsp;above.
                              </P>
                           </DIV>
                        </DIV>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Liquidity and Capital Resources</B></DIV>
                        </P><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Sources of Liquidity and Cash Flows</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">As a result of our significant research and development expenditures
                              and the lack of any approved products or other sources of revenue, we
                              have not been profitable and have generated significant operating
                              losses since we were incorporated in 2003. We initially funded our
                              research and development operations through aggregate gross proceeds
                              of $26.6 million from our private financing transactions that we
                              completed prior to our initial public offering. We received an
                              aggregate of approximately $206 million from our initial public
                              offering in May 2007, our follow-on offering in February 2008, our
                              registered direct offerings in August 2010 and May 2011, our private
                              placement in June 2012, our public offering in June 2013, our sales
                              agreement with MLV, and purchase agreement with&nbsp;LPC.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">At September 30, 2014, we had cash and cash equivalents totaling
                              approximately $24.6 million. We plan to continue to invest our cash
                              and cash equivalents in accordance with our approved investment
                              policy guidelines.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Net cash used in operating activities was $18.7 million for the year
                              ended September 30, 2014, and $18.6 million for the year ended
                              September 30, 2013. Net cash used in operating activities for the
                              years ended September 30, 2014 and 2013 primarily reflects the net
                              loss for the period, offset in part by depreciation and amortization,
                              share-based compensation and changes in the fair value of the common
                              stock-warrant liability.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Net cash used in investing activities was $0.05 million for the year
                              ended September 30, 2014 and $0.1 million for the year ended
                              September 30, 2013. Net cash used in investing activities for the
                              years ended September 30, 2014, and 2013 reflects the purchase of
                              property and equipment.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Net cash provided by financing activities was $3.6 million for the
                              year ended September 30, 2014 and $19.4 million for the year ended
                              September 30, 2013. Net cash provided by financing activities for the
                              year ended September 30, 2014 primarily reflects proceeds from the
                              sale our securities through our sales agreement with MLV, our
                              purchase agreement with LPC, and through our employee stock purchase
                              plan. Net cash provided by financing activities for the year ended
                              September 30, 2013 primarily reflects proceeds from the sale of our
                              securities in our underwritten public offering in June 2013 and
                              through our employee stock purchase plan.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">On July 25, 2014, we entered into the purchase agreement with LPC.
                              Under the terms, and subject to the conditions of the purchase
                              agreement, we have the right to sell to LPC, and LPC is obligated to
                              purchase, up to $15 million in shares of our common stock, subject to
                              certain limitations, from time to time over the 36-month period
                              commencing on the date that a registration statement, which we have
                              filed with the SEC, was declared effective by the SEC and a final
                              prospectus in connection therewith was filed. As of September 30,
                              2014 we sold an aggregate of 300,000 shares of common stock pursuant
                              to this agreement and received proceeds, net of sales commissions, of
                              $0.5 million.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In May 2013, we entered into the sales agreement with MLV, under
                              which we may initially issue and sell up to $14 million in shares of
                              our common stock from time to time through MLV as our sales agent. On
                              July 2, 2014 we began selling shares pursuant to this agreement. As
                              of September 30, 2014 we sold an aggregate of 1,564,821 shares of
                              common stock pursuant to the sales agreement and received proceeds,
                              net of sales commissions, of $3.0 million.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In June 2013, we completed an underwritten public offering of
                              securities in which we issued 4,482,760 shares of our common stock at
                              a price to the public of $4.35 per share. In July 2013 we issued
                              236,007 additional shares of common stock, at the public offering
                              price of $4.35 per share, in connection with the underwriters'
                              exercise of a portion of their over-allotment. We received net
                              proceeds, after deducting underwriting fees and other offering
                              expenses of approximately $19.2 million from this financing.
                           </P>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">49</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Funding Requirements</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We believe that our existing cash and cash equivalents will be
                              sufficient to fund our anticipated operating expenses and capital
                              expenditures at least until the third calendar quarter of 2015. We
                              have based this estimate upon assumptions that may prove to be wrong
                              and we could use our available capital resources sooner than we
                              currently expect. Our existing capital resources are not sufficient
                              to complete our clinical development program for an
                              ultra-rapid-acting insulin product candidate. Because of the numerous
                              risks and uncertainties associated with the development and
                              commercialization of our product candidates, and to the extent that
                              we may or may not enter into collaborations with third parties to
                              participate in their development and commercialization, we are unable
                              to estimate the amounts of increased capital outlays and operating
                              expenditures associated with our current anticipated clinical trials.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Our future capital requirements will depend on many factors, including:</P>
                           <DIV style="padding-left: 37pt; ">
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the progress, timing or success of our research and development and
                                 clinical programs for our product candidates, particularly our GEM
                                 product candidate and our BIOD-531 product candidate;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to conduct the development work necessary to finalize the
                                 formulation and presentation of our GEM product candidate, as well as
                                 the preclinical studies, clinical trials and manufacturing activities
                                 necessary to support the submission of an NDA for that candidate;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the ability and willingness of our existing strategic partners,
                                 service providers and suppliers, upon which we rely in the
                                 advancement of our product candidates, to meet the obligations set
                                 forth in our agreements with them, including Unilife, which is
                                 responsible for designing and manufacturing the device intended for
                                 use with our GEM product candidate, as well as delivering three
                                 registration lots of the filled and finished GEM device required for
                                 submitting an NDA to the&nbsp;FDA;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the success of our formulation development work to improve the
                                 stability of our newer ultra-and rapid-acting insulin analog-based
                                 formulations while maintaining the pharmacokinetic and injection site
                                 toleration characteristics associated with earlier formulations;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the results of our real-time stability programs for our glucagon-,
                                 RHI-, and insulin analog-based product candidates, including the
                                 reproducibility of earlier, smaller scale, stability studies and our
                                 ability to accurately project long term stability on the basis of
                                 accelerated testing;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to accurately anticipate technical challenges that we may
                                 face in the development of our glucagon-, RHI-, and insulin
                                 analog-based product candidates;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to secure approval by the FDA for our product candidates
                                 under Section 505(b)(2) of the&nbsp;FFDCA;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to enter into collaboration arrangements for the
                                 commercialization of our product candidates and the success or
                                 failure of any such collaborations into which we enter, or our
                                 ability to commercialize our product candidates ourselves;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to enforce our patents for our product candidates and our
                                 ability to secure additional patents for our product candidates;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to protect our intellectual property and operate our
                                 business without infringing upon the intellectual property rights
                                 of&nbsp;others;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the degree of clinical utility of our product candidates,
                                 particularly with regard to our ultra-rapid-acting insulin
                                 formulations, which have not yet been shown to be clinically superior
                                 to existing rapid-acting insulin analogs;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the emergence of competing technologies and products and other
                                 adverse market developments, such as advancements in glucagon
                                 stabilization technologies that could enable a room-temperature
                                 rescue product in a portable, easy to use presentation;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>the ability of our contract manufacturing organizations or
                                 collaborators to produce our products in our final dosage form and in
                                 the quantities we may&nbsp;require;
                              </P>
                           </DIV>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">50</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <DIV style="padding-top: 0px; text-align: left; ">
                           <DIV style="padding-left: 37pt; ">
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to secure adequate supplies of active pharmaceutical
                                 ingredients to support our product development programs and, if
                                 successful, the commercialization of one or more product candidates;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our capabilities and strategies for manufacturing, marketing and
                                 commercializing a product candidate; and
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>our ability to accurately estimate anticipated operating losses,
                                 future revenues, capital requirements and our needs for additional
                                 financing.
                              </P>
                           </DIV>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We do not anticipate generating product revenue for the next few
                              years. In the absence of additional funding, we expect our continuing
                              operating losses to result in increases in our cash used in
                              operations over the next several years. To the extent our capital
                              resources are insufficient to meet our future capital requirements,
                              we will need to finance our future cash needs through public or
                              private equity offerings, debt financings or corporate collaboration
                              and licensing arrangements. Other than our agreements with MLV and
                              LPC, we do not currently have any commitments for future external
                              funding.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We may receive additional proceeds from the exercise of the warrants
                              that we issued in connection with our May 2011 registered direct
                              offering and our June 2012 private placement, if any of those
                              warrants are exercised for cash. Whether the warrants are exercised
                              for cash will depend on decisions made by the warrant holders and on
                              whether the market price of our common stock exceeds the $9.92 per
                              share warrant exercise price of the May 2011 warrants or the $2.66
                              per share warrant exercise price of the June 2012 warrants. The May
                              2011 warrants and the June 2012 warrants will expire on May 17, 2016
                              and June 26, 2017, respectively.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">While we continue to pursue cost saving initiatives to reduce
                              operating expenses, we will also need to raise additional funds and
                              periodically explore sources of equity or debt financing. We may seek
                              to raise such capital through public or private equity financings,
                              partnerships, joint ventures, debt financings, bank borrowings or
                              other sources. However, additional funding may not be available on
                              favorable terms or at all. If additional funds are raised by issuing
                              equity securities, substantial dilution to existing shareholders may
                              result. If we fail to obtain additional capital when needed, we may
                              be required to delay, scale back, or eliminate some or all of our
                              research and development programs. The accompanying financial
                              statements do not include any adjustments that may result from the
                              outcome of this uncertainty.
                           </P>
                           <P style="padding-left: 0pt; padding-top: 6px; line-height: 1.3; text-indent: 10.00pt; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Going Concern Consideration</B></I></P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 18.00pt; text-align: left; ">Our consolidated financial statements as of September 30, 2014 have
                              been prepared under the assumption that we will continue as a going
                              concern. Our independent registered public accounting firm has issued
                              a report on our financial statements that included an explanatory
                              paragraph referring to our recurring and expected continuing future
                              losses from operations and expressing substantial doubt in our
                              ability to continue as a going concern without additional capital
                              becoming available. While we could sell an additional $9.2 million worth of common shares through the sales
agreement with MLV or direct LPC to purchase up to $14 million worth of shares of common stock under our stock purchase agreement with LPC,
there are certain factors, such as volume of trading in the stock, the stock price and the ability to terminate the agreement with notice,
which could limit the amount we could raise in a short period of time.


Our ability to continue as a going concern is
                              dependent upon our ability to obtain additional equity or debt
                              financing, attain further operating efficiencies and, ultimately, to
                              generate revenue. The consolidated financial statements do not
                              include any adjustments that might result from the outcome of this
                              uncertainty.
                           </P>
                        </DIV>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Off-Balance Sheet Arrangements</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We have no off-balance sheet arrangements.</P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; "><A name="Item7a"></A>ITEM 7A.&nbsp;<I><B>QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</B></I></B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Our exposure to market risk is limited to our cash, cash equivalents
                           and marketable securities. We invest in high-quality financial
                           instruments, as permitted by the terms of our investment policy
                           guidelines. Currently, our excess funds are invested in a premium
                           commercial money market fund with one major financial institution. We
                           do not hedge interest rate exposure. A portion of our investments may
                           be subject to interest rate risk and could fall in value if interest
                           rates were to&nbsp;increase.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Because most of our transactions are denominated in United States
                           dollars, we do not have any material exposure to fluctuations in
                           currency exchange rates.
                        </P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">51</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; "><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; "><A name="Item8"></A>ITEM 8.&nbsp;<I><B>FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</B></I></B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Refer to page F-1&nbsp;below.</P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; "><A name="Item9"></A>ITEM 9.&nbsp;<I><B>CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
                                       FINANCIAL DISCLOSURE</B></I></B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">None.</P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; "><A name="Item9a"></A>ITEM 9A.&nbsp;<I><B>CONTROLS AND PROCEDURES</B></I></B></DIV>
                        </P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Management's Evaluation of Disclosure Controls and Procedures</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We are required to maintain disclosure controls and procedures
                           designed to ensure that material information related to us is
                           recorded, processed, summarized and reported within the time periods
                           specified in the SEC rules and forms. The term "disclosure controls
                           and procedures," as defined in Rules 13a-15(e) and 15d-15(e) under
                           the Securities Exchange Act of 1934, as amended, or the Exchange Act,
                           means controls and other procedures of a company that are designed to
                           ensure that information required to be disclosed by a company in the
                           reports that it files or submits under the Exchange Act is recorded,
                           processed, summarized and reported, within the time periods specified
                           in the SEC's rules and forms. Disclosure controls and procedures
                           include, without limitation, controls and procedures designed to
                           ensure that information required to be disclosed by a company in the
                           reports that it files or submits under the Exchange Act is
                           accumulated and communicated to the company's management, including
                           its principal executive and principal financial officers, as
                           appropriate to allow timely decisions regarding required disclosure.
                           Management recognizes that any controls and procedures, no matter how
                           well designed and operated, can provide only reasonable assurance of
                           achieving their objectives and management necessarily applies its
                           judgment in evaluating the cost-benefit relationship of possible
                           controls and procedures.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Our management, with the participation of our chief executive officer
                           and chief financial officer, evaluated the effectiveness of our
                           disclosure controls and procedures as of September 30, 2014 and,
                           based on this evaluation, our chief executive officer and chief
                           financial officer have concluded that, as of the end of the period
                           covered by this report, our disclosure controls and procedures were
                           effective.
                        </P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Management's Annual Report on Internal Control over Financial Reporting</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Our management is responsible for establishing and maintaining
                           adequate internal control over financial reporting for the company.
                           Internal control over financial reporting is defined in Rule
                           13a-15(f) or 15d-15(f) promulgated under the Securities Exchange Act
                           of 1934 as a process designed by, or under the supervision of, the
                           company's principal executive and principal financial officers and
                           effected by the company's board of directors, management and other
                           personnel, to provide reasonable assurance regarding the reliability
                           of financial reporting and the preparation of financial statements
                           for external purposes in accordance with generally accepted
                           accounting principles and includes those policies and procedures that:
                        </P>
                        <DIV style="padding-left: 37pt; ">
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>pertain to the maintenance of records that in reasonable detail
                              accurately and fairly reflect the transactions and dispositions of
                              the assets of the&nbsp;company;
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>provide reasonable assurance that transactions are recorded as
                              necessary to permit preparation of financial statements in accordance
                              with generally accepted accounting principles, and that receipts and
                              expenditures of the company are being made only in accordance with
                              authorizations of management and directors of the company;&nbsp;and
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>provide reasonable assurance regarding prevention or timely detection
                              of unauthorized acquisition, use or disposition of the company's
                              assets that could have a material effect on the financial statements.
                           </P>
                        </DIV>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Because of its inherent limitations, internal control over financial
                           reporting may not prevent or detect misstatements. Projections of any
                           evaluation of effectiveness to future periods are subject to the risk
                           that controls may become inadequate because of changes in conditions,
                           or that the degree of compliance with the policies or procedures may
                           deteriorate.
                        </P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">52</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Our management assessed the effectiveness of our internal control
                           over financial reporting as of September 30, 2014. In making this
                           assessment, our management used the criteria set forth by the
                           Committee of Sponsoring Organizations of the Treadway Commission
                           (COSO) in Internal Control-Integrated Framework (2013).
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Based on our assessment, our Chief Executive Officer and our Chief
                           Financial Officer concluded that, as of September 30, 2014, our
                           internal control over financial reporting is effective based on those
                           criteria.
                        </P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Changes in Internal Control over Financial Reporting</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">No change in our internal control over financial reporting occurred
                           during the fiscal quarter ended September 30, 2014 that has
                           materially affected, or is reasonably likely to materially affect,
                           our internal control over financial reporting.
                        </P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; "><B>ITEM 9B. </B>OTHER INFORMATION</B></I></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">None.</P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">53</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: center; ">
               <DIV style="padding-top: 0px; text-align: center; "><BR><DIV style="padding-top: 0px; text-align: center; ">
                     <P>
                        <DIV style="padding-top: 0px; text-align: center; "><B style="text-align: center; font-size: 10.0pt; "><A name="allpages_continue8"></A>PART III</B></DIV>
                     </P>
                     <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Certain information required by Part III is omitted from this Annual
                        Report on Form 10-K because we will file a definitive proxy statement
                        within 120 days after the end of our fiscal year for our 2015 annual
                        meeting of stockholders, or proxy statement, and the information
                        included in the proxy statement is incorporated herein by reference.
                     </P><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; "><A name="Item10"></A>ITEM 10.&nbsp;<I><B>DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</B></I></B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Certain information required by this Item is contained under the
                           heading "Executive Officers of the Registrant" in Part I of this
                           Annual Report on Form 10-K. Other information required by this Item
                           will appear in our proxy statement and is incorporated herein by
                           reference.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We have adopted a written code of business conduct and ethics that
                           applies to our principal executive officer, principal financial
                           officer, and principal accounting officer or controller, or persons
                           performing similar functions. Our code of business conduct and
                           ethics, which also applies to our directors and all of our officers
                           and employees, can be found on our website, which is located at <U>www.biodel.com</U>. We intend to disclose any amendments to, or waivers from, our code
                           of business conduct and ethics that are required to be publicly
                           disclosed pursuant to rules of the Securities and Exchange Commission
                           and the NASDAQ Capital Market by filing such amendment or waiver with
                           the Securities and Exchange Commission and by posting it on
                           our&nbsp;website.
                        </P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; "><A name="Item11"></A>ITEM 11.&nbsp;<I><B>EXECUTIVE COMPENSATION</B></I></B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The information required by this Item will appear in our proxy
                           statement and is incorporated herein by reference.
                        </P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; "><A name="Item12"></A>ITEM 12.&nbsp;<I><B>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND
                                       RELATED STOCKHOLDER MATTERS</B></I></B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The information required by this Item will appear under the headings
                           "Security Ownership of Certain Beneficial Owners and Management" and
                           "Securities Authorized for Issuance under Equity Compensation Plans"
                           in our proxy statement, which sections are incorporated herein by
                           reference.
                        </P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; "><A name="Item13"></A>ITEM 13.&nbsp;<I><B>CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</B></I></B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The information required by this Item will appear in our proxy
                           statement and is incorporated herein by reference.
                        </P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; "><A name="Item14"></A>ITEM 14.&nbsp;<I><B>PRINCIPAL ACCOUNTANT FEES AND SERVICES</B></I></B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The information required by this Item will appear in our proxy
                           statement and is incorporated herein by reference.
                        </P>
                     </DIV>
                  </DIV><BR><DIV style="padding-top: 0px; text-align: center; ">
                     <P>
                        <DIV style="padding-top: 0px; text-align: center; "><B style="text-align: center; font-size: 10.0pt; ">PART IV</B></DIV>
                     </P><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; "><A name="Item15"></A>ITEM 15.&nbsp;<I><B>EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</B></I></B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">(1) Financial Statements: See Index to Financial Statements and Schedules.</P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">(2) Financial Statement Schedules: Not applicable.</P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">(3) Exhibits: The Exhibit Index annexed to this report is
                           incorporated by reference.
                        </P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">54</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: center; ">
               <DIV style="padding-top: 0px; text-align: center; "><BR><DIV style="padding-top: 0px; text-align: center; ">
                     <P>
                        <DIV style="padding-top: 0px; text-align: center; "><B style="text-align: center; font-size: 10.0pt; "><A name="allpages_continue9"></A>SIGNATURES</B></DIV>
                     </P>
                     <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Pursuant to the requirements of Section 13 or 15(d) of the Securities
                        Exchange Act of 1934, the registrant has duly caused this report to
                        be signed on its behalf by the undersigned, thereunto duly authorized.
                     </P>
                     <P style="text-align: left; margin: 0pt; padding: 0pt; ">
                        <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                           <TR>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 52.15%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 5.60%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 42.25%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                           </TR>
                           <DIV style="padding-top: 3px; text-align: left; ">
                              <TR style="margin-top: 06.00pt; text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="4" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">BIODEL INC.</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 48.00pt; text-align: left; ">
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 48.00pt; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 48.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 48.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 48.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 48.00pt; ">By:</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 48.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 48.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 48.00pt; ">/s/ <FONT style="font-variant: small-caps; ">Errol De Souza</FONT></TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 48.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; padding-left: 0pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; padding-left: 0pt; ">
                                    <P style=" line-height: 1.3; margin-top: 0pt; text-align: left; ">Dr. Errol De Souza<BR>President and Chief Executive Officer<BR>Date: December 19, 2014<BR></P>
                                    <P style=" line-height: 1.3; margin-top: 0pt; text-align: left; "></P>
                                 </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; padding-left: 0pt; ">&nbsp;</TD>
                              </TR>
                           </DIV>
                        </TABLE>
                     </P>
                     <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Pursuant to the requirements of the Securities Exchange Act of 1934,
                        this report has been signed below by the following persons on behalf
                        of the registrant and in the capacities and on the dates indicated.
                     </P>
                     <P style="text-align: left; margin: 0pt; padding: 0pt; ">
                        <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                           <TR>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 35.53%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 1.97%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 41.45%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 1.97%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 19.08%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                           </TR>
                           <DIV style="padding-top: 3px; text-align: center; ">
                              <TR cont_lvl="1" style="text-align: left; ">
                                 <TD style="vertical-align: top; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><U><B style="text-align: center; font-size: 8.0pt; ">Signature</B></U></TD>
                                 <TD style="vertical-align: top; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><U><B style="text-align: center; font-size: 8.0pt; ">Title</B></U></TD>
                                 <TD style="vertical-align: top; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><U><B style="text-align: center; font-size: 8.0pt; ">Date</B></U></TD>
                                 <TD style="vertical-align: top; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 12.00pt; text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; border-bottom: 1pt black solid; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; border-bottom: 1pt black solid; "><FONT style="font-variant: small-caps; text-align: left; font-size: 10.0pt; ">/s/&nbsp;Errol De Souza</FONT></TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; border-bottom: 1pt black solid; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; ">President and Chief Executive Officer<BR>(Principal Executive Officer), Director
                                 </TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; ">December 19, 2014</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 06.00pt; text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">Errol De Souza</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 12.00pt; text-align: left; ">
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; border-bottom: 1pt black solid; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; border-bottom: 1pt black solid; "><FONT style="font-variant: small-caps; text-align: left; font-size: 10.0pt; ">/s/&nbsp;Gary G. Gemignani</FONT></TD>
                                 <TD style="vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; border-bottom: 1pt black solid; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" style="vertical-align: top; padding-left: 0pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" colspan="1" style="vertical-align: top; padding-left: 0pt; ">
                                    <P style=" line-height: 1.3; margin-top: 0pt; text-align: center; ">Chief Financial Officer<BR></P>
                                    <P style=" line-height: 1.3; margin-top: 0pt; text-align: center; ">(Principal Financial and Accounting Officer)<BR></P>
                                 </TD>
                                 <TD rowspan="2" style="vertical-align: top; padding-left: 0pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; ">&nbsp;</TD>
                                 <TD rowspan="2" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; ">December 19, 2014</TD>
                                 <TD rowspan="2" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 06.00pt; text-align: left; ">
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">Gary G. Gemignani&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 12.00pt; text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; border-bottom: 1pt black solid; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; border-bottom: 1pt black solid; "><FONT style="font-variant: small-caps; text-align: left; font-size: 10.0pt; ">/s/&nbsp;Julia R. Brown</FONT></TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; border-bottom: 1pt black solid; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; ">Director</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; ">December 19, 2014</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 06.00pt; text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">Julia R. Brown</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 12.00pt; text-align: left; ">
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; border-bottom: 1pt black solid; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; border-bottom: 1pt black solid; "><FONT style="font-variant: small-caps; text-align: left; font-size: 10.0pt; ">/s/&nbsp;Barry H. Ginsberg</FONT></TD>
                                 <TD style="vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; border-bottom: 1pt black solid; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; ">Director</TD>
                                 <TD rowspan="2" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; ">&nbsp;</TD>
                                 <TD rowspan="2" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; ">December 19, 2014</TD>
                                 <TD rowspan="2" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 06.00pt; text-align: left; ">
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">Barry H. Ginsberg</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 12.00pt; text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; border-bottom: 1pt black solid; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; border-bottom: 1pt black solid; "><FONT style="font-variant: small-caps; text-align: left; font-size: 10.0pt; ">/s/&nbsp;Ira W. Lieberman</FONT></TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; border-bottom: 1pt black solid; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; ">Director</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; ">December 19, 2014</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 06.00pt; text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">Ira W. Lieberman</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 12.00pt; text-align: left; ">
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; border-bottom: 1pt black solid; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; border-bottom: 1pt black solid; "><FONT style="font-variant: small-caps; text-align: left; font-size: 10.0pt; ">/s/&nbsp;Daniel Lorber</FONT></TD>
                                 <TD style="vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; border-bottom: 1pt black solid; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; ">Director</TD>
                                 <TD rowspan="2" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; ">&nbsp;</TD>
                                 <TD rowspan="2" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; ">December 19, 2014</TD>
                                 <TD rowspan="2" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 06.00pt; text-align: left; ">
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">Daniel Lorber</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 12.00pt; text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; border-bottom: 1pt black solid; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; border-bottom: 1pt black solid; "><FONT style="font-variant: small-caps; text-align: left; font-size: 10.0pt; ">/s/&nbsp;Brian J.G. Pereira</FONT></TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; border-bottom: 1pt black solid; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; ">Director</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; ">December 19, 2014</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 06.00pt; text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">Brian J.G. Pereira</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 12.00pt; text-align: left; ">
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; border-bottom: 1pt black solid; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; border-bottom: 1pt black solid; "><FONT style="font-variant: small-caps; text-align: left; font-size: 10.0pt; ">/s/&nbsp;Davey S. Scoon</FONT></TD>
                                 <TD style="vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; border-bottom: 1pt black solid; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; ">Director</TD>
                                 <TD rowspan="2" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; ">&nbsp;</TD>
                                 <TD rowspan="2" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; ">December 19, 2014</TD>
                                 <TD rowspan="2" style="vertical-align: top; line-height: 1.3; text-align: center; padding-left: 00.00pt; margin-top: 12.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 06.00pt; text-align: left; ">
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">Davey S. Scoon</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              </TR>
                           </DIV>
                        </TABLE>
                     </P>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">55</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: center; ">
               <DIV style="padding-top: 0px; text-align: center; "><BR><DIV style="padding-top: 0px; text-align: center; ">
                     <P>
                        <DIV style="padding-top: 0px; text-align: center; "><B style="text-align: center; font-size: 10.0pt; ">Exhibits Index</B></DIV>
                     </P>
                     <P style="text-align: left; margin: 0pt; padding: 0pt; ">
                        <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                           <TR>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 9.87%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 1.97%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 88.16%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                           </TR>
                           <DIV style="padding-top: 3px; text-align: center; ">
                              <TR cont_lvl="1" style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Exhibit<BR><U><B>Number</B></U></B></TD>
                                 <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><U><B style="text-align: center; font-size: 8.0pt; ">Description of Document</B></U></TD>
                                 <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 06.00pt; text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">3.1</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Registrant's Second Amended and Restated Certificate of Incorporation
                                    (Incorporated by reference to Exhibit 3.1 to the Registrant's
                                    Registration Statement on Form S-1 (333-140504) filed on February 7,
                                    2007).
                                 </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 06.00pt; text-align: left; ">
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">3.2</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Certificate of Designation of Series A Convertible Preferred Stock of
                                    the Registrant (Incorporated by reference to Exhibit 4.6 to the
                                    Registrant's Current Report on Form 8-K filed on May 19, 2011).
                                 </TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 06.00pt; text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">3.3</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Certificate of Amendment to Registrant's Second Amended and Restated
                                    Certificate of Incorporation, as amended (Incorporated by reference
                                    to Exhibit 3.1 to the Registrant's Current Report on Form 8-K filed
                                    on June 11, 2012).
                                 </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 06.00pt; text-align: left; ">
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">3.4</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Certificate of Designation of Series B Convertible Preferred Stock of
                                    the Registrant (Incorporated by reference to Exhibit 4.8 to the
                                    Registrant's Current Report on Form 8-K filed on June 27, 2012).
                                 </TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 06.00pt; text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">3.5</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Certificate of Amendment of Registrant's Second Amended and Restated
                                    Certificate of Incorporation, as amended (Incorporated by reference
                                    to Exhibit 3.5 to the Registrant's Annual Report on Form 10-K filed
                                    on December 21, 2012).
                                 </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 06.00pt; text-align: left; ">
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">3.6</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Registrant's Amended and Restated Bylaws (Incorporated by reference
                                    to Exhibit 3.6 to the Registrant's Registration Statement on Form
                                    S-1, Amendment No. 1 (333-140504), filed on May 10, 2007).
                                 </TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 06.00pt; text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">4.1</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Specimen Common Stock Certificate (Incorporated by reference to
                                    Exhibit 4.1 to the Registrant's Registration Statement on Form S-1,
                                    Amendment No. 1 (333-140504), filed on May 10, 2007).
                                 </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 06.00pt; text-align: left; ">
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">4.2</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Form of Warrant to Purchase Shares of Common Stock issued in the
                                    Registrant's May 2011 registered direct offering (Incorporated by
                                    reference to Exhibit 4.7 to the Registrant's Current Report on Form
                                    8-K filed on May 13, 2011).
                                 </TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 06.00pt; text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">4.3</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Form of Warrant issued in the Registrant's June 2012 private
                                    placement (Incorporated by reference to Exhibit 4.9 to the
                                    Registrant's Current Report on Form 8-K filed on June 22, 2012).
                                 </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 06.00pt; text-align: left; ">
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">10.1*</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">2010 Stock Incentive Plan, as amended March 8, 2012 (Incorporated by
                                    reference to Exhibit A of the Registrant's Definitive Proxy Statement
                                    on Schedule 14A filed on January 26, 2012).
                                 </TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 06.00pt; text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">10.2*</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">2010 Incentive Stock Option Agreement (Incorporated by reference to
                                    Exhibit 10.2 to the Registrant's Quarterly Report on Form 10-Q filed
                                    on May 7, 2010).
                                 </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 06.00pt; text-align: left; ">
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">10.3*</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">2010 Non Statutory Stock Option Agreement (Incorporated by reference
                                    to Exhibit 10.3 to the Registrant's Quarterly Report on Form 10-Q
                                    filed on May 7, 2010).
                                 </TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 06.00pt; text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">10.4*</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">2010 Restricted Stock Unit Agreement (Incorporated by reference to
                                    Exhibit 10.4 to the Registrant's Quarterly Report on Form 10-Q filed
                                    on May 7, 2010).
                                 </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 06.00pt; text-align: left; ">
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">10.5*</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Form of Indemnification Agreement entered into between the Registrant
                                    and its directors and certain of its executive officers (Incorporated
                                    by reference to Exhibit 10.1 to the Registrant's Registration
                                    Statement on Form S-1 (333-140504) filed on February 7, 2007).
                                 </TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 06.00pt; text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">10.6*</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Amended and Restated 2004 Stock Incentive Plan (Incorporated by
                                    reference to Exhibit 10.3 to the Registrant's Registration Statement
                                    on Form S-1, Amendment No. 1 (333-140504), filed on May 10, 2007).
                                 </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 06.00pt; text-align: left; ">
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">10.7*</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">2005 Employee Stock Purchase Plan (Incorporated by reference to
                                    Exhibit 10.4 to the Registrant's Registration Statement on Form S-1,
                                    Amendment No. 1 (333-140504), filed on May 10, 2007).
                                 </TD>
                                 <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              </TR>
                           </DIV>
                        </TABLE>
                     </P>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">56</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <P style="text-align: left; margin: 0pt; padding: 0pt; ">
                        <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; ">
                           <TR>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 9.87%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 1.97%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 88.16%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                           </TR>
                           <TR cont_lvl="1" style="text-align: left; ">
                              <TD style="vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Exhibit<BR><U><B>Number</B></U></B></TD>
                              <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                              <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><U><B style="text-align: center; font-size: 8.0pt; ">Description of Document</B></U></TD>
                              <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">10.8*</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">2005 Non-Employee Directors' Stock Option Plan (Incorporated by
                                 reference to Exhibit 10.5 to the Registrant's Registration Statement
                                 on Form S-1, Amendment No. 1 (333-140504), filed on May 10, 2007).
                              </TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">10.9*</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Employment Agreement, dated March 26, 2010, between the Registrant
                                 and Errol B. De Souza (Incorporated by reference to the Registrant's
                                 Current Report on Form 8-K filed on April 1, 2010).
                              </TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">10.10*</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Change of Control Agreement entered into between the Registrant and
                                 certain of its executive officers (Incorporated by reference to
                                 Exhibit 10.12 to the Registrant's Registration Statement on Form S-1
                                 (333-140504) filed on February 7, 2007).
                              </TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">10.11*</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Executive Severance Agreement entered into between the Registrant and
                                 certain of its executive officers (Incorporated by reference to
                                 Exhibit 10.13 to the Registrant's Registration Statement on Form S-1
                                 (333-140504) filed on February 7, 2007).
                              </TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">10.12</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Commercial Lease, dated February 2, 2004, by and between the
                                 Registrant and Mulvaney Properties, LLC and an amendment thereto
                                 dated September 29, 2006 (for the premises located at 6 Christopher
                                 Columbus Avenue, Danbury, CT 06810) (Incorporated by reference to
                                 Exhibit 10.14 to the Registrant's Registration Statement on Form S-1,
                                 Amendment No. 1 (333-140504), filed on May 10, 2007).
                              </TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">10.13</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Commercial Lease, dated October 19, 2006, by and between the
                                 Registrant and Mulvaney Properties, LLC (for the premises located at
                                 8 Christopher Columbus Avenue, Danbury, CT 06810) (Incorporated by
                                 reference to Exhibit 10.15 to the Registrant's Registration Statement
                                 on Form S-1, Amendment No. 1 (333-140504), filed on May 10, 2007).
                              </TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">10.14</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Amendment to Commercial Lease, dated July 23, 2007 by and between the
                                 Registrant and Mulvaney Properties, LLC (for the premises located at
                                 6 Christopher Columbus Avenue, Danbury, CT 06810) (Incorporated by
                                 reference to Exhibit 10.2 to the Registrant's Current Report on Form
                                 8-K filed on July 27, 2007).
                              </TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">10.15</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Amendment to Commercial Lease, dated July 23, 2007 by and between the
                                 Registrant and Mulvaney Properties, LLC (for the premises located at
                                 8 Christopher Columbus Avenue, Danbury, CT 06810) (Incorporated by
                                 reference to Exhibit 10.3 to the Registrant's Current Report on Form
                                 8-K filed on July 27, 2007).
                              </TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">10.16</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Commercial Lease, dated July 23, 2007, by and between the Registrant
                                 and Mulvaney Properties, LLC (for the premises located at 100 Saw
                                 Mill Road, Danbury, CT 06810) (Incorporated by reference to Exhibit
                                 10.1 the Registrant's Current Report on Form 8-K filed on July 27,
                                 2007).
                              </TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">10.17</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Lease Amendment, dated October 1, 2007, to Commercial Lease, dated
                                 July 23, 2007, by and between the Registrant and Mulvaney Properties,
                                 LLC (for the premises located at 100 Saw Mill Road, Danbury, CT
                                 06810) (Incorporated by reference to Exhibit 10.1 to the Registrant's
                                 Current Report on Form 8-K filed on October 4, 2007).
                              </TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">10.18</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Option to Renew, dated as of November 6, 2013, to Commercial Lease,
                                 dated as of July 23, 2007, as amended, by and between the Registrant
                                 and Mulvaney Properties, LLC (for the premises located at 100 Saw
                                 Mill Road, Danbury, CT 06810) (Incorporated by reference to Exhibit
                                 10.15 to Registrant's Annual Report on Form 10-K filed on December
                                 20, 2013).
                              </TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">10.19*</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Offer Letter, dated November 12, 2007, by and between the Registrant
                                 and Gerard J. Michel (Incorporated by reference to the Registrant's
                                 Current Report on Form 8-K filed on November 14, 2007).
                              </TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">10.20*</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Form of Incentive Stock Option Agreement for 2004 Amended and
                                 Restated Stock Incentive Plan (Incorporated by reference to Exhibit
                                 10.19 to the Registrant's Annual Report on Form 10-K filed on
                                 December 21, 2007).
                              </TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                        </TABLE>
                     </P>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">57</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <P style="text-align: left; margin: 0pt; padding: 0pt; ">
                        <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; ">
                           <TR>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 9.87%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 1.97%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 88.16%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                           </TR>
                           <TR cont_lvl="1" style="text-align: left; ">
                              <TD style="vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Exhibit<BR><U><B>Number</B></U></B></TD>
                              <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                              <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><U><B style="text-align: center; font-size: 8.0pt; ">Description of Document</B></U></TD>
                              <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">10.21*</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Form of Option Agreement for 2005 Non-Employee Directors' Stock
                                 Option Plan (Incorporated by reference to Exhibit 10.20 to the
                                 Registrant's Annual Report on Form 10-K filed on December 21, 2007).
                              </TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">10.22</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">At-the-Market Issuance Sales Agreement, dated May 13, 2013, between
                                 the Registrant and MLV &amp; Co. LLC (Incorporated by reference to
                                 Exhibit 10.1 to the Registrant's Quarterly Report on Form 10-Q filed
                                 on May 13, 2013).
                              </TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">10.23</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Underwriting Agreement, dated June 19, 2013, among the Registrant and
                                 the several Underwriters named therein (Incorporated by reference to
                                 Exhibit 1.1 to the Registrant's Current Report on Form 8-K filed on
                                 June 20, 2013).
                              </TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">10.24</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Purchase Agreement, dated as of July 25, 2014, by and between the
                                 Registrant and Lincoln Park Capital Fund, LLC (Incorporated by
                                 reference to Exhibit 10.1 to the Registrant's Current Report on Form
                                 8-K filed on July 28, 2014).
                              </TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">10.25</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Registration Rights Agreement, dated as of July 25, 2014, by and
                                 between the Registrant and Lincoln Park Capital Fund, LLC
                                 (Incorporated by reference to Exhibit 10.2 to the Registrant's
                                 Current Report on Form 8-K filed on July 28, 2014).
                              </TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">10.26*</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Employment Agreement, dated August 21, 2014, by and between the
                                 Registrant and Gary G. Gemignani (Incorporated by reference to
                                 Exhibit 10.1 to Registrant's Current Report on Form 8-K filed on
                                 August 27, 2014).
                              </TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">10.27&#134;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">License Agreement, effective as of June 8, 2012, between Aegis
                                 Therapeutics, LLC and the Registrant (Incorporated by reference to
                                 Exhibit 10.01 to the Registrant's Quarterly Report on Form 10-Q filed
                                 on August 14, 2012).
                              </TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">10.28&#134;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Commercial Supply Agreement for Glucagon, dated July 17, 2012, among
                                 Bachem Americas, Inc., Bachem AG and the Registrant (Incorporated by
                                 reference to Exhibit 10.25 to Registrant's Annual Report on Form 10-K
                                 filed on December 20, 2013).
                              </TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">10.29&#134;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Customization and Commercial Supply Agreement, effective April 8,
                                 2013, between Unilife Medical Solutions, Inc. and the Registrant
                                 (Incorporated by reference to Exhibit 10.26 to Registrant's Annual
                                 Report on Form 10-K filed on December 20, 2013).
                              </TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">10.30</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Securities Purchase Agreement, dated as of June 21, 2012, among the
                                 Registrant and the purchasers named therein (Incorporated by
                                 reference to Exhibit 10.1 to the Registrant's Current Report on Form
                                 8-K filed on June 22, 2012).
                              </TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">21.1</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Subsidiaries of the Registrant.</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">23.1</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Consent of BDO USA, LLP, Independent Registered Public Accounting Firm.</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">31.01</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Chief Executive Officer &#151; Certification pursuant to Rule 13a-14(a) or
                                 Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted
                                 pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
                              </TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">31.02</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Chief Financial Officer &#151; Certification pursuant to Rule 13a-14(a) or
                                 Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted
                                 pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
                              </TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">32.01</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">Chief Executive Officer and Chief Financial Officer &#151; Certification
                                 pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities
                                 Exchange Act of 1934 and 18 U.S.C. Section 1350, as adopted pursuant
                                 to Section 906 of the Sarbanes-Oxley Act of 2002.
                              </TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">101.INS</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">XBRL Instance Document.</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">101.SCH</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">XBRL Taxonomy Extension Schema Document.</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">101.CAL</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">XBRL Taxonomy Calculation Linkbase Document.</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                        </TABLE>
                     </P>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">58</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <P style="text-align: left; margin: 0pt; padding: 0pt; ">
                        <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; ">
                           <TR>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 9.87%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 1.97%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 88.16%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                           </TR>
                           <TR cont_lvl="1" style="text-align: left; ">
                              <TD style="vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Exhibit<BR><U><B>Number</B></U></B></TD>
                              <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                              <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><U><B style="text-align: center; font-size: 8.0pt; ">Description of Document</B></U></TD>
                              <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">101.LAB</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">XBRL Taxonomy Label Linkbase Document.</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">101.PRE</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">XBRL Taxonomy Presentation Linkbase Document.</TD>
                              <TD style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                           <TR style="margin-top: 06.00pt; text-align: left; ">
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">101.DEF</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; width: 15px; ">&nbsp;</TD>
                              <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">XBRL Taxonomy Extension Definition Linkbase Document.</TD>
                              <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; text-align: left; padding-left: 00.00pt; margin-top: 06.00pt; ">&nbsp;</TD>
                           </TR>
                        </TABLE>
                     </P>
                     <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; margin-top: 12.00pt; text-align: left; ">____________</P>
                     <P style="padding-top: 6px; line-height: 1.3; padding-left: 20.05pt; text-indent: -20.05pt; text-align: left; ">&#134;&nbsp;&nbsp;Confidential treatment granted with respect to certain portions of
                        this exhibit. Omitted portions have been filed separately with the
                        Securities and Exchange Commission.
                     </P>
                     <P style="padding-top: 6px; line-height: 1.3; padding-left: 20.05pt; text-indent: -20.05pt; margin-top: 06.00pt; text-align: left; ">&#134;&#134;&nbsp;&nbsp;Confidential treatment requested with respect to certain portions
                        of this exhibit. Omitted portions have been filed separately with the
                        Securities and Exchange Commission.
                     </P>
                     <P style="padding-top: 6px; line-height: 1.3; padding-left: 20.05pt; text-indent: -20.05pt; margin-top: 06.00pt; text-align: left; ">*&nbsp;&nbsp; Indicates a management contract or compensatory plan or arrangement.</P>
                     <P style="padding-top: 6px; line-height: 1.3; padding-left: 20.00pt; margin-top: 06.00pt; text-align: left; ">Attached as Exhibit 101 to this are the following formatted in XBRL
                        (Extensible Business Reporting Language):&nbsp;(i) Balance Sheets; (ii)
                        Statements of Operations, (iii) Statements of Stockholders' Equity;
                        (iv) Statements of Comprehensive Loss;&nbsp;(v) Statements of Cash Flows;
                        and (vi) Notes to Financial Statements.
                     </P>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">59</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: center; ">
               <DIV style="padding-top: 0px; text-align: center; "><BR><DIV style="padding-top: 0px; text-align: center; ">
                     <P>
                        <DIV style="padding-top: 0px; text-align: center; "><B style="text-align: center; font-size: 10.0pt; "><A name="fpages"></A>BIODEL INC.</B></DIV>
                     </P>
                  </DIV><BR><DIV style="padding-top: 0px; text-align: center; ">
                     <P>
                        <DIV style="padding-top: 0px; text-align: center; "><B style="text-align: center; font-size: 10.0pt; ">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</B></DIV>
                     </P>
                     <P style="text-align: left; margin: 0pt; padding: 0pt; ">
                        <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                           <TR>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 92.76%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 1.97%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 5.26%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                           </TR>
                           <DIV style="padding-top: 3px; text-align: center; ">
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><U><B style="text-align: center; font-size: 8.0pt; ">Page</B></U></TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 03.00pt; text-align: left; ">
                                 <TD style="vertical-align: middle; line-height: 1.3; margin-top: 03.00pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: middle; line-height: 1.3; padding-left: 10.00pt; text-indent: -10.00pt; margin-top: 03.00pt; text-align: left; ">Report of independent registered public accounting firm </TD>
                                 <TD style="vertical-align: middle; line-height: 1.3; padding-left: 10.00pt; margin-top: 03.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: middle; line-height: 1.3; text-align: right; margin-top: 03.00pt; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: middle; line-height: 1.3; text-align: right; padding-left: 00.00pt; margin-top: 03.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: middle; line-height: 1.3; text-align: right; margin-top: 03.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; text-align: right; vertical-align: bottom; margin-top: 03.00pt; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; vertical-align: bottom; padding-left: 00.00pt; margin-top: 03.00pt; text-align: right; ">F-<FONT style="text-decoration: none; ">2</FONT></TD>
                                 <TD style="line-height: 1.3; vertical-align: bottom; margin-top: 03.00pt; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 03.00pt; text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 03.00pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; padding-left: 10.00pt; text-indent: -10.00pt; margin-top: 03.00pt; text-align: left; ">Consolidated balance sheets </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; padding-left: 10.00pt; margin-top: 03.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; text-align: right; margin-top: 03.00pt; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; text-align: right; padding-left: 00.00pt; margin-top: 03.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; text-align: right; margin-top: 03.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; text-align: right; vertical-align: bottom; margin-top: 03.00pt; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; vertical-align: bottom; padding-left: 00.00pt; margin-top: 03.00pt; text-align: right; ">F-<FONT style="text-decoration: none; ">3</FONT></TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; vertical-align: bottom; margin-top: 03.00pt; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 03.00pt; text-align: left; ">
                                 <TD style="vertical-align: middle; line-height: 1.3; margin-top: 03.00pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: middle; line-height: 1.3; padding-left: 10.00pt; text-indent: -10.00pt; margin-top: 03.00pt; text-align: left; ">Consolidated statements of operations </TD>
                                 <TD style="vertical-align: middle; line-height: 1.3; padding-left: 10.00pt; margin-top: 03.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: middle; line-height: 1.3; text-align: right; margin-top: 03.00pt; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: middle; line-height: 1.3; text-align: right; padding-left: 00.00pt; margin-top: 03.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: middle; line-height: 1.3; text-align: right; margin-top: 03.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; text-align: right; vertical-align: bottom; margin-top: 03.00pt; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; vertical-align: bottom; padding-left: 00.00pt; margin-top: 03.00pt; text-align: right; ">F-<FONT style="text-decoration: none; ">4</FONT></TD>
                                 <TD style="line-height: 1.3; vertical-align: bottom; margin-top: 03.00pt; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 03.00pt; text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 03.00pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; padding-left: 10.00pt; text-indent: -10.00pt; margin-top: 03.00pt; text-align: left; ">Consolidated statements of stockholders' equity </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; padding-left: 10.00pt; margin-top: 03.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; text-align: right; margin-top: 03.00pt; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; text-align: right; padding-left: 00.00pt; margin-top: 03.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; text-align: right; margin-top: 03.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; text-align: right; vertical-align: bottom; margin-top: 03.00pt; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; vertical-align: bottom; padding-left: 00.00pt; margin-top: 03.00pt; text-align: right; ">F-<FONT style="text-decoration: none; ">5</FONT></TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; vertical-align: bottom; margin-top: 03.00pt; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 03.00pt; text-align: left; ">
                                 <TD style="vertical-align: middle; line-height: 1.3; margin-top: 03.00pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: middle; line-height: 1.3; padding-left: 10.00pt; text-indent: -10.00pt; margin-top: 03.00pt; text-align: left; ">Consolidated statements of cash flows </TD>
                                 <TD style="vertical-align: middle; line-height: 1.3; padding-left: 10.00pt; margin-top: 03.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: middle; line-height: 1.3; text-align: right; margin-top: 03.00pt; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: middle; line-height: 1.3; text-align: right; padding-left: 00.00pt; margin-top: 03.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: middle; line-height: 1.3; text-align: right; margin-top: 03.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; text-align: right; vertical-align: bottom; margin-top: 03.00pt; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; vertical-align: bottom; padding-left: 00.00pt; margin-top: 03.00pt; text-align: right; ">F-<FONT style="text-decoration: none; ">6</FONT></TD>
                                 <TD style="line-height: 1.3; vertical-align: bottom; margin-top: 03.00pt; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="margin-top: 03.00pt; text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 03.00pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; padding-left: 10.00pt; text-indent: -10.00pt; margin-top: 03.00pt; text-align: left; ">Notes to consolidated financial statements </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; padding-left: 10.00pt; margin-top: 03.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; text-align: right; margin-top: 03.00pt; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; text-align: right; padding-left: 00.00pt; margin-top: 03.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; text-align: right; margin-top: 03.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; text-align: right; vertical-align: bottom; margin-top: 03.00pt; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; vertical-align: bottom; padding-left: 00.00pt; margin-top: 03.00pt; text-align: right; ">F-<FONT style="text-decoration: none; ">7</FONT></TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; vertical-align: bottom; margin-top: 03.00pt; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                           </DIV>
                        </TABLE>
                     </P>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">F-1</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: center; ">
               <DIV style="padding-top: 0px; text-align: center; "><BR><DIV style="padding-top: 0px; text-align: center; ">
                     <P>
                        <DIV style="padding-top: 0px; text-align: center; "><B style="text-align: center; font-size: 10.0pt; "><A name="ReportofIndependentRegisteredPublic"></A>Report of Independent Registered Public Accounting Firm</B></DIV>
                     </P>
                     <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; margin-top: 18.00pt; text-align: left; ">Board of Directors and Stockholders<BR>Biodel Inc.<BR>Danbury, Connecticut
                     </P>
                     <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We have audited the accompanying consolidated balance sheets of
                        Biodel Inc. as of September 30, 2014 and 2013 and the related
                        consolidated statements of operations, stockholders' equity and cash
                        flows for the years then ended. These financial statements are the
                        responsibility of the Company's management. Our responsibility is to
                        express an opinion on these financial statements based on our&nbsp;audits.
                     </P>
                     <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">We conducted our audits in accordance with the standards of the
                        Public Company Accounting Oversight Board (United States). Those
                        standards require that we plan and perform the audit to obtain
                        reasonable assurance about whether the financial statements are free
                        of material misstatement. The Company is not required to have, nor
                        were we engaged to perform an audit of its internal control over
                        financial reporting. Our audits included consideration of internal
                        control over financial reporting as a basis for designing audit
                        procedures that are appropriate in the circumstances, but not for the
                        purpose of expressing an opinion on the effectiveness of the
                        Company's internal control over financial reporting. An audit also
                        includes examining, on a test basis, evidence supporting the amounts
                        and disclosures in the financial statements, assessing the accounting
                        principles used and significant estimates made by management, as well
                        as evaluating the overall financial statement presentation. We
                        believe that our audits provide a reasonable basis for our&nbsp;opinion.
                     </P>
                     <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In our opinion, the consolidated financial statements referred to
                        above present fairly, in all material respects, the financial
                        position of Biodel Inc. as of September 30, 2014 and 2013, and the
                        results of its operations and its cash flows for the years then
                        ended, in conformity with accounting principles generally accepted in
                        the United States.
                     </P>
                     <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The accompanying financial statements have been prepared assuming
                        that the Company will continue as a going concern. As discussed in
                        Note 2 to the financial statements, the Company has suffered
                        recurring losses from operations and expects continuing future losses
                        that raise substantial doubt about its ability to continue as a going
                        concern. Management's plans in regard to these matters are also
                        described in Note 2. The financial statements do not include any
                        adjustments that might result from the outcome of this uncertainty.
                     </P>
                     <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; margin-top: 24.00pt; text-align: left; ">/s/ BDO USA, LLP<BR>&nbsp;<BR>New York, New York<BR>December 19,&nbsp;2014
                     </P>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">F-2</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: center; ">
               <DIV style="padding-top: 0px; text-align: center; "><BR><DIV style="padding-top: 0px; text-align: center; ">
                     <P>
                        <DIV style="padding-top: 0px; text-align: center; "><B style="text-align: center; font-size: 10.0pt; ">Biodel Inc.<BR></B></DIV>
                     </P>
                  </DIV><BR><DIV style="padding-top: 0px; text-align: center; ">
                     <P>
                        <DIV style="padding-top: 0px; text-align: center; "><B style="text-align: center; font-size: 10.0pt; "><A name="BalanceSheets"></A>Consolidated Balance Sheets<BR>(In thousands, except share and per share amounts)</B></DIV>
                     </P>
                     <P style="text-align: left; margin: 0pt; padding: 0pt; ">
                        <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                           <TR>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 75.91%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 1.31%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 10.47%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 1.31%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 11.00%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                           </TR>
                           <DIV style="padding-top: 3px; text-align: center; ">
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="7" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>September 30,</B></TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2013</B></TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2014</B></TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="13" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center; "><B>ASSETS</B></TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">Current:</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Cash and cash equivalents </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">39,781</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">24,588</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Taxes receivable </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">6</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">5</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Grant receivable </TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">26</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">-</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Prepaid and other assets </TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">264</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">311</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 39.95pt; text-indent: -9.95pt; text-align: left; ">Total current assets </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 39.95pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">40,077</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">24,904</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Property and equipment, net </TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1,031</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">481</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Intellectual property, net </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">43</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">40</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 39.95pt; text-indent: -9.95pt; text-align: left; ">Total assets </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 39.95pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">41,151</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">25,425</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                 <TD colspan="13" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center; "><B>LIABILITIES AND STOCKHOLDERS' EQUITY</B></TD>
                                 <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">Current:</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Accounts payable </TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">246</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">172</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 19.90pt; text-indent: -9.95pt; ">Accrued expenses:</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 19.90pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 30.00pt; text-indent: -9.95pt; text-align: left; ">Clinical trial expenses </TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 30.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">181</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">214</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 30.00pt; text-indent: -9.95pt; text-align: left; ">Payroll and related </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 30.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1,139</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">958</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 30.00pt; text-indent: -9.95pt; text-align: left; ">Accounting and legal fees </TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 30.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">226</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">131</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 30.00pt; text-indent: -9.95pt; text-align: left; ">Severance </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 30.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">255</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">-</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 30.00pt; text-indent: -9.95pt; text-align: left; ">Other </TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 30.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">319</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">141</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Income taxes payable </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">75</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">-</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 39.95pt; text-indent: -9.95pt; text-align: left; ">Total current liabilities </TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 39.95pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">2,441</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1,616</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Common stock warrant liability </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">6,121</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1,014</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Severance payable, long term portion </TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">26</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">-</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 39.95pt; text-indent: -9.95pt; text-align: left; ">Total liabilities </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 39.95pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">8,588</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">2,630</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">Commitments</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 19.90pt; text-indent: -9.95pt; ">Stockholders' equity:</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 19.90pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Convertible preferred stock, $.01 par value; 50,000,000 shares
                                    authorized, 1,950,000 and 1,950,000 issued and outstanding
                                 </TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">19</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">19</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Common stock, $.01 par value; 62,500,000 shares authorized;
                                    21,070,824 and 23,079,543 issued and outstanding, respectively
                                 </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">211</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">231</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Additional paid-in capital </TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">247,761</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">252,104</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Accumulated deficit </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(215,428</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(229,559</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">)</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 39.95pt; text-indent: -9.95pt; text-align: left; ">Total stockholders' equity </TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 39.95pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">32,563</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">22,795</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 00.00pt; text-indent: -9.95pt; text-align: left; ">Total liabilities and stockholders' equity </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 00.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">41,151</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">25,425</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                           </DIV>
                        </TABLE>
                     </P>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">See accompanying notes to financial statements.<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">F-3</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: center; ">
               <DIV style="padding-top: 0px; text-align: center; "><BR><DIV style="padding-top: 0px; text-align: center; ">
                     <P>
                        <DIV style="padding-top: 0px; text-align: center; "><B style="text-align: center; font-size: 10.0pt; ">Biodel Inc.<BR></B></DIV>
                     </P>
                  </DIV><BR><DIV style="padding-top: 0px; text-align: center; ">
                     <P>
                        <DIV style="padding-top: 0px; text-align: center; "><B style="text-align: center; font-size: 10.0pt; "><A name="StatementsofOperations"></A>Consolidated Statements of Operations<BR>(In thousands, except share and per share amounts)</B></DIV>
                     </P>
                     <P style="text-align: left; margin: 0pt; padding: 0pt; ">
                        <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                           <TR>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 58.62%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 3.45%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 3.45%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 13.79%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 3.45%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 13.79%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 3.45%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                           </TR>
                           <DIV style="padding-top: 3px; text-align: center; ">
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="7" style="border-bottom: 1pt black solid; vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center; "><B>September 30,</B></TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2013</B></TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2014</B></TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Revenue </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">Operating expenses:</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Research and development </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">14,296</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">14,194</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Government grants </TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(546</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(531</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">General and administrative </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">6,843</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">5,598</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 39.95pt; text-indent: -9.95pt; text-align: left; ">Total operating expenses </TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 39.95pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">20,593</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">19,261</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">Other (income):</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Interest and other income </TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(56</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(49</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Adjustments to fair value of common stock warrant liability </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(1,217</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(5,107</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Loss before tax provision </TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(19,320</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(14,105</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Tax provision </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">15</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">26</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Net loss </TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(19,335</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(14,131</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Net loss per share &#151; basic and diluted </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(1.24</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(0.66</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Weighted average shares outstanding &#151; basic<BR> and diluted
                                 </TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">15,650,538</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">21,404,258</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                           </DIV>
                        </TABLE>
                     </P>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">See accompanying notes to financial statements.<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">F-4</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: center; ">
               <DIV style="padding-top: 0px; text-align: center; "><BR><DIV style="padding-top: 0px; text-align: center; ">
                     <P>
                        <DIV style="padding-top: 0px; text-align: center; "><B style="text-align: center; font-size: 10.0pt; ">Biodel Inc.<BR></B></DIV>
                     </P>
                  </DIV><BR><DIV style="padding-top: 0px; text-align: center; ">
                     <P>
                        <DIV style="padding-top: 0px; text-align: center; "><B style="text-align: center; font-size: 10.0pt; ">Consolidated Statements of Stockholders' Equity<BR>(In thousands, except share and per share amounts)</B></DIV>
                     </P>
                     <P style="text-align: left; margin: 0pt; padding: 0pt; ">
                        <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                           <TR>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 28.99%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 0.72%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 7.25%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 0.72%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 5.80%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 0.72%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 7.25%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 0.72%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 5.80%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 0.72%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 7.25%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 0.72%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 5.80%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 0.72%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 7.25%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 0.72%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 8.70%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 0.72%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 8.70%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 0.72%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                           </TR>
                           <DIV style="padding-top: 3px; text-align: center; ">
                              <TR style="text-align: left; ">
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="7" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Common Stock<BR>$.01 Par Value</B></TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="7" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>&nbsp;<BR>Series A<BR>Preferred stock<BR>$.01 Par Value</B></TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="7" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>&nbsp;<BR>Series B<BR>Preferred stock<BR>$.01 Par Value</B></TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Additional<BR>Paid in<BR>Capital</B></TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Accumulated<BR>Deficit</B></TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Total<BR>Stockholders'<BR>Equity</B></TD>
                                 <TD rowspan="2" bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Shares</B></TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Amount</B></TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Shares</B></TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Amount</B></TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Shares</B></TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Amount</B></TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; font-size: 7pt; line-height: 1.1; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; text-indent: -7pt; padding-top: 2px; line-height: 1.1; text-align: left; "><B>Balance, September 30, 2012 </B></TD>
                                 <TD style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; padding-top: 2px; line-height: 1.1; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">14,174,545</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">142</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1,813,944</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">18</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">3,605,607</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">36</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">226,913</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(196,093</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">31,016</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; font-size: 7pt; line-height: 1.1; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; text-indent: -7pt; padding-top: 2px; line-height: 1.1; text-align: left; ">Proceeds from sale of common stock </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; padding-top: 2px; line-height: 1.1; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">4,718,767</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">47</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">19,192</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">19,239</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; font-size: 7pt; line-height: 1.1; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; text-indent: -7pt; padding-top: 2px; line-height: 1.1; text-align: left; ">Preferred stock conversion </TD>
                                 <TD style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; padding-top: 2px; line-height: 1.1; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">2,109,090</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">22</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(1,813,944</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(18</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(1,655,607</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(17</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">13</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 00.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; font-size: 7pt; line-height: 1.1; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; text-indent: -7pt; padding-top: 2px; line-height: 1.1; text-align: left; ">Stock-based compensation </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; padding-top: 2px; line-height: 1.1; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1,538</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1,538</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; font-size: 7pt; line-height: 1.1; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; text-indent: -7pt; padding-top: 2px; line-height: 1.1; text-align: left; ">Proceeds from the sale of stock &#151; ESPP </TD>
                                 <TD style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; padding-top: 2px; line-height: 1.1; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">13,395</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">30</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">30</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; font-size: 7pt; line-height: 1.1; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; text-indent: -7pt; padding-top: 2px; line-height: 1.1; text-align: left; ">Stock options exercised </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; padding-top: 2px; line-height: 1.1; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">30,250</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">75</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">75</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; font-size: 7pt; line-height: 1.1; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; text-indent: -7pt; padding-top: 2px; line-height: 1.1; text-align: left; ">RSUs granted </TD>
                                 <TD style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; padding-top: 2px; line-height: 1.1; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">24,777</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; font-size: 7pt; line-height: 1.1; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; text-indent: -7pt; padding-top: 2px; line-height: 1.1; text-align: left; ">Net loss </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; padding-top: 2px; line-height: 1.1; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(19,335</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(19,335</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">)</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; font-size: 7pt; line-height: 1.1; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; text-indent: -7pt; padding-top: 2px; line-height: 1.1; text-align: left; "><B>Balance, September 30, 2013</B></TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; padding-top: 2px; line-height: 1.1; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">21,070,824</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">211</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1,950,000</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">19</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">247,761</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(215,428</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">32,563</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; font-size: 7pt; line-height: 1.1; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; text-indent: -7pt; padding-top: 2px; line-height: 1.1; text-align: left; ">Proceeds from ATM facility </TD>
                                 <TD style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; padding-top: 2px; line-height: 1.1; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1,564,821</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">16</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">3,010</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">3,026</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; font-size: 7pt; line-height: 1.1; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; text-indent: -7pt; padding-top: 2px; line-height: 1.1; text-align: left; ">Proceeds from equity line </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; padding-top: 2px; line-height: 1.1; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">395,000</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">4</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">486</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">490</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; font-size: 7pt; line-height: 1.1; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; text-indent: -7pt; padding-top: 2px; line-height: 1.1; text-align: left; ">Stock-based compensation </TD>
                                 <TD style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; padding-top: 2px; line-height: 1.1; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">784</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">784</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; font-size: 7pt; line-height: 1.1; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; text-indent: -7pt; padding-top: 2px; line-height: 1.1; text-align: left; ">Proceeds from the sale of stock &#151; ESPP </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; padding-top: 2px; line-height: 1.1; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">8,189</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">15</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">15</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; font-size: 7pt; line-height: 1.1; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; text-indent: -7pt; padding-top: 2px; line-height: 1.1; text-align: left; ">Stock options exercised </TD>
                                 <TD style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; padding-top: 2px; line-height: 1.1; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">19,241</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">48</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">48</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; font-size: 7pt; line-height: 1.1; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; text-indent: -7pt; padding-top: 2px; line-height: 1.1; text-align: left; ">RSUs converted to common stock </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; padding-top: 2px; line-height: 1.1; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">21,468</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; font-size: 7pt; line-height: 1.1; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; text-indent: -7pt; padding-top: 2px; line-height: 1.1; text-align: left; ">Net loss </TD>
                                 <TD style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; padding-top: 2px; line-height: 1.1; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(14,131</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(14,131</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">)</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; font-size: 7pt; line-height: 1.1; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; text-indent: -7pt; padding-top: 2px; line-height: 1.1; text-align: left; "><B>Balance, September 30, 2014</B></TD>
                                 <TD style="vertical-align: bottom; font-size: 7pt; padding-left: 7pt; padding-top: 2px; line-height: 1.1; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">23,079,543</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">231</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1,950,000</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">19</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">252,104</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(229,559</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">22,795</TD>
                                 <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                           </DIV>
                        </TABLE>
                     </P>
                     <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; margin-top: 12.00pt; text-align: center; "><A name="StatementsofComprehensiveLoss"></A></P>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">See accompanying notes to financial statements.<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">F-5</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: center; ">
               <DIV style="padding-top: 0px; text-align: center; "><BR><DIV style="padding-top: 0px; text-align: center; ">
                     <P>
                        <DIV style="padding-top: 0px; text-align: center; "><B style="text-align: center; font-size: 10.0pt; ">Biodel Inc.<BR></B></DIV>
                     </P>
                  </DIV><BR><DIV style="padding-top: 0px; text-align: center; ">
                     <P>
                        <DIV style="padding-top: 0px; text-align: center; "><B style="text-align: center; font-size: 10.0pt; "><A name="cashflows"></A><A name="StatementsofCashFlows"></A><A name="StatementsofCashFlows"></A>Consolidated Statements of Cash Flows<BR>(In thousands)</B></DIV>
                     </P>
                     <P style="text-align: left; margin: 0pt; padding: 0pt; ">
                        <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                           <TR>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 70.00%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 1.67%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 1.67%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 11.67%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 1.67%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 11.67%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                              <TD style="width: 1.67%; font-size: 1pt;">&nbsp;</TD>
                              <TD style="font-size: 1pt;">&nbsp;</TD>
                           </TR>
                           <DIV style="padding-top: 3px; text-align: center; ">
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="7" style="border-bottom: 1pt black solid; vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center; "><B>September 30,</B></TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: top; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2013</B></TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2014</B></TD>
                                 <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; "><B>Cash flows from operating activities:</B></TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Net loss </TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(19,335</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(14,131</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 19.90pt; text-indent: -9.95pt; ">Adjustments to reconcile net loss to net cash used in operating activities:</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 19.90pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 30.00pt; text-indent: -9.95pt; text-align: left; ">Depreciation and amortization </TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 30.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">641</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">603</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 30.00pt; text-indent: -9.95pt; text-align: left; ">Stock-based compensation for employees and directors </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 30.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1,538</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">784</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 30.00pt; text-indent: -9.95pt; text-align: left; ">Adjustment to fair value of common stock warrant liability </TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 30.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(1,217</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(5,107</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 30.00pt; text-indent: -9.95pt; ">(Increase) decrease in:</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 30.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 39.95pt; text-indent: -9.95pt; text-align: left; ">Prepaid expenses and other assets </TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 39.95pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">31</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(47</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 39.95pt; text-indent: -9.95pt; text-align: left; ">Income taxes receivable </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 39.95pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">28</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 39.95pt; text-indent: -9.95pt; text-align: left; ">Grant receivable </TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 39.95pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">63</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">26</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 39.95pt; text-indent: -9.95pt; text-align: left; ">Other receivable </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 39.95pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">8</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 30.00pt; text-indent: -9.95pt; ">Increase (decrease) in:</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 30.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 39.95pt; text-indent: -9.95pt; text-align: left; ">Accounts payable </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 39.95pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(39</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(74</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 39.95pt; text-indent: -9.95pt; text-align: left; ">Income tax payable </TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 39.95pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(26</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(75</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 39.95pt; text-indent: -9.95pt; text-align: left; ">Accrued expenses and other liabilities </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 39.95pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(247</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(703</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; "><B>Total adjustments </B></TD>
                                 <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">780</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(4,592</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; "><B>Net cash used in operating activities </B></TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(18,555</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(18,723</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; "><B>Cash flows from investing activities:</B></TD>
                                 <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Purchase of property and equipment </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(118</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(49</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; "><B>Net cash used in investing activities </B></TD>
                                 <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(118</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(49</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; "><B>Cash flows from financing activities:</B></TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Restricted cash </TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">60</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Options exercised </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">75</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">48</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Net proceeds from employee stock purchase plan </TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">30</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">15</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Net proceeds from ATM facility </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">3,026</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Net proceeds from equity line </TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">490</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Net proceeds from sale of common stock </TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">19,239</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; "><B>Net cash provided by financing activities </B></TD>
                                 <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">19,404</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">3,579</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; "><B>Net increase (decrease) in cash and cash equivalents </B></TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">731</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(15,193</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; "><B>Cash and cash equivalents, beginning of period </B></TD>
                                 <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">39,050</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">39,781</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; "><B>Cash and cash equivalents, end of period </B></TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">39,781</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">24,588</TD>
                                 <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">Cash paid for interest and income taxes:</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Interest...............................................................</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Income taxes </TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">12</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">25</TD>
                                 <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; "><B>Non-cash financing and investing activities</B></TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                              </TR>
                              <TR style="text-align: left; ">
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                 <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Conversion of convertible preferred stock to common
                                    stock...............................................................
                                 </TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">35</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                 <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                 <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                              </TR>
                           </DIV>
                        </TABLE>
                     </P>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">See accompanying notes to financial statements.<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">F-6</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; "><A name="notespages"></A><A name="NotestoFinancialStatements"></A><A name="NotestoFinancialStatements"></A>Biodel Inc.<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center; ">Notes to Consolidated Financial Statements<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; ">(In thousands, except share and per share amounts)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: center; ">
               <DIV style="padding-top: 0px; text-align: center; ">
                  <DIV style="padding-top: 0px; text-align: center; ">
                     <P style="padding-left: 0pt; padding-top: 0px; line-height: 1.3; margin-top: 0pt; text-align: center; "> </P>
                     <P style="padding-left: 0pt; padding-top: 0px; line-height: 1.3; margin-top: 0pt; text-align: center; "> </P>
                     <P style="padding-left: 0pt; padding-top: 0px; line-height: 1.3; margin-top: 0pt; text-align: center; "> </P><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">1.&nbsp;Business</B></DIV>
                        </P><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Business</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Biodel Inc. and its wholly owned subsidiary (collectively, "Biodel"
                              or the "Company", and formerly Global Positioning Group Ltd.) is a
                              specialty pharmaceutical company located in Danbury, Connecticut. The
                              Company was incorporated in the State of Delaware on December 3, 2003
                              and commenced operations in January 2004. The Company formed a wholly
                              owned subsidiary in the United Kingdom in October 2011 ("Biodel UK
                              Limited"). This subsidiary has been inactive since its inception.
                           </P>
                           <P style="padding-left: 0pt; padding-top: 6px; line-height: 1.3; text-indent: 20.05pt; background-color: white; color: black; text-align: left; "><B style="text-align: left; font-size: 10.0pt; background-color: white; color: black; ">2. Basis of Presentation and Going Concern</B></P>
                           <P style="padding-top: 6px; line-height: 1.3; background-color: white; color: black; padding-left: 00.00pt; text-indent: 18.00pt; text-align: left; ">In June 2014, the FASB issued ASU No. 2014-10, to eliminate the
                              concept of a development stage entity (DSE) from U.S. GAAP, effective
                              for interim periods and years beginning after December 15, 2014. The
                              issuance of ASU No. 2014-10 rescinds certain financial reporting
                              requirements that have historically applied to DSEs, such as
                              inception-to-date information in the statements of income, cash
                              flows, and stockholder equity. Additionally, the financial statements
                              no longer need to be labeled as those of a DSE. ASU No. 2014-10 was
                              early adopted and the adoption of this standard did not have a
                              material effect on the Company's financial statements.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 18.00pt; text-align: left; ">These consolidated financial statements as of September 30, 2014 have
                              been prepared under the assumption that the Company will continue as
                              a going concern. Due to the Company&rsquo;s recurring and expected continuing losses from operations,
the Company has concluded there is substantial doubt in the Company&rsquo;s ability to continue as a going concern without additional
capital becoming available. While the Company could sell an additional $9.2 million worth of common stock through its Sales Agreement
with MLV &amp; Co. LLC or direct Lincoln Park Capital Fund, LLC to purchase up to $14 million worth of shares of common stock under the Company&rsquo;s
stock purchase agreement with Lincoln Park Capital Fund, LLC, there are certain factors, such as volume of trading in the stock, the stock price
and the ability to terminate the agreement with notice, which could limit the amount the Company could raise in a short period of time (see Note 9).


The consolidated financial statements do not include
                              any adjustments that might result from the outcome of this
                              uncertainty.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 18.00pt; text-align: left; ">The Company will be required to raise additional capital within the
                              next year to continue the development and commercialization of
                              current product candidates and to continue to fund operations at the
                              current cash expenditure levels. The Company cannot be certain that
                              additional funding will be available on acceptable terms, or at all.
                              To the extent that the Company raises additional funds by issuing
                              equity securities, the Company's stockholders may experience
                              significant dilution. If the Company is unable to raise additional
                              capital when required or on acceptable terms, the Company may have
                              to&nbsp;(i) significantly delay, scale back or discontinue the development
                              and/or commercialization of one or more product candidates; (ii) seek
                              collaborators for product candidates at an earlier stage than
                              otherwise would be desirable and on terms that are less favorable
                              than might otherwise be available; or (iii) relinquish or otherwise
                              dispose of rights to technologies, product candidates or products
                              that the Company would otherwise seek to develop or commercialize
                              ourselves on unfavorable terms.
                           </P>
                        </DIV>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">3.&nbsp;Summary of Significant Accounting Policies</B></DIV>
                        </P><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Research and Development Costs</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Company is in the business of research and development and,
                              therefore, research and development costs include, but are not
                              limited to, salaries and benefits, lab supplies, preclinical fees,
                              clinical trial and related clinical manufacturing costs, allocated
                              overhead costs and professional service providers. Research and
                              development costs are expensed when incurred. Research and
                              development costs aggregated $14,296, and $14,194 for the years ended
                              September 30, 2013 and 2014, respectively.
                           </P>
                        </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Government Grants</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Grants received are recognized as grant income when the grants become
                              receivable, provided there is reasonable assurance that the Company
                              will comply with the conditions attached to the grant and there is
                              reasonable assurance the grant will be received. The Company requests
                              cash funding under approved grants as expenses are incurred (not in
                              advance) and report these receipts on the statement of operations as
                              a separate line item entitled "Government Grants". The corresponding
                              expenses are included in research and development expenses. In July
                              and September 2012, the Company was awarded two National Institutes
                              of
                           </P>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">F-7</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; "><A name="notespages"></A><A name="NotestoFinancialStatements"></A><A name="NotestoFinancialStatements"></A>Biodel Inc.<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center; ">Notes to Consolidated Financial Statements&#8201;&#151;&#8201;(Continued)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; ">(In thousands, except share and per share amounts)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <DIV style="padding-top: 0px; text-align: left; ">
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 0pt; margin-top: 06.00pt; text-align: left; ">Health grants for the development of a concentrated
                              ultra-rapid-acting insulin formulation and a stable glucagon
                              formulation for use in an artificial pancreas, in the amounts of $582
                              and $583, respectively. Each award was for two&nbsp;years.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Work on the grant for the development of concentrated
                              ultra-rapid-acting insulin formulation started in August 2012 and
                              completed in June 2014. Expenses incurred and grant income were $327
                              and $167, for the years ended September 30, 2013 and 2014,
                              respectively.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Work on the grant for the stable glucagon formulation started in
                              January 2013 and completed in June 2014. Expenses incurred and grant
                              income were $219 and $364 for the years ended September 30, 2013 and
                              2014, respectively.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Company reported grant income of $546 and $531, for the years
                              ended September 30, 2013 and 2014, respectively.
                           </P>
                        </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Use of Estimates</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The preparation of financial statements in conformity with generally
                              accepted accounting principles requires management to make estimates
                              and assumptions that affect the reported amounts of assets and
                              liabilities and disclosure of contingent assets and liabilities at
                              the date of the financial statements and the reported amounts of
                              revenues and expenses during the reporting period. On an ongoing
                              basis, the Company evaluates its estimates and assumptions including,
                              but not limited to, accruals, forfeiture rate used in the computation
                              of share-based compensation, deferred tax assets, and warrant
                              liability estimated at fair value. Actual results may differ from
                              those estimates.
                           </P>
                        </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Cash and Cash Equivalents</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Company considers currency on hand, demand deposits and all
                              highly liquid investments with an original maturity of three months
                              or less at the date of purchase to be cash and cash equivalents. As
                              of September 30, 2013 and 2014, the Company had cash and cash
                              equivalents of $39,781 and $24,588, respectively, which are primarily
                              held in a premium commercial money market account.
                           </P>
                        </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Fair Value of Financial Instruments</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The carrying amounts of the Company's financial instruments, which
                              include cash and cash equivalents and accounts payable, approximate
                              their fair values due to their short term maturities. Warrant
                              liability is recorded at fair&nbsp;value.
                           </P>
                        </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Pre-Launch Inventory</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Inventory costs associated with product candidates that have not yet
                              received regulatory approval are capitalized if the Company believes
                              there is probable future commercial use and future economic benefit.
                              If the probability of future commercial use and future economic
                              benefit cannot be reasonably determined, then pre-launch inventory
                              costs associated with such product candidates are expensed as
                              research and development expense during the period the costs are
                              incurred. Because all of its product candidates are in early stages
                              of preclinical or clinical development, the Company currently
                              expenses all purchases of pre-launch inventory as research and
                              development, and expects to continue to do so until it can determine
                              the probability of regulatory approval for the applicable product
                              candidate.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">For the years ended September 30, 2013 and 2014, the Company expensed
                              $121 and $3, respectively, of costs associated with the purchase of
                              RHI and glucagon as research and development expense after such
                              materials passed quality control inspection by the Company and
                              transfer of title occurred.
                           </P>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">F-8</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; "><A name="notespages"></A><A name="NotestoFinancialStatements"></A><A name="NotestoFinancialStatements"></A>Biodel Inc.<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center; ">Notes to Consolidated Financial Statements&#8201;&#151;&#8201;(Continued)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; ">(In thousands, except share and per share amounts)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Intellectual Property</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Intangible assets consist primarily of capitalized costs associated
                              with the Company's ultra-rapid-acting insulin patents and the
                              purchase of two domain addresses. They are amortized using the
                              straight-line method over twenty years. If the Company determines
                              that a patent will not result in future revenues, the cost related to
                              such patent will be expensed in full on the date of that
                              determination. Intellectual property amortization expense was $3 for
                              each of the years ended September 30, 2013 and 2014.
                           </P>
                        </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Property and Equipment</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Property and equipment are stated at cost, net of accumulated
                              depreciation or amortization. Major improvements are capitalized,
                              while maintenance and repairs are expensed in the period the cost is
                              incurred. Property and equipment are depreciated over their estimated
                              useful lives using the straight-line method. Leasehold improvements
                              are amortized using the straight-line method over their estimated
                              useful lives, or the remaining term of the lease, whichever is
                              shorter. When assets are retired or otherwise disposed of, the assets
                              and related accumulated depreciation are removed from the accounts
                              and resulting gains or losses are included in other income (expense)
                              in the statement of operations. Estimated useful lives for each asset
                              category are as follows: Furniture and fixtures &#151; 7 years; Leasehold
                              improvements &#151; estimated useful life or remaining term of lease,
                              whichever is shorter; Laboratory equipment &#151; 7 years; Manufacturing
                              equipment &#151; 5 years; Device development&#151; 5 years; Facility equipment&#151;
                              3 years and 7 years; Computer equipment &#151; 5 years; and Computer
                              software &#151; 3&nbsp;years.
                           </P>
                        </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Impairment of Long-Lived Assets</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Whenever events or changes in circumstances indicate that the
                              carrying amounts of a long-lived asset may not be recoverable, the
                              Company reviews these assets for impairment and determines whether
                              adjustments are needed to carrying values. There were no adjustments
                              to the carrying value of long-lived assets at September 30, 2013 and
                              2014.
                           </P>
                        </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Warrant Liability</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Company applies the provisions of Accounting Standards
                              Codification Topic 480 ("ASC 480") (formerly FASB Staff Position
                              150-5 (FSP 15-5)), Issuers Accounting under FASB Statement No. 150
                              for Freestanding Warrants and other Similar Instruments on Shares
                              that are Redeemable or Distinguishing Liabilities from Equities.
                              Pursuant to ASC 480, a freestanding financial instrument (other than
                              outstanding share) that, at inception, embodies an obligation to
                              repurchase the issuer's shares and "requires or may require" the
                              obligation to be settled by transferring assets, qualifies as a
                              liability (if the obligation is conditional, the number of conditions
                              is irrelevant).
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Company issued warrants in May 2011 and June 2012 and recorded a
                              liability determined by the Black-Scholes valuation model. The
                              Black-Scholes valuation model was used because the warrants do not
                              contain a repricing provision. The Black-Scholes valuation model
                              takes into account, as of the valuation date, factors including the
                              current exercise price, the expected life of the warrant, the current
                              price of the underlying stock and its expected volatility, expected
                              dividends on the stock, and the risk-free interest rate for the term
                              of the warrant. These warrants will be revalued at each reporting
                              period and changes in fair value are recognized currently in the
                              statements of operations under the caption "Adjustments to fair value
                              of common stock warrant liability."
                           </P>
                        </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Income Taxes</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Company uses the asset and liability method of accounting for
                              deferred income taxes. The provision for income taxes includes income
                              taxes currently payable and those deferred as a result of temporary
                              differences between the financial statement and tax bases of assets
                              and liabilities. A valuation allowance is
                           </P>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">F-9</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; "><A name="notespages"></A><A name="NotestoFinancialStatements"></A><A name="NotestoFinancialStatements"></A>Biodel Inc.<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center; ">Notes to Consolidated Financial Statements&#8201;&#151;&#8201;(Continued)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; ">(In thousands, except share and per share amounts)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <DIV style="padding-top: 0px; text-align: left; ">
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 0pt; margin-top: 06.00pt; text-align: left; ">provided to reduce deferred tax assets to the amount of future tax
                              benefit when it is more likely than not that some portion of the
                              deferred tax assets will not be realized. Projected future taxable
                              income and ongoing tax planning strategies are considered and
                              evaluated when assessing the need for a valuation allowance. Any
                              increase or decrease in a valuation allowance could have a material
                              adverse or beneficial impact on the Company's income tax provision
                              and net income or loss in the period which the determination is&nbsp;made.
                           </P>
                        </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Concentration of Risks and Uncertainties</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Financial instruments that potentially subject the Company to a
                              concentration of credit risk consist of cash and cash equivalents.
                              The Company deposits excess cash with major financial institutions in
                              the United States. Balances may exceed the amount of insurance
                              provided on such deposits. The Company believes that its investment
                              policy guideline for its excess cash maintains safety and liquidity
                              through its policies on credit requirements, diversification and
                              investment maturity.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Company has experienced significant operating losses since
                              inception. At September 30, 2014, the Company had a deficit
                              accumulated of $229,559. The Company has generated no revenue to
                              date. The Company has funded its operations to date principally from
                              the sale of securities. The Company expects to incur substantial
                              additional operating losses for the next several years and will need
                              to obtain additional financing in order to complete the clinical
                              development of an ultra-rapid-acting insulin or a glucagon rescue
                              product, launch and commercialize the product if it receives
                              regulatory approval, and continue research and development programs.
                              There can be no assurance that such financing will be available or
                              will be at terms acceptable to the&nbsp;Company.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Company is currently developing its first product candidates and
                              has no products that have received regulatory approval. Any products
                              developed by the Company will require approval from the FDA or
                              foreign regulatory agencies prior to commercial sales. There can be
                              no assurance that the Company's products will receive the necessary
                              approvals. If the Company is denied such approvals or such approvals
                              are delayed, it would have a material adverse effect on the Company's
                              future operating results.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">To achieve profitable operations, the Company must successfully
                              develop, test, manufacture and market products, as well as secure the
                              necessary regulatory approvals. There can be no assurance that any
                              such products can be developed successfully or manufactured at an
                              acceptable cost and with appropriate performance characteristics, or
                              that such products will be successfully marketed. These factors would
                              have a material adverse effect on the Company's future financial
                              results.
                           </P>
                        </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Stock-Based Compensation</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In March 2013, the stockholders of the Company approved the amended
                              and restated 2010 Stock Incentive Plan (the "2010 Plan"). Up to
                              3,750,000 shares of the Company's common stock may be issued pursuant
                              to awards granted under the 2010 Plan, plus 1,540,739 shares of
                              common stock underlying already outstanding awards under the
                              Company's prior plans. As of September 30, 2014, the Company had a
                              total of 2,643,523 shares of common stock subject to outstanding
                              awards from prior and current plans. The contractual life of options
                              granted under the 2010 Plan may not exceed seven years. The 2010 Plan
                              uses a "fungible share" concept under which any awards that are not a
                              full-value award will be counted against the share limit as one (1)
                              share for each share of common stock and any award that is a
                              full-value award will be counted against the share limit as 1.5
                              shares for each one share of common stock. The Company has not made
                              any new awards under any prior equity plans after March 2, 2010, the
                              effective date the 2010 Plan was approved by the Company's
                              stockholders. The 2010 Plan replaces the 2004 Stock Incentive Plan
                              and 2005 Non-Employee Directors Stock Option&nbsp;Plan.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Company uses the Black-Scholes pricing model to calculate the
                              fair value of stock options. The expected life for grants was
                              calculated in accordance with the simplified method described in the
                              Securities and Exchange Commission Staff Accounting Bulletin (SAB)
                              Topic 14.D.2 in accordance with SAB No. 110. The Company bases its
                              estimates of expected volatility on the Company's historical
                              volatility.
                           </P>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">F-10</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; "><A name="notespages"></A><A name="NotestoFinancialStatements"></A><A name="NotestoFinancialStatements"></A>Biodel Inc.<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center; ">Notes to Consolidated Financial Statements&#8201;&#151;&#8201;(Continued)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; ">(In thousands, except share and per share amounts)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: center; ">
               <DIV style="padding-top: 0px; text-align: center; ">
                  <DIV style="padding-top: 0px; text-align: center; ">
                     <DIV style="padding-top: 0px; text-align: center; ">
                        <DIV style="padding-top: 0px; text-align: center; ">
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The risk-free rate of interest for periods within the contractual
                              life of the stock option award is based on the yield of U.S. Treasury
                              strips on the date the award is granted with a maturity equal to the
                              expected term of the award. The Company estimates forfeitures based
                              on actual forfeitures during its limited history. Additionally, the
                              Company has assumed that dividends will not be&nbsp;paid.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Company expenses ratably over the vesting period the cost of the
                              stock options granted to employees and directors. The total
                              compensation cost for the years ended September 30, 2013, and 2014
                              was $1,538, and $784 respectively. At September 30, 2014, the total
                              compensation cost related to non-vested options not yet recognized
                              was $1,423, which will be recognized over the next three years
                              assuming the employees complete their service period for vesting of
                              the options. The Black-Scholes valuation model assumptions are as
                              follows and were determined as discussed above:
                           </P>
                           <P style="text-align: center; margin: 0pt; padding: 0pt; ">
                              <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                                 <TR>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 51.61%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 4.97%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 5.46%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 16.51%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 4.97%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 16.48%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                 </TR>
                                 <DIV style="padding-top: 3px; text-align: center; ">
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="7" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Year Ended September 30,</B></TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2013</B></TD>
                                       <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2014</B></TD>
                                       <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Expected life (in years) </TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">2.39 - 4.75</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">3.77-4.75</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Expected volatility </TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">80 - 96%</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">70-83%</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Expected dividend yield </TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">0%</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">0%</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Risk-free interest rate </TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">0.25 - 0.75%</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">0.58-1.63%</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Weighted-average grant date fair value </TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="border-bottom: 2pt black double; vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">$2.43</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="border-bottom: 2pt black double; vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">$2.35</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    </TR>
                                 </DIV>
                              </TABLE>
                           </P>
                        </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Participating Securities</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In June 2008 the Financial Accounting Standards Board ("FASB") issued
                              ASC 260-10-55 Earnings Per Share &#151; Overall (formerly Financial
                              Statement Position Emerging Issues Task Force 03-6-1, Determining
                              Whether Instruments Granted in Share-Based Payment Transactions Are
                              Participating Securities) ("ASC 260-10-55"). ASC 260-10-55 provides
                              that securities and unvested share-based payment awards that contain
                              non-forfeitable rights to dividends or dividend equivalents (whether
                              paid or unpaid) are participating securities and shall be included in
                              the computation of earnings per share pursuant to the two-class
                              method.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Warrant Liability &#151; Given that the warrant holders will participate
                              fully on any dividends or dividend equivalents, the Company
                              determined that the warrants are participating securities and
                              therefore are subject to ASC 260-10-55. These securities were
                              excluded from the per share calculation for all years since their
                              inclusion would be anti-dilutive.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Restricted Stock Units &#151; Given that the holders of Restricted Stock
                              Unit awards ("RSUs") will only receive dividends or dividend
                              equivalents on RSUs that have vested prior to the Company declaring
                              dividends as well as forfeiting their rights to receive dividends or
                              dividend equivalents on any unvested portion, the Company determined
                              that the RSUs are non-participating securities and therefore are not
                              subject to ASC 260-10-55.
                           </P>
                        </DIV>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">4.&nbsp;Fair Value Measurement</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">ASC Topic 820 ("ASC 820"), originally issued as SFAS No. 157, Fair
                           Value Measurements, applies under other accounting pronouncements
                           that require or permit fair value measurements, the FASB having
                           previously concluded in those accounting pronouncements that fair
                           value is the relevant measurement attribute. Accordingly, ASC 820
                           does not require any new fair value measurements. The fair value
                           framework requires the categorization of assets and liabilities into
                           three levels based upon the assumptions (inputs) used to price the
                           assets or liabilities. The three levels of inputs used are as&nbsp;follows:
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 20.05pt; text-indent: 40.10pt; margin-top: 06.00pt; text-align: left; ">Level 1 &#151; Quoted prices in active markets for identical assets or liabilities.</P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 20.05pt; text-indent: 40.10pt; margin-top: 06.00pt; text-align: left; ">Level 2 &#151; Observable inputs other than quoted prices included in
                           Level 1, such as quoted prices for similar assets and liabilities in
                           active markets; quoted prices for identical or similar assets and
                           liabilities in markets that are not active; or other inputs that are
                           observable or can be corroborated by observable market&nbsp;data.
                        </P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">F-11</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; "><A name="notespages"></A><A name="NotestoFinancialStatements"></A><A name="NotestoFinancialStatements"></A>Biodel Inc.<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center; ">Notes to Consolidated Financial Statements&#8201;&#151;&#8201;(Continued)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; ">(In thousands, except share and per share amounts)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: center; ">
               <DIV style="padding-top: 0px; text-align: center; ">
                  <DIV style="padding-top: 0px; text-align: center; ">
                     <DIV style="padding-top: 0px; text-align: center; ">
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 20.05pt; text-indent: 40.10pt; margin-top: 06.00pt; text-align: left; ">Level 3 &#151; Unobservable inputs that are supported by little or no
                           market activity and that are significant to the fair value of the
                           assets or liabilities. This includes certain pricing models,
                           discounted cash flow methodologies and similar techniques that use
                           significant unobservable inputs.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">As of September 30, 2013 and 2014, the Company had assets and
                           liabilities that fell under the scope of ASC 820. The fair value of
                           the Company's warrant liability was determined by the Black-Scholes
                           valuation model for the warrants issued in connection with the
                           Company's May 2011 and June 2012 financings. Accordingly, the
                           Company's fair value measurements of its warrant liability is
                           classified as a Level 3&nbsp;input.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The fair value of the Company's financial assets and liabilities
                           carried at fair value and measured on a recurring basis are
                           as&nbsp;follows:
                        </P>
                        <P style="text-align: left; margin: 0pt; padding: 0pt; ">
                           <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                              <TR>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 38.16%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 2.63%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 11.84%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 2.63%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 15.79%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 2.63%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 11.84%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 2.63%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 11.84%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                              </TR>
                              <DIV style="padding-top: 3px; text-align: center; ">
                                 <TR cont_lvl="1" style="text-align: left; ">
                                    <TD style="vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: left; "><U><B style="text-align: left; font-size: 8.0pt; ">Description</B></U></TD>
                                    <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Fair Value at<BR>September 30,<BR>2014</B></TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Quoted Prices in<BR>Active Markets for<BR>Identical Assets<BR>(Level 1)</B></TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Significant<BR>Other<BR>Observable<BR>Market Inputs<BR>(Level 2)</B></TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Significant<BR>Unobservable<BR>Inputs<BR>(Level 3)</B></TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">Assets:</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Cash and cash equivalents </TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">24,588</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">24,588</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Subtotal </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">24,588</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">24,588</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">Liabilities:</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Common stock warrant liability </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(1,014</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(1,014</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">)</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 30.00pt; text-indent: -9.95pt; text-align: left; ">Subtotal </TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 30.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(1,014</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(1,014</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">)</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Total </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">23,574</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">24,588</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(1,014</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">)</TD>
                                 </TR>
                              </DIV>
                           </TABLE>
                        </P>
                        <P style="text-align: left; margin: 0pt; padding: 0pt; ">
                           <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                              <TR>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 38.16%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 2.63%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 11.84%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 2.63%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 15.79%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 2.63%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 11.84%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 2.63%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 11.84%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                              </TR>
                              <DIV style="padding-top: 3px; text-align: center; ">
                                 <TR cont_lvl="1" style="text-align: left; ">
                                    <TD style="vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: left; "><U><B style="text-align: left; font-size: 8.0pt; ">Description</B></U></TD>
                                    <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Fair Value at<BR>September 30,<BR>2013</B></TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Quoted Prices in<BR>Active Markets for<BR>Identical Assets<BR>(Level 1)</B></TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Significant<BR>Other<BR>Observable<BR>Market Inputs<BR>(Level 2)</B></TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Significant<BR>Unobservable<BR>Inputs<BR>(Level 3)</B></TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">Assets:</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="4" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Cash and cash equivalents </TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">39,781</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">39,781</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Subtotal </TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">39,781</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">39,781</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">Liabilities:</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 60.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 60.00pt; text-indent: -42.00pt; ">&nbsp;
                                       <DIV style="padding-left: 37pt; ">
                                          <P style="line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; ">
<FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; "></FONT></P>
                                       </DIV>
                                    </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 60.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="4" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Common stock warrant liability </TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(6,121</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(6,121</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">)</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 30.00pt; text-indent: -9.95pt; text-align: left; ">Subtotal </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 30.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(6,121</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(6,121</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">)</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Total </TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">33,660</TD>
                                    <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">39,781</TD>
                                    <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                    <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(6,121</TD>
                                    <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">)</TD>
                                 </TR>
                              </DIV>
                           </TABLE>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Company recognizes transfers into and out of the levels indicated
                           above on the actual date of the event or change in circumstances that
                           caused the transfer of change. All changes within Level 3 can be
                           found in the following Level 3 reconciliation table:
                        </P>
                        <P style="text-align: center; margin: 0pt; padding: 0pt; ">
                           <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                              <TR>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 88.22%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 2.16%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 9.61%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                              </TR>
                              <DIV style="padding-top: 3px; text-align: left; ">
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 00.00pt; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Balance at September 30, 2012 </TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(7,338</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">)</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Decrease in fair value </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1,217</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Balance at September 30, 2013 </TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(6,121</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">)</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Decrease in fair
                                       value</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">5,107</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Balance at September 30,
                                       2014</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(1,014</TD>
                                    <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">)</TD>
                                 </TR>
                              </DIV>
                           </TABLE>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The unrealized gains or losses on the derivative liabilities are
                           recorded as a change in fair value of derivative liabilities in the
                           Company's statement of operations. A financial instrument's level
                           within the fair
                        </P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">F-12</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; "><A name="notespages"></A><A name="NotestoFinancialStatements"></A><A name="NotestoFinancialStatements"></A>Biodel Inc.<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center; ">Notes to Consolidated Financial Statements&#8201;&#151;&#8201;(Continued)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; ">(In thousands, except share and per share amounts)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: center; ">
               <DIV style="padding-top: 0px; text-align: center; ">
                  <DIV style="padding-top: 0px; text-align: center; ">
                     <DIV style="padding-top: 0px; text-align: center; ">
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 0pt; margin-top: 06.00pt; text-align: left; ">value hierarchy is based on the lowest level of any input that is
                           significant to the fair value measurement. At each reporting period,
                           the Company reviews the assets and liabilities that are subject to
                           ASC Topic 815-40. At each reporting period, all assets and
                           liabilities for which the fair value measurement is based on
                           significant unobservable inputs or instruments which trade
                           infrequently and therefore have little or no price transparency are
                           classified as Level&nbsp;3.
                        </P><BR><DIV style="padding-top: 0px; text-align: center; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Fair Value Assumptions Used in Accounting for Warrant Liability</B></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Company has determined its warrant liability to be a Level 3 fair
                              value measurement and used the Black Scholes valuation model to
                              calculate the fair value for the fiscal year ended September 30, 2013
                              and 2014.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">At the measurement date, the Company estimated the fair value for the
                              June 2012 warrants using the Black-Scholes valuation model using the
                              following assumptions:
                           </P>
                           <P style="text-align: center; margin: 0pt; padding: 0pt; ">
                              <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                                 <TR>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 68.75%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 17.31%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 13.94%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                 </TR>
                                 <DIV style="padding-top: 3px; text-align: center; ">
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>September 30,<BR>2013</B></TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>September 30,<BR>2014</B></TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; "><B>June 2012 Financing</B></TD>
                                       <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Stock price </TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: 0px; width: 15px; ">$</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: right; ">3.15</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">$1.67</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 00.00pt; text-indent: -10.00pt; text-align: left; ">Exercise price </TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 00.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: 0px; width: 15px; ">$</TD>
                                       <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: right; ">2.66</TD>
                                       <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">$2.66</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Risk-free interest rate </TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: right; ">0.63</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">%</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">1.07%</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Expected remaining term </TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: right; ">3.74 years</TD>
                                       <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">2.74 years</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Expected volatility </TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: right; ">82</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">%</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">61%</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Dividend yield </TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: right; ">0</TD>
                                       <TD style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">%</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">0%</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Warrants outstanding June 2012 financing </TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: right; ">2,749,469</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: top; line-height: 1.3; margin-top: 0pt; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">2,749,469</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    </TR>
                                 </DIV>
                              </TABLE>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Company estimated the fair value for the May 2011 warrants using
                              the Black-Scholes valuation model at the measurement dates of
                              September 30, 2013 and 2014, respectively using the following
                              assumptions:
                           </P>
                           <P style="text-align: center; margin: 0pt; padding: 0pt; ">
                              <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                                 <TR>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 65.39%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 2.93%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 14.37%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 2.93%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 14.37%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                 </TR>
                                 <DIV style="padding-top: 3px; text-align: center; ">
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>September 30,<BR>2013</B></TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>September 30,<BR>2014</B></TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; "><B>May 2011 Financing</B></TD>
                                       <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Stock price </TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">$3.15</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">$1.67</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Exercise price </TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">$9.92</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">$9.92</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Risk-free interest rate </TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">0.63%</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">0.58%</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Expected remaining term </TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">2.63 years</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">1.63 years</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Expected volatility </TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">77%</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">62%</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Dividend yield </TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">0%</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">0%</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Warrants outstanding May 2011 financing </TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">2,256,929</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; text-indent: -10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">2,256,929</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    </TR>
                                 </DIV>
                              </TABLE>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; "><I>Risk-Free Interest Rate.</I> This is the United States Treasury rate for the measurement date
                              having a term equal to the expected remaining term of the warrant. An
                              increase in the risk-free interest rate will increase the fair value
                              and the associated derivative liability.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; "><I>Expected Remaining Term.</I> This is the remaining contractual life of the&nbsp;warrant.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; "><I>Expected Volatility.</I> This is a measure of the amount by which the stock price has
                              fluctuated or is expected to fluctuate. Since the Company's stock has
                              been traded for the expected remaining term of the warrants, the
                              Company uses its own historic volatility over the retrospective
                              period corresponding to the expected remaining term of the warrants
                              on the measurement date. An increase in the expected volatility will
                              increase the fair value and the associated derivative liability.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; "><I>Dividend Yield.</I> The Company has not made any dividend payments nor does it have
                              plans to pay dividends in the foreseeable future. An increase in the
                              dividend yield will decrease the fair value and the associated
                              derivative liability.
                           </P>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">F-13</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; "><A name="notespages"></A><A name="NotestoFinancialStatements"></A><A name="NotestoFinancialStatements"></A>Biodel Inc.<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center; ">Notes to Consolidated Financial Statements&#8201;&#151;&#8201;(Continued)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; ">(In thousands, except share and per share amounts)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: center; ">
               <DIV style="padding-top: 0px; text-align: center; ">
                  <DIV style="padding-top: 0px; text-align: center; ">
                     <DIV style="padding-top: 0px; text-align: center; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">5.&nbsp;Net Loss per Share</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Net loss per share information is determined using the two-class
                           method, which includes the weighted-average number of common shares
                           outstanding during the period and other securities that participate
                           in dividends ("participating securities"). The Company considers the
                           outstanding warrants participating securities because they include
                           rights to participate in dividends with the common stock on a
                           one-for-one basis. In applying the two-class method, earnings are
                           allocated to both common stock shares and warrants based on their
                           respective weighted-average shares outstanding for the period. Since
                           losses are not allocated to the participating securities, the
                           two-class method results in the same loss per common share calculated
                           using the basic method for the periods presented in these financial
                           statements.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Basic and diluted net loss per share has been calculated by dividing
                           net loss applicable to common stockholders by the weighted average
                           number of common shares outstanding during the period. All
                           potentially dilutive common shares have been excluded from the
                           calculation of weighted average common shares outstanding since their
                           inclusion would be anti-dilutive.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The amount of options, warrants, shares of preferred stock and
                           restricted stock units excluded are as&nbsp;follows:
                        </P>
                        <P style="text-align: center; margin: 0pt; padding: 0pt; ">
                           <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                              <TR>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 67.28%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 3.37%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 3.37%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 0.33%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 10.88%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 3.37%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 11.07%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 0.33%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                              </TR>
                              <DIV style="padding-top: 3px; text-align: center; ">
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="4" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="7" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Year Ended September 30,</B></TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style=" width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="4" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2013</B></TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="4" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2014</B></TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Common shares issuable upon conversion of Series B<BR> Preferred Stock
                                    </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="4" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1,950,000</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="4" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1,950,000</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Common shares underlying warrants issued for common stock </TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="4" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">5,006,398</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="4" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">5,006,398</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Stock options </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="4" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1,920,051</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="4" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">2,643,523</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Restricted stock units </TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="4" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">31,296</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="4" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                              </DIV>
                           </TABLE>
                        </P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: center; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">6.&nbsp;Property and Equipment</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Property and equipment consists of the following:</P>
                        <P style="text-align: center; margin: 0pt; padding: 0pt; ">
                           <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                              <TR>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 79.81%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 1.63%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 8.46%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 1.63%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 8.46%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                              </TR>
                              <DIV style="padding-top: 3px; text-align: center; ">
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="7" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>September 30,</B></TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2013</B></TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2014</B></TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Furniture and fixtures </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">324</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">324</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Leasehold improvements </TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1,548</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1,548</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Laboratory equipment </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">2,062</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">2,112</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Manufacturing equipment </TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">655</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">655</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Facility equipment </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">65</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">65</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Computer equipment and other </TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1,308</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1,308</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Sub-Total </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">5,962</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">6,012</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Less: Accumulated depreciation and amortization </TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">4,931</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">5,531</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Total </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1,031</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">481</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                              </DIV>
                           </TABLE>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Depreciation expense for the years ended September 30, 2013, and 2014
                           was $638, and $599, respectively.
                        </P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">7.&nbsp;Commitments</B></DIV>
                        </P><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Chief Executive Officer Employment Agreement</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">On March 30, 2010, the Company announced the appointment of Errol B.
                              De Souza, Ph.D., as the Company's President, Chief Executive Officer
                              and a Director. In connection with his appointment, Dr. De
                           </P>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">F-14</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; "><A name="notespages"></A><A name="NotestoFinancialStatements"></A><A name="NotestoFinancialStatements"></A>Biodel Inc.<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center; ">Notes to Consolidated Financial Statements&#8201;&#151;&#8201;(Continued)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; ">(In thousands, except share and per share amounts)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <DIV style="padding-top: 0px; text-align: left; ">
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 0pt; margin-top: 06.00pt; text-align: left; ">Souza signed an employment agreement, dated March 26, 2010, setting
                              forth the terms of his employment. The agreement provided for an
                              initial term of employment for the period from March 29, 2010 to
                              March 28, 2014 and it continues for successive one-year terms unless
                              the agreement is terminated by either party on 120 days prior written
                              notice in accordance with the terms of the agreement. The agreement
                              provides for an annual salary of $450 and eligibility for a target
                              bonus of 50% of the annual salary. In addition, Dr. De Souza was
                              granted options to purchase 175,000 shares of the Company's common
                              stock pursuant to the Company's 2010 Plan. These options were fully
                              vested as of March&nbsp;2014.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Company may terminate the agreement with or without cause. Dr. De
                              Souza will not be entitled to severance benefits if the Company
                              terminates his employment for cause, or if he terminates his
                              employment without good reason, as defined in the agreement. If the
                              Company terminates Dr. De Souza's employment without cause, or he
                              terminates his employment with the Company for good reason, he is
                              entitled&nbsp;to:
                           </P>
                           <DIV style="padding-left: 37pt; ">
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>two times his then current salary, plus two times his target annual
                                 bonus for the fiscal year in which he is terminated, plus the pro
                                 rata amount of his target annual bonus for the fiscal year in which
                                 he is terminated;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>COBRA benefits until the earlier of the end of the 24th month after
                                 the date his employment with the Company ends or the date his COBRA
                                 coverage expires;
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>24 months of acceleration of his outstanding equity compensation awards;&nbsp;and
                              </P>
                              <P style="padding-top: 6px; line-height: 1.3; text-align: left; padding-left: 30pt; text-indent: -36pt; margin-bottom: 6pt; margin-left: 6pt; "><FONT style="                  margin-left: -38pt; display: inline-table; text-align: left; text-indent: 0pt; width: 30pt; margin-right: 8pt; ">&#149;</FONT>full vesting of his outstanding equity compensation awards, if the
                                 Company terminates his employment without cause, or he resigns within
                                 12 months following a change in control, as defined in the agreement.
                              </P>
                           </DIV>
                        </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Change in Control and Severance Agreements</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Certain employees have agreements which provide for payouts in the
                              event that the Company consummates a change in control. The amount of
                              compensation due as a result of this event is approximately $3,501,
                              as set forth in the agreements. These employees are also entitled to
                              full vesting of their outstanding equity awards. These agreements
                              also provide for routine severance compensation. As of September 30,
                              2014 and September 30, 2013, no amounts have been accrued.
                           </P>
                        </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Leases</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">As of September 30, 2014, the Company leased three facilities in
                              Danbury, Connecticut.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Company renewed its lease for laboratory space for one year on
                              October 10, 2014. This lease provides for annual basic lease payments
                              from February 1, 2015 through January 31, 2016 of $68, plus the
                              annual Consumers Price Index ("CPI") increase for October, not to
                              exceed 6%, plus operating expenses.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Company renewed its lease agreement for additional office space
                              adjacent to its laboratory space for one year on October 10, 2014.
                              This lease provides for annual basic lease payments from February 1,
                              2015 through January 31, 2016 of $31, plus the annual CPI increase for
                              October, not to exceed 6%, plus operating expenses.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Company renewed its lease for its corporate office for five years
                              on November 6, 2013. This lease provides for annual basic lease
                              payments from August 1, 2014 through July 31, 2019 of $388, plus the
                              annual CPI increase for May, not to exceed 6%, plus operating
                              expenses. Escalations shall be on an annual basis from August 1, 2015
                              through July 31, 2019, and will be calculated using the preceding
                              year's basic lease payment, plus the annual CPI increase for May, not
                              to exceed&nbsp;6%.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Lease expense for the years ended September 30, 2013, and 2014 was
                              $646, and $627, respectively.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Minimum lease payments under these agreements as of September 30,
                              2014, as well as equipment leases subsequently entered into, are
                              as&nbsp;follows:
                           </P>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">F-15</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; "><A name="notespages"></A><A name="NotestoFinancialStatements"></A><A name="NotestoFinancialStatements"></A>Biodel Inc.<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center; ">Notes to Consolidated Financial Statements&#8201;&#151;&#8201;(Continued)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; ">(In thousands, except share and per share amounts)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: center; ">
               <DIV style="padding-top: 0px; text-align: center; ">
                  <DIV style="padding-top: 0px; text-align: center; ">
                     <DIV style="padding-top: 0px; text-align: center; ">
                        <DIV style="padding-top: 0px; text-align: center; ">
                           <P style="text-align: center; margin: 0pt; padding: 0pt; ">
                              <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                                 <TR>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 86.06%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 2.40%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 11.54%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                 </TR>
                                 <DIV style="padding-top: 3px; text-align: center; ">
                                    <TR cont_lvl="1" style="text-align: left; ">
                                       <TD style="vertical-align: middle; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; padding-left: 0pt; ">
                                          <P style=" text-align: left; line-height: 1.2; margin-top: 0pt; text-align: left; "><U><B style="text-align: left; font-size: 8.0pt; ">Years Ending September 30,</B></U><BR></P>
                                          <P style=" line-height: 1.3; margin-top: 0pt; text-align: left; "></P>
                                       </TD>
                                       <TD style="vertical-align: middle; padding-left: 0pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">2015 </TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">683</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">2016 </TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">598</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">2017 </TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">558</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">2018 </TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">564</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">2019 </TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">480</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Total </TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">2,883</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                 </DIV>
                              </TABLE>
                           </P>
                        </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Purchase Commitments</B></I></DIV>
                           </P>
                           <P style="padding-left: 0pt; padding-top: 6px; line-height: 1.3; text-indent: 20.05pt; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Commercial Supply Agreement with Bachem Americas</B></P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Company has entered into a commercial supply agreement for the
                              supply of glucagon with Bachem Americas, a supplier of glucagon. The
                              Company is obligated to purchase certain quantities of glucagon
                              pursuant to a rolling forecast submitted by the Company under this
                              agreement. At this time, the Company is obligated to purchase $392 of
                              glucagon in fiscal year 2015. There is no obligation after&nbsp;2015.
                           </P>
                           <P style="padding-left: 0pt; padding-top: 6px; line-height: 1.3; text-indent: 20.05pt; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Customization and Commercial Supply Agreement with Unilife Medical
                                 Solutions, Inc.</B></P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 10.00pt; margin-top: 06.00pt; text-align: left; ">The Company has entered into a customization and commercial supply
                              agreement with Unilife Medical Solutions, Inc. ("Unilife"), a wholly
                              owned subsidiary of Unilife Corporation, a company which designs,
                              develops and manufactures advanced drug delivery devices. The
                              agreement obligates Unilife to develop and supply dual-chamber
                              reconstitution devices to be used with the Company's glucagon rescue
                              product candidate. The Company is obligated to make payments to
                              Unilife on the achievement of certain development milestones,
                              including a payment of $750 upon the delivery of registration batches
                              for the Company's glucagon rescue product candidate. The Company
                              anticipates the milestone to be met in fiscal year&nbsp;2015.
                           </P>
                           <P style="padding-left: 0pt; padding-top: 6px; line-height: 1.3; text-indent: 20.05pt; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Manufacturing Agreement with Cangene bioPharma</B></P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Company has entered into manufacturing agreement with Cangene
                              bioPharma Inc., doing business as Emergent BioSolutions, or Emergent,
                              under which Emergent will fill and finish the GEM device, using
                              lyophilized glucagon and an aqueous diluent. During the term of the
                              agreement following validation of the manufacturing process, the
                              Company is required to purchase, and Emergent is obligated to deliver
                              to the Company, one manufactured lot of the GEM device every quarter
                              beginning in the third quarter of fiscal year 2017. The Company
                              expects to reserve and commit to additional manufacturing capacity
                              with Emergent following the commercial launch of our GEM product
                              candidate, if successful. Either party may terminate the agreement
                              without cause upon thirty-six months prior written notice.
                           </P>
                           <P style="padding-left: 0pt; padding-top: 6px; line-height: 1.3; text-indent: 20.05pt; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">Agreement with Aegis Therapeutics</B></P>
                           <P style="padding-top: 6px; line-height: 1.3; background-color: white; color: black; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In June 2012, the Company entered into an agreement with Aegis
                              Therapeutics, LLC, or Aegis, to acquire an exclusive, sublicensable,
                              worldwide license to the protein stabilization technology that it is
                              using in the development of liquid glucagon formulations. Under the
                              terms of the agreement, Aegis will prepare, file, prosecute and
                              maintain patents and patent applications that are specific to the
                              Company's liquid glucagon formulations in jurisdictions that the
                              Company may designate from time to time. In October 2014, the Company
                              amended this agreement to require the Company to pay Aegis $25
                              quarterly, beginning June 2015, subject to certain terms and
                              conditions. The Company did not make any payments to Aegis during
                              fiscal year&nbsp;2014.
                           </P>
                        </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Other Commitments</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Company has entered into certain licensing and collaboration
                              agreements for products currently under development. The Company may
                              be obligated in future periods to make additional payments, which
                           </P>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">F-16</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; "><A name="notespages"></A><A name="NotestoFinancialStatements"></A><A name="NotestoFinancialStatements"></A>Biodel Inc.<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center; ">Notes to Consolidated Financial Statements&#8201;&#151;&#8201;(Continued)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; ">(In thousands, except share and per share amounts)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: center; ">
               <DIV style="padding-top: 0px; text-align: center; ">
                  <DIV style="padding-top: 0px; text-align: center; ">
                     <DIV style="padding-top: 0px; text-align: center; ">
                        <DIV style="padding-top: 0px; text-align: center; ">
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 0pt; margin-top: 06.00pt; text-align: left; ">would become due and payable only upon the achievement of certain
                              research and development, regulatory, and approval milestones. The
                              specific timing of such milestones cannot be predicted and depend
                              upon future discretionary research and clinical developments, as well
                              as, regulatory agency actions. Further, under the terms of certain
                              agreements the Company may be obligated to pay commercial milestones
                              contingent upon the realization of sales revenues and sublicense
                              revenues. Due to the long range nature of such commercial milestones,
                              they are neither probable at this time nor predictable, and
                              consequently are not considered contingent milestone payment amounts.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The following table represents the Company's long term commitments:</P>
                           <P style="text-align: center; margin: 0pt; padding: 0pt; ">
                              <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                                 <TR>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 86.06%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 2.40%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 11.54%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                 </TR>
                                 <DIV style="padding-top: 3px; text-align: center; ">
                                    <TR cont_lvl="1" style="text-align: left; ">
                                       <TD style="vertical-align: middle; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; padding-left: 0pt; ">
                                          <P style=" text-align: left; line-height: 1.2; margin-top: 0pt; text-align: left; "><U><B style="text-align: left; font-size: 8.0pt; ">Years Ending September 30,</B></U><BR></P>
                                          <P style=" line-height: 1.3; margin-top: 0pt; text-align: left; "></P>
                                       </TD>
                                       <TD style="vertical-align: middle; padding-left: 0pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">2015(1) </TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1,219</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">2016 </TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">127</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">2017 </TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">630</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">2018 </TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1,685</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">2019 </TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">3,271</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Total </TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">6,932</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                 </DIV>
                              </TABLE>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">(1) Includes a $750 milestone payment</P>
                        </DIV>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: center; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">8.&nbsp;Income Taxes</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Company files its tax returns on a fiscal year basis. For the
                           years ended September 30, 2013 and 2014, the Company paid only
                           state&nbsp;taxes.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The provision for income taxes is as&nbsp;follows:</P>
                        <P style="text-align: center; margin: 0pt; padding: 0pt; ">
                           <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                              <TR>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 71.59%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 2.89%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 3.10%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 9.56%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 2.97%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 9.43%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 0.46%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                              </TR>
                              <DIV style="padding-top: 3px; text-align: center; ">
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="7" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Year Ended<BR>September 30,</B></TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style=" width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2013</B></TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="4" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2014</B></TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">Current expense</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="4" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Federal </TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD colspan="4" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">State </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">15</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="4" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">26</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Tax provision </TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">15</TD>
                                    <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD colspan="4" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">26</TD>
                                    <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                              </DIV>
                           </TABLE>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The following reconciles the amount of tax expense at the federal
                           statutory rate to the tax provision (benefit) in operations:
                        </P>
                        <P style="text-align: center; margin: 0pt; padding: 0pt; ">
                           <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                              <TR>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 67.93%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 3.21%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 3.21%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 0.41%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 10.81%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 3.21%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 11.23%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                              </TR>
                              <DIV style="padding-top: 3px; text-align: center; ">
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="4" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="7" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Year Ended September 30,</B></TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="4" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2013</B></TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2014</B></TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Federal statutory rate </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="4" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">34.00</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">%</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">34.00</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">%</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Federal taxes at statutory rate </TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD colspan="4" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(6,569</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(4,796</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">)</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Tax expense on permanent differences (a) </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="4" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">163</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(1,475</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">)</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">State taxes, net of federal tax effect </TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="4" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">10</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">17</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Valuation allowance increase (b) </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="4" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">6,439</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">6,316</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Other </TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="4" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(28</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(36</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">)</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Actual tax provision </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD bgcolor="#CCEEFF" colspan="4" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">15</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">26</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                              </DIV>
                           </TABLE>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; margin-top: 06.00pt; text-align: left; ">____________</P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 21.60pt; text-indent: -21.60pt; text-align: left; ">(a)&nbsp;Permanent differences were derived from share based compensation
                           and adjustments to common stock warrant liability.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 21.60pt; text-indent: -21.60pt; text-align: left; ">(b)&nbsp;Net of the Section 382 Adjustment.</P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">F-17</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; "><A name="notespages"></A><A name="NotestoFinancialStatements"></A><A name="NotestoFinancialStatements"></A>Biodel Inc.<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center; ">Notes to Consolidated Financial Statements&#8201;&#151;&#8201;(Continued)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; ">(In thousands, except share and per share amounts)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: center; ">
               <DIV style="padding-top: 0px; text-align: center; ">
                  <DIV style="padding-top: 0px; text-align: center; ">
                     <DIV style="padding-top: 0px; text-align: center; ">
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The following table summarized the activity related to the Company's
                           liabilities for uncertain tax positions:
                        </P>
                        <P style="text-align: center; margin: 0pt; padding: 0pt; ">
                           <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                              <TR>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 71.78%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 3.22%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 2.37%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 9.70%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 3.22%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 9.45%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 0.26%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                              </TR>
                              <DIV style="padding-top: 3px; text-align: center; ">
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="7" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Year Ended September 30,</B></TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 00.00pt; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2013</B></TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2014</B></TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Balance, beginning of year </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">75</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">75</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Decrease related to prior year's tax position </TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(75</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">)</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Balance, at end of year </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">75</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                              </DIV>
                           </TABLE>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Company files U.S. federal and state tax returns and has
                           determined that its major tax jurisdictions are the United States and
                           Connecticut. The tax years through 2014 remain open due to net
                           operating loss and are subject to examination by the appropriate
                           governmental agencies in the United States and Connecticut
                           carry-forwards.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">As of September 30, 2014, the Company had net operating loss ("NOL")
                           carry-forwards of approximately $71,898 (net of Section 382
                           limitation discussed below) for U.S. federal tax purposes and
                           $126,484 for state tax purposes. These loss carry-forwards expire
                           between 2024 and 2034. To the extent these net operating loss
                           carry-forwards are available, the Company intends to use them to
                           reduce the corporate income tax liability associated with its
                           operations.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The ability of the Company to utilize its NOL carry-forwards to
                           reduce future taxable income is subject to various limitations under
                           the Internal Revenue Code Section 382 ("Section 382"). The
                           utilization of such carry-forwards may be limited upon the occurrence
                           of certain ownership changes, including the purchase or sale of stock
                           by 5% shareholders and the offering of stock by the Company during
                           any three-year period resulting in an aggregate change of more than
                           50% in the beneficial ownership of the Company. In the event of an
                           ownership change, Section 382 imposes an annual limitation on the
                           amount of a Company's taxable income that can be offset by these
                           carry-forwards. As of September 30, 2011, the Company completed a
                           study of the impact of Section 382 limitation on future payments and
                           determined that the statutory provisions limited the Company's
                           ability to realize future tax benefits. Accordingly, the Company
                           decreased federal net operating loss carry-forwards by approximately
                           $55,929 and federal research and development credit carry-forwards by
                           $1,817. The Company completed an additional study of the impact of
                           Section 382 limitation on future payments in November 2013 and
                           determined that there were no additional limitations on the Company's
                           existing NOLs.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Company also has state research and development credit
                           carry-forwards of approximately $348, which expire commencing in
                           fiscal 2022.The major components of deferred tax assets and valuation
                           allowances and deferred tax liabilities at September 30, 2013 and
                           2014 are as&nbsp;follows:
                        </P>
                        <P style="text-align: center; margin: 0pt; padding: 0pt; ">
                           <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                              <TR>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 74.04%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 2.93%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 10.05%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 2.93%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                                 <TD style="width: 10.05%; font-size: 1pt;">&nbsp;</TD>
                                 <TD style="font-size: 1pt;">&nbsp;</TD>
                              </TR>
                              <DIV style="padding-top: 3px; text-align: center; ">
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="7" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>September 30,</B></TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2013</B></TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                    <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2014</B></TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; "><B>Deferred Tax Assets</B></TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; padding-left: 0pt; line-height: 1.3; margin-top: 0pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Net operating losses </TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">25,149</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">30,706</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Capitalized expense </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">28,913</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">30,762</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Research and development credits </TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">224</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">230</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Depreciation of fixed assets </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">445</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">467</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Other </TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">283</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">196</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Total deferred tax asset </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">55,014</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">62,361</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-indent: -9.95pt; text-align: left; ">Valuation Allowance </TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 19.90pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(55,014</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(62,361</TD>
                                    <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">)</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; "><B>Net Deferred Tax Assets</B></TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                              </DIV>
                           </TABLE>
                        </P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">F-18</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; "><A name="notespages"></A><A name="NotestoFinancialStatements"></A><A name="NotestoFinancialStatements"></A>Biodel Inc.<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center; ">Notes to Consolidated Financial Statements&#8201;&#151;&#8201;(Continued)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; ">(In thousands, except share and per share amounts)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Due to the substantial doubt related to Biodel's ability to continue
                           as a going concern and utilize its deferred tax assets, a valuation
                           allowance for the full amount of the deferred tax assets has been
                           established as of September 30, 2013 and 2014.
                        </P>
                     </DIV> <BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">9.&nbsp;Stockholders' Equity</B></DIV>
                        </P><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Common Stock</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Company's authorized common stock consists of 62,500,000 shares
                              of a single class of common stock, having a par value of $0.01 per
                              share. The holders of the common stock are entitled to one vote for
                              each share and have no cumulative voting rights or preemptive rights.
                           </P>
                        </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Preferred Stock</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Company is authorized to issue up to 50,000,000 shares of
                              preferred stock, having a par value of $0.01 per share. The Company's
                              preferred stock may be issued in one or more series, the terms of
                              which may be determined at the time of issuance by the Company's
                              Board of Directors, without further action by stockholders, and may
                              include voting rights (including the right to vote as a series on
                              particular matters), preferences as to dividends and liquidation and
                              conversion, redemption rights and sinking fund provisions. The
                              issuance of preferred stock could reduce the rights, including voting
                              rights, of the holders of common stock and, therefore, could reduce
                              the value of the common stock. In particular, specific rights granted
                              to holders of preferred stock could be used to restrict the Company's
                              ability to merge with or sell the Company's assets to a third party,
                              thereby preserving control of the Company by existing management.
                           </P>
                        </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Financings</B></I></DIV>
                           </P>
                           <P style="padding-left: 0pt; padding-top: 6px; line-height: 1.3; text-indent: 20.05pt; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">July 2014 Purchase Agreement</B></P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-align: left; ">On July 25, 2014, the Company entered into a purchase agreement (the
                              "Purchase Agreement"), together with a registration rights agreement
                              (the "Registration Rights Agreement") with Lincoln Park Capital Fund,
                              LLC ("LPC"). Under the terms, and subject to the conditions of the
                              Purchase Agreement, the Company has the right to sell to LPC, and LPC
                              is obligated to purchase, up to $15 million in shares of common
                              stock, subject to certain limitations, from time to time over the
                              36-month period commencing on the date that a registration statement,
                              which the Company agreed to file with the SEC pursuant to the
                              Registration Rights Agreement, is declared effective by the SEC and a
                              final prospectus in connection therewith is filed. The Company's
                              registration statement was declared effective on September 2, 2014.
                              The Company was obligated, within twenty (20) calendar days, to file
                              with the SEC an initial Registration Statement covering the maximum
                              number of Registrable Securities as shall be permitted to be included
                              thereon in accordance with applicable SEC rules, regulations and
                              interpretations so as to permit the resale of such Registrable
                              Securities by the Investor under Rule 415 under the Securities Act at
                              then prevailing market prices (and not fixed prices), as mutually
                              determined by both the Company and LPC in consultation with their
                              respective legal counsel, subject to the aggregate number of
                              authorized shares of the Company's Common Stock then available for
                              issuance in its Certificate of Incorporation. The Company shall use
                              its commercially reasonable efforts to keep the Registration
                              Statement effective pursuant to Rule 415 promulgated under the
                              Securities Act and available for the resale by the Investor of all of
                              the Registrable Securities covered thereby at all times until the
                              date on which LPC shall have resold all the Registrable Securities
                              covered thereby and no Available Amount remains under the Purchase
                              Agreement. The Company may direct LPC, at its sole discretion and
                              subject to certain conditions, to purchase up to 150,000 shares of
                              common stock in any business day, increasing to amounts of up to
                              250,000 shares, depending upon the closing sale price of the common
                              stock. In addition, the Company may direct LPC to purchase additional
                              shares as accelerated purchases if, on the date of a regular
                              purchase, the closing sale price of the common stock is not below
                              $2.50 per share (subject to adjustment). The purchase price of shares
                              of common stock to be purchased under the Purchase Agreement are
                              based on the prevailing market prices of such shares at the time of
                              sales, but in no event will the Company be able to sell shares to
                           </P>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">F-19</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; "><A name="notespages"></A><A name="NotestoFinancialStatements"></A><A name="NotestoFinancialStatements"></A>Biodel Inc.<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center; ">Notes to Consolidated Financial Statements&#8201;&#151;&#8201;(Continued)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; ">(In thousands, except share and per share amounts)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <DIV style="padding-top: 0px; text-align: left; ">
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-align: left; ">LPC on a day when the closing sale price of the common stock is less
                              than a floor price of $1.50 per share (subject to adjustment). The
                              Company will control the timing and amount of any sales of common
                              stock to LPC under the Purchase Agreement. As consideration for LPC's
                              commitment to purchase shares of common stock pursuant to the
                              Purchase Agreement, the Company issued to LPC 95,000 shares of Common
                              Stock as commitment shares, with a fair market value of $189, which
                              is recorded as the cost of capital in additional paid in capital. As
                              of September 30, 2014, the Company sold 300,000 shares of common
                              stock pursuant to the Purchase Agreement, and received proceeds, net
                              of expenses, of $490. During the period from October 1, 2014 through
                              the date of this filing, the Company sold an aggregate of 300,000
                              shares of common stock pursuant to the Purchase Agreement, and
                              received proceeds, net of expenses, of&nbsp;$468.
                           </P>
                           <P style="padding-left: 0pt; padding-top: 6px; line-height: 1.3; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">May 2013 At-the-Market Issuance Sales Agreement</B></P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-align: left; ">In May 2013, the Company entered into an At-the-Market Issuance Sales
                              Agreement (the "Sales Agreement") with MLV &amp; Co. LLC ("MLV"), under
                              which the Company may initially issue and sell shares of common stock
                              having aggregate sales proceeds of up to $14 million from time to
                              time through MLV as the Company's sales agent. For the year ended
                              September 30, 2014, the Company sold an aggregate of 1,564,821 shares
                              of common stock pursuant to the Sales Agreement and received
                              proceeds, net of sales agent commissions and expenses, of $3.0
                              million. During the period from October 1, 2014 through the date of
                              this filing, the Company sold an aggregate of 66,057 shares of common
                              stock pursuant to the Sales Agreement, and received proceeds, net of
                              expenses, of&nbsp;$100.
                           </P>
                           <P style="padding-left: 0pt; padding-top: 6px; line-height: 1.3; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">June 2013 Public Offering</B></P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">On June 24, 2013, the Company completed an underwritten public
                              offering of 4,482,760 shares of its common stock at a price to the
                              public of $4.35 per share. On July 22, 2013, the Company issued
                              236,007 additional shares of common stock, at the public offering
                              price of $4.35 per share, in connection with the underwriters'
                              exercise of a portion of their over-allotment option. The Company
                              received net proceeds from this offering, after deducting
                              underwriting discounts, commissions and expenses, of $19.2 million.
                           </P>
                           <P style="padding-left: 0pt; padding-top: 6px; line-height: 1.3; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">June 2012 Private Placement</B></P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">On June 27, 2012 the Company completed a private placement (the "2012
                              Private Placement") of an aggregate of 4,250,020 shares of common
                              stock, 3,605,607 shares of Series B preferred stock and warrants to
                              purchase 2,749,469 shares of common stock at an exercise price of
                              $2.66 per share. For each unit consisting of either, a share of
                              common stock or Series B preferred stock and a warrant to purchase
                              0.35 of a share of common stock, the purchasers in the June 2012
                              Private Placement paid a negotiated price of $2.355. The warrants are
                              immediately exercisable and will expire on June 26, 2017, five years
                              from the original issuance date of June 27, 2012.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Each share of Series B preferred stock is convertible into one share
                              of the Company's common stock at any time at the option of the
                              holder, except that the securities purchase agreement that the
                              Company entered into in connection with the 2012 Private Placement
                              (the "Securities Purchase Agreement") provides that a holder will be
                              prohibited from converting shares of Series B preferred stock into
                              shares of common stock if, as a result of such conversion, such
                              holder, together with its affiliates, would beneficially own more
                              than 9.98% of the total number of shares of common stock then issued
                              and outstanding. In the event of the Company's liquidation,
                              dissolution or winding up, holders of the Series B preferred stock
                              will receive a payment equal to $0.01 per share of Series B preferred
                              stock before any proceeds are distributed to the holders of common
                              stock. After the payment of this preferential amount, and subject to
                              the rights of holders of any class or series of capital stock
                              specifically ranking by its terms senior to the Series B preferred
                              stock, holders of Series B preferred stock and holders of the
                              Company's Series A preferred stock will participate ratably in the
                              distribution of any remaining assets with the common stock and any
                              other class or series of capital stock that participates with the
                              common stock in such distributions. Shares of Series B preferred
                              stock will generally have no voting rights, except as required by law
                              and except that the consent of the holders of a majority of the
                              outstanding Series B preferred stock will be required to amend the
                              terms of the Series B preferred stock. Holders of Series B preferred
                              stock are entitled to receive, and the Company is required to
                           </P>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">F-20</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; "><A name="notespages"></A><A name="NotestoFinancialStatements"></A><A name="NotestoFinancialStatements"></A>Biodel Inc.<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center; ">Notes to Consolidated Financial Statements&#8201;&#151;&#8201;(Continued)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; ">(In thousands, except share and per share amounts)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <DIV style="padding-top: 0px; text-align: left; ">
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 0pt; margin-top: 06.00pt; text-align: left; ">pay, dividends on shares of the Series B preferred stock equal (on an
                              as-if-converted-to-common-stock basis) to and in the same form as
                              dividends (other than dividends in the form of common stock) actually
                              paid on shares of the common stock when, as and if such dividends
                              (other than dividends in the form of common stock) are paid on shares
                              of the common stock.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">As required by the Securities Purchase Agreement, the Company filed a
                              Registration Statement on Form S-3 (the "Registration Statement")
                              with the Securities and Exchange Commission (the "SEC") on July 27,
                              2012, which was within 30 days after the closing of the 2012 Private
                              Placement. The Registration Statement, which was declared effective
                              on August 13, 2012, registers the resale of the shares of common
                              stock and Series B preferred stock issued and sold in the 2012
                              Private Placement, the shares of common stock issuable upon
                              conversion of the Series B preferred stock issued and sold in the
                              2012 Private Placement, and the shares of common stock issuable upon
                              exercise of the warrants issued and sold in the 2012 Private
                              Placement. Pursuant to the terms of the Securities Purchase
                              Agreement, the Company agreed to pay liquidated damages to the
                              purchasers in the 2012 Private Placement if, after effectiveness of
                              the Registration Statement and subject to certain specified
                              exceptions, the Company suspends the use of the Registration
                              Statement or the Registration Statement ceases to remain continuously
                              effective as to all the securities for which it is required to be
                              effective (each such event, a "Registration Default"). Subject to
                              specified exceptions, for each 30-day period or portion thereof
                              during which a Registration Default remains uncured, the Company is
                              obligated to pay liquidated damages to each purchaser in cash in an
                              amount equal to 1.0% of the aggregate purchase price paid by each
                              such purchaser in the 2012 Private Placement, up to a maximum of 8.0%
                              of such aggregate purchase price. As of the date of these financial
                              statements, the Company does not believe that it is probable that it
                              will be obligated to pay any such liquidated damages. Accordingly,
                              the Company has not established an accrual for liquidated damages.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Company received net proceeds, after deducting placement agent
                              fees and other offering expenses of approximately $17,100 from this
                              financing. In June 2013, 176,964 shares of the Company's Series B
                              preferred stock were converted into an equal number of shares of
                              common stock. In September 2013, 1,478,643 shares of the Company's
                              Series B preferred stock were converted into an equal number of
                              shares of common stock. As of September 30, 2014, the Company has
                              1,950,000 shares of the Series B preferred stock outstanding.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In the event that the Company enters into a merger or change of
                              control transaction, the holders of the warrants issued in the 2012
                              Private Placement will be entitled to receive consideration as if
                              they had exercised the warrants immediately prior to such
                              transaction, or they may require the Company to purchase the
                              unexercised warrants at the Black-Scholes value (as defined in the
                              warrant) of the warrant on the date of such transaction. The holders
                              have up to 30 days following any such transaction to exercise this
                              right. As a result of this provision, the Company recognizes the
                              warrants as liabilities at their fair value on each reporting date.
                           </P>
                           <P style="padding-left: 0pt; padding-top: 6px; line-height: 1.3; text-indent: 20.05pt; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">May 2011 Registered Direct Offering</B></P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">On May 12, 2011, the Company completed a registered direct offering
                              of an aggregate of 3,018,736 shares of common stock, 1,813,044 shares
                              of Series A preferred stock to one investor and warrants to purchase
                              2,256,929 shares of common stock at an exercise price of $9.92 per
                              share. The investor who purchased Series A preferred stock units
                              received units consisting of one share of Series A preferred stock
                              and a warrant to purchase 0.1625 of a share of common stock. No
                              fractional warrants were issued. Each unit was sold at a price of
                              $8.84 per&nbsp;unit.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Each share of Series A preferred stock was convertible into 0.25 of a
                              share of the Company's common stock at any time at the option of the
                              holder, provided that the holder would be prohibited from converting
                              the shares of
                              <BR> Series A preferred stock into shares of the Company's common stock
                              if, as a result of such conversion, the holder, together with its
                              affiliates, would beneficially own more than 9.98% of the total
                              number of shares of the Company's common stock then issued and
                              outstanding. In the event of the Company's liquidation, dissolution
                              or winding up, holders of the Series A preferred stock would receive
                              a payment equal to $0.01 per
                           </P>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">F-21</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; "><A name="notespages"></A><A name="NotestoFinancialStatements"></A><A name="NotestoFinancialStatements"></A>Biodel Inc.<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center; ">Notes to Consolidated Financial Statements&#8201;&#151;&#8201;(Continued)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; ">(In thousands, except share and per share amounts)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <DIV style="padding-top: 0px; text-align: left; ">
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 0pt; margin-top: 06.00pt; text-align: left; ">share of Series A preferred stock before any proceeds are distributed
                              to the holders of the Company's common stock. After the payment of
                              this preferential amount, and subject to the rights of holders of any
                              class or series of capital stock specifically ranking by its terms
                              senior to the Series A preferred stock, holders of Series A preferred
                              stock and holders of the Company's Series B preferred stock will
                              participate ratably in the distribution of any remaining assets with
                              the Company's common stock and any other class or series of capital
                              stock that participates with the common stock in such distributions.
                              Shares of Series A preferred stock generally have no voting rights,
                              except as required by law and except that the consent of the holders
                              of a majority of the outstanding Series A preferred stock will be
                              required to amend the terms of the Series A preferred stock. The
                              Series A preferred stock will not be entitled to receive any
                              dividends, unless and until specifically declared by the Company's
                              board of directors.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Company received net proceeds, after deducting placement agent
                              fees and other offering expenses, of approximately $28,000 from this
                              financing. As of September 2013, all of the Company's Series A
                              preferred stock was converted into 453,483 shares of common stock.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In the event that the Company enters into a merger or change of
                              control transaction, the holders of the warrants issued in the May
                              2011 financing will be entitled to receive consideration as if they
                              had exercised the warrant immediately prior to such transaction, or
                              they may require the Company to purchase the unexercised warrants at
                              the Black-Scholes value (as defined in the warrant) of the warrant on
                              the date of such transaction. As per the terms of the warrants, the
                              holders have up to 30 days following any such transaction to exercise
                              this right. As a result of this provision, the Company recognizes the
                              warrants as liabilities at their fair value on each reporting date.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Company's warrant liability is marked-to-market each reporting
                              period with the change in fair value recorded as a gain or loss
                              within Other (Income) Expense ("Adjustments to fair value of common
                              stock warrant liability"), until the warrants are exercised, expire
                              or other facts and circumstances lead the warrant liability to be
                              reclassified as an equity instrument.
                           </P>
                        </DIV> <BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">2004 Stock Incentive Plan</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Company established the 2004 Stock Incentive Plan on October 1,
                              2004 (the "Plan"), as amended in March 2007, and subsequently
                              replaced by the 2010 Stock Incentive Plan. The Plan provides for the
                              granting of shares of common stock or securities convertible into or
                              exercisable for shares of common stock, including stock options
                              ("Incentive Stock Options") to directors, employees, consultants and
                              advisors of or to the Company. Incentive Stock Options can be awarded
                              only to persons who are employees of the Company at the time of the
                              grant. Stock options are exercisable at the conclusion of the vesting
                              period. Employees can exercise their vested shares up to 90 days
                              after termination of services. No awards may be granted under the
                              Plan after the effective date of the 2010&nbsp;Plan.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Plan is administered by either the Board of Directors of the
                              Company or a Committee thereof, which determines the terms and
                              conditions of the awards granted under the Plan, including the
                              recipient of the award, the nature of the award, the exercise price
                              of the award, the number of shares subject to the award and the
                              exercisability thereof.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Non-employee directors are not entitled to receive awards other than
                              the non-qualified stock options the plan directs be issued to
                              non-employee directors.
                           </P>
                        </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">2010 Stock Incentive Plan</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In March 2013, the stockholders of the Company approved the amended
                              and restated 2010 Stock Incentive Plan (the "2010 Plan"). Up to
                              3,750,000 shares of the Company's common stock may be issued pursuant
                              to awards granted under the 2010 Plan, plus 1,540,739 shares of
                              common stock underlying already outstanding awards under the
                              Company's prior plans. As of September 30, 2014, the Company had
                              2,643,523
                           </P>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">F-22</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; "><A name="notespages"></A><A name="NotestoFinancialStatements"></A><A name="NotestoFinancialStatements"></A>Biodel Inc.<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center; ">Notes to Consolidated Financial Statements&#8201;&#151;&#8201;(Continued)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; ">(In thousands, except share and per share amounts)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <DIV style="padding-top: 0px; text-align: left; ">
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 0pt; margin-top: 06.00pt; text-align: left; ">shares of common stock subject to outstanding awards. The contractual
                              life of options granted under the 2010 Plan may not exceed seven
                              years. The 2010 Plan uses a "fungible share" concept under which any
                              awards that are not a full-value award will be counted against the
                              share limit as one (1) share for each share of common stock and any
                              award that is a full-value award will be counted against the share
                              limit as 1.5 shares for each one share of common stock. The Company
                              has not made any new awards under any prior equity plans after March
                              2, 2010 &#151; the effective date the 2010 Plan was approved by the
                              Company's stockholders. The 2010 Plan replaces the 2004 Stock
                              Incentive Plan and 2005 Non-Employee Directors Stock Option&nbsp;Plan.
                           </P>
                        </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">2005 Employee Stock Purchase Plan</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Company's 2005 Employee Stock Purchase Plan, or the Purchase
                              Plan, was adopted by its Board of Directors and approved by its
                              stockholders on March 20, 2007. The Purchase Plan became effective
                              upon the closing of the Company's initial public offering. The
                              Purchase Plan is intended to qualify as an employee stock purchase
                              plan within the meaning of Section 423 of the&nbsp;Code.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Under the Purchase Plan, eligible employees may contribute up to 15%
                              of their eligible earnings for the period of that offering for the
                              purchase of common stock under the Purchase Plan. The employee's
                              purchase price is equal to the lower of: 85% of the fair market value
                              per share on the start date of the offering period in which the
                              employee is enrolled or 85% of the fair market value per share on the
                              semi-annual purchase date. The Purchase Plan imposes a limitation
                              upon a participant's right to acquire common stock if immediately
                              after the purchase, the employee would own 5% or more of the total
                              combined voting power or value of the Company's common stock or of
                              any of its affiliates not eligible to participate in the Purchase
                              Plan. The Purchase Plan provides for an automatic rollover when the
                              purchase price for a new offering period is lower than previously
                              established purchase price(s). The Purchase Plan also provides for a
                              one-time election that allows an employee the opportunity to enroll
                              into a new offering period when the new offering is higher than their
                              current offering price. This election must be made within 30 days
                              from the start of a new offering period. Offering periods are
                              twenty-seven months in length. The compensation cost in connection
                              with the plan for the years ended September 30, 2013 and 2014 was $5
                              and $4 respectively.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">An aggregate of 500,000 shares of common stock are reserved for
                              issuance pursuant to purchase rights to be granted to the Company's
                              eligible employees under the Purchase Plan. The Purchase Plan shares
                              are replenished annually on the first day of each fiscal year by
                              virtue of an evergreen provision. The provision allows for share
                              replenishment equal to the lesser of 1% of the total number of shares
                              outstanding on that date or 25,000 shares. As of September 30, 2013
                              and 2014, a total of 366,926 and 383,737 shares, respectively, were
                              reserved and available for issuance under this plan. For the years
                              ended September 30, 2013 and 2014, the Company issued a total of
                              108,074, and 116,263 shares, respectively, under the Purchase Plan.
                           </P>
                        </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">2005 Non-Employee Directors' Stock Option Plan</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Company's 2005 Non-Employee Directors' Stock Option Plan (the
                              "Directors' Plan") was adopted by its Board of Directors and approved
                              by its stockholders on March 20, 2007 and subsequently replaced with
                              the 2010 Stock Incentive Plan. The Directors' Plan became effective
                              upon the closing of the Company's initial public offering. An
                              aggregate of 125,000 shares of common stock were reserved for
                              issuance under the Directors' Plan. Upon the effective date of the
                              registration statement in connection with the Company's initial
                              public offering, each of its non-employee directors automatically
                              received an initial option to purchase 6,250 shares of common stock.
                              Upon appointment, non-employee directors receive a one-time grant of
                              an option to purchase 6,250 shares of common stock. Annually,
                              non-employee directors receive an option to purchase 10,000 shares of
                              common stock. Effective March 3, 2009, these shares vest pro rata
                              over one year. However, in the event a non-employee director has not
                              served since the date of the preceding annual meeting of
                              stockholders, that director will receive an annual grant that has
                              been reduced pro rata for each full quarter prior to the date of
                              grant during which such person did not serve as a non-employee
                              director.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The following table summarizes all stock option activity through
                              September 30, 2014:
                           </P>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">F-23</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; "><A name="notespages"></A><A name="NotestoFinancialStatements"></A><A name="NotestoFinancialStatements"></A>Biodel Inc.<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center; ">Notes to Consolidated Financial Statements&#8201;&#151;&#8201;(Continued)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; ">(In thousands, except share and per share amounts)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: center; ">
               <DIV style="padding-top: 0px; text-align: center; ">
                  <DIV style="padding-top: 0px; text-align: center; ">
                     <DIV style="padding-top: 0px; text-align: center; ">
                        <DIV style="padding-top: 0px; text-align: center; ">
                           <P style="text-align: left; margin: 0pt; padding: 0pt; ">
                              <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                                 <TR>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 49.35%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 2.60%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 9.09%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 2.60%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 10.39%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 2.60%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 10.39%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 2.60%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 10.39%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                 </TR>
                                 <DIV style="padding-top: 3px; text-align: center; ">
                                    <TR cont_lvl="1" style="text-align: left; ">
                                       <TD style="vertical-align: bottom; line-height: 1.2; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: left; "><B>Options</B></TD>
                                       <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Number</B></TD>
                                       <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Weighted<BR>Average<BR>Exercise Price</B></TD>
                                       <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Weighted<BR>Average<BR>Remaining<BR>Contractual<BR>Life in Years</B></TD>
                                       <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Aggregate<BR>Intrinsic Value</B></TD>
                                       <TD style="vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Outstanding balance September 30, 2012 </TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1,546,454</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">27.80</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Granted </TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">486,000</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">2.43</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Exercised </TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(30,250</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">2.48</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Forfeited, expired </TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(82,153</TD>
                                       <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">15.37</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Outstanding balance September 30, 2013 </TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1,920,051</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">22.31</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">4</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">445</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Granted</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1,427,000</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">2.35</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">6</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Exercised </TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(19,241</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">2.48</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">5</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">10</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Forfeited, expired</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(684,287</TD>
                                       <TD style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">16.48</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Outstanding balance September 30, 2014</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">2,643,523</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">13.15</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">5</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Exercisable shares, September 30, 2014</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1,217,854</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">25.81</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">3</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                 </DIV>
                              </TABLE>
                           </P>
                        </DIV><BR><DIV style="padding-top: 0px; text-align: center; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Restricted Stock Units</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The Company grants restricted stock units ("RSUs") to executive
                              officers and employees pursuant to the 2010 Plan from time to time.
                              There is no direct cost to the recipients of RSUs, except for any
                              applicable taxes.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">In December 2010, the Company issued RSU awards to our executive
                              officers and employees. Each RSU award represents one share of common
                              stock and each award vests annually over three years, with fifty
                              percent vesting on the first anniversary of the date of grant and the
                              remainder vesting in two equal installments on each anniversary
                              thereafter. Each year following the annual vesting date, between
                              January 1st and March 15th, the Company will issue common stock for
                              each vested RSU. During the period when the RSU is vested but not
                              distributed, the RSUs cannot be transferred and the grantee has no
                              voting rights. If the Company declares a dividend, RSU recipients
                              will receive payment based upon the percentage of RSUs that have
                              vested prior to the date of declaration. The costs of the awards,
                              determined as the fair market value of the shares on the grant date,
                              are expensed per the vesting schedule outlined in the award. For
                              example, the December 2010 RSU awards vested over three years and
                              were expensed 50% the first year and 25% the next two years; whereas,
                              the December 2009 RSU awards were expensed ratably over the four year
                              vesting period.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Based on historical experience of option cancellations, the Company
                              has estimated an annualized forfeiture rate of 10% for all employee
                              options and RSUs. Forfeiture rates will be adjusted over the
                              requisite service period when actual forfeitures differ, or are
                              expected to differ, from the estimate. As of September 30, 2014, the
                              executives, the board of directors and employees had 418,295 vested
                              and distributed RSUs.
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The stock-based compensation expense associated with the RSUs has
                              been recorded in the statement of operations and in additional
                              paid-in-capital on the balance sheets as&nbsp;follows:
                           </P>
                           <P style="text-align: center; margin: 0pt; padding: 0pt; ">
                              <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                                 <TR>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 65.70%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 6.22%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 5.83%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 0.17%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 8.16%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 6.05%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 7.71%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 0.17%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                 </TR>
                                 <DIV style="padding-top: 3px; text-align: center; ">
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="10" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>September 30,</B></TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style=" width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="4" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2013</B></TD>
                                       <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="4" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>2014</B></TD>
                                       <TD style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Stock compensation expense &#151; RSUs </TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="4" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">363</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                       <TD bgcolor="#CCEEFF" colspan="4" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">54</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                 </DIV>
                              </TABLE>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">At September 30, 2014, all of the RSU awards had vested and were distributed.</P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">The following table summarizes RSU activity from October 1, 2012
                              through September 30, 2014:
                           </P>
                           <P style="text-align: center; margin: 0pt; padding: 0pt; ">
                              <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                                 <TR>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 72.50%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 4.33%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 9.23%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 3.75%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 10.19%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                 </TR>
                                 <DIV style="padding-top: 3px; text-align: center; ">
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Shares</B></TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: center; padding-left: 00.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; "><B>Weighted<BR>Average<BR>Grant-Date<BR>Fair Value</B></TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; vertical-align: bottom; padding-left: 0pt; line-height: 1.2; margin-top: 0pt; text-align: center; ">&nbsp;</TD>
                                    </TR>
                                 </DIV>
                              </TABLE>
                           </P>
                        </DIV>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">F-24</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; "><A name="notespages"></A><A name="NotestoFinancialStatements"></A><A name="NotestoFinancialStatements"></A>Biodel Inc.<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center; ">Notes to Consolidated Financial Statements&#8201;&#151;&#8201;(Continued)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: bold; font-size: 10pt; text-align: center; ">(In thousands, except share and per share amounts)<BR></P>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: left; ">
               <DIV style="padding-top: 0px; text-align: left; ">
                  <DIV style="padding-top: 0px; text-align: left; ">
                     <DIV style="padding-top: 0px; text-align: left; ">
                        <DIV style="padding-top: 0px; text-align: left; ">
                           <P style="text-align: center; margin: 0pt; padding: 0pt; ">
                              <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; ">
                                 <TR>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 72.50%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 4.33%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 9.23%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 3.75%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 10.19%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Non-vested and outstanding balance at September 30, 2012 </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">68,153</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">$</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">10.51</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Changes during the period:</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Shares granted </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Shares vested and issued </TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(36,851</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">10.26</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Shares forfeited or expired </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">(6</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">)</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">15.80</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Non-vested and outstanding balance at September 30, 2013</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">31,296</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">10.48</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Changes during the period:</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Shares granted </TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                    <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Shares vested and issued </TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">31,296</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">10.48</TD>
                                    <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD style="border-bottom: 1pt black solid; vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; ">&nbsp;</TD>
                                 </TR>
                                 <TR style="text-align: left; ">
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Non-vested and outstanding balance at September 30, 2014</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; " width="0">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; padding-left: 00.00pt; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="vertical-align: bottom; line-height: 1.3; margin-top: 0pt; text-align: right; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">&#151;</TD>
                                    <TD bgcolor="#CCEEFF" style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                 </TR>
                              </TABLE>
                           </P>
                        </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                           <P>
                              <DIV style="padding-top: 0px; text-align: left; "><I><B style="text-align: left; font-size: 10.0pt; ">Shares Reserved for Future Issuance</B></I></DIV>
                           </P>
                           <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">As of September 30, 2014, the Company reserved shares of common stock
                              for future issuance as&nbsp;follows:
                           </P>
                           <P style="text-align: center; margin: 0pt; padding: 0pt; ">
                              <TABLE border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; table-layout: auto; overflow: visible; padding-top: 0; padding-bottom: 0; vertical-align: bottom; text-align: center; ">
                                 <TR>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 85.48%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 2.98%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                    <TD style="width: 11.54%; font-size: 1pt;">&nbsp;</TD>
                                    <TD style="font-size: 1pt;">&nbsp;</TD>
                                 </TR>
                                 <DIV style="padding-top: 3px; text-align: left; ">
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">2010 stock incentive plan </TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">5,240,202</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">2005 employee stock purchase plan </TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">500,000</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Common stock issuable upon conversion of Series B Preferred Stock </TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">1,950,000</TD>
                                       <TD bgcolor="#CCEEFF" style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 00.00pt; text-indent: -10.00pt; text-align: left; ">Warrants issued in connection with May 2011 registered direct offering </TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 00.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">2,256,929</TD>
                                       <TD style="line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Warrants issued in connection with June 2012 private placement </TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">2,749,469</TD>
                                       <TD bgcolor="#CCEEFF" style="border-bottom: 1pt black solid; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                    <TR style="text-align: left; ">
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-indent: -10.00pt; text-align: left; ">Total </TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; padding-left: 10.00pt; text-align: left; width: 15px; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD colspan="1" style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; text-indent: -10.00pt; ">&nbsp;</TD>
                                       <TD style="vertical-align: middle; line-height: 1.3; margin-top: 0pt; text-align: left; padding-left: 10.00pt; width: 15px; ">&nbsp;</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; text-align: right; vertical-align: bottom; text-indent: 0px; width: 15px; ">&nbsp;</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; padding-left: 00.00pt; text-align: right; ">12,696,600</TD>
                                       <TD style="border-bottom: 2pt black double; line-height: 1.3; margin-top: 0pt; vertical-align: bottom; text-align: left; text-indent: 0px; white-space: nowrap; ">&nbsp;</TD>
                                    </TR>
                                 </DIV>
                              </TABLE>
                           </P>
                        </DIV>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">10.&nbsp;Employee Benefit Plan</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">Effective January 1, 2006, the Company established a 401(k) plan
                           covering substantially all employees. Employees may contribute up to
                           100% of their salary per year (subject to maximum limit prescribed by
                           federal tax law). The Company may elect to make a discretionary
                           contribution or match a discretionary percentage of employee
                           contributions. For the years ended September 30, 2013 and 2014, the
                           Company had not elected to make any contributions to the&nbsp;plan.
                        </P>
                     </DIV><BR><DIV style="padding-top: 0px; text-align: left; ">
                        <P>
                           <DIV style="padding-top: 0px; text-align: left; "><B style="text-align: left; font-size: 10.0pt; ">11.&nbsp;Subsequent Event</B></DIV>
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; margin-top: 06.00pt; text-align: left; ">On November 11, 2014, the Company issued 131,128 restricted stock
                           units to Errol De Souza, its CEO, in place of a discretionary cash
                           bonus for the fiscal year ended September 30, 2014, in furtherance of
                           the Company's cash conservation measures. The restricted stock units
                           were valued using the market price of $1.50, which was the closing
                           price of the Company's common stock on November 10, 2014. The Company
                           has accrued and expensed $197 for the fiscal year ended September 30,
                           2014 for Errol De Souza's bonus. The restricted stock units vest in
                           full on September 30, 2015. Vested shares will be delivered on
                           September 30, 2015.
                        </P>
                        <P style="padding-top: 6px; line-height: 1.3; padding-left: 00.00pt; text-indent: 20.05pt; margin-top: 06.00pt; text-align: left; ">See Note 9 for additional subsequent events for the fund raising
                           relating to the July 2014 Purchase Agreement and May 2013 At-The
                           Market Issuance Sales Agreement.
                        </P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <DIV style=" margin-left: 1in; display: block; ">
            <P style="margin-top: 1pt; margin-bottom: 1pt; font-weight: normal; font-size: 10pt; text-align: center; ">F-25</P>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
         			<P STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P>
         			<PAGE>

      </DIV>
      <DIV style="display:block; width: 100%;">
         <DIV style=" margin-left: 1in; display: block; ">
            <DIV style="font-weight: normal; font-size: 10pt; padding-left: 0pt; text-decoration: none; background-color: white; color: black; padding-top: 6px; line-height: 1.3; text-align: center; ">
               <DIV style="padding-top: 0px; text-align: center; ">
                  <DIV style="padding-top: 0px; text-align: center; ">
                     <DIV style="padding-top: 0px; text-align: center; ">
                        <P style="padding-left: 0pt; padding-top: 6px; line-height: 1.3; text-align: center; "><A name="nofolio"></A>This page intentionally left&nbsp;blank
                        </P>
                     </DIV>
                  </DIV>
               </DIV>
            </DIV>
         </DIV>
         <HR style="margin-left: 50px;" NOSHADE ALIGN="CENTER" WIDTH="100%" SIZE=4>
      </DIV>
   </BODY>
</HTML>
</TEXT>
</DOCUMENT>
